Page last updated: 2024-10-26

diclofenac and Ache

diclofenac has been researched along with Ache in 429 studies

Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.

Research Excerpts

ExcerptRelevanceReference
"To evaluate the efficacy and safety of intra-articular injection of diclofenac etalhyaluronate (DF-HA) in patients with osteoarthritis (OA) of the hip, ankle, shoulder, or elbow."9.51Diclofenac-hyaluronate conjugate (diclofenac etalhyaluronate) intra-articular injection for hip, ankle, shoulder, and elbow osteoarthritis: a randomized controlled trial. ( Ikegami, H; Kano, K; Kubo, T; Kumai, T; Nishii, M; Seo, T, 2022)
"To compare the efficacy and safety of ketoprofen plasters and diclofenac plasters after 3 weeks of administration in patients with osteoarthritis-related knee pain."9.41Comparison of the Efficacy and Safety of Ketoprofen Plaster and Diclofenac Plaster for Osteoarthritis-Related Knee Pain: A Multicenter, Randomized, Active-Controlled, Open-Label, Parallel-Group, Phase III Clinical Trial. ( Cha, JE; Ershova, O; Hyun, BJ; Kastanayan, A; Krechikova, D; Nikulenkova, N; Polyakova, S; Shvarts, Y; Vinogradova, I; Yakushin, S, 2021)
"To compare the effectiveness of suppository diclofenac (100mg), cervical lidocaine 25mg -prilocaine 25mg cream (5% EMLA) and placebo in pain relief for hysterosalpingography."9.41Pain Relief for Hysterosalpingography: A Randomized Controlled, Double Blinded Trial Comparing Suppository Diclofenac, Prilocaine/Lignocaine (EMLA) Cream And Placebo. ( Agboghoroma, OC; Babandi, RM; Durojaiye, KW; Essiet, EA; Jimoh, KO, 2021)
"The application of topical diclofenac has been suggested as a possible treatment for Achilles tendinopathy."9.41Topical diclofenac vs placebo for the treatment of chronic Achilles tendinopathy: A randomized controlled clinical trial. ( Bovard, J; Bussin, E; Cairns, B; Fredericson, M; Gerschman, T; Scott, A, 2021)
"Both diclofenac and tramadol are equally effective in controlling pain in AP with similar safety profile."9.34Comparison of efficacy of diclofenac and tramadol in relieving pain in patients of acute pancreatitis: A randomized parallel group double blind active controlled pilot study. ( Dhaka, N; Gupta, V; Kochhar, R; Kumar, NS; Muktesh, G; Samanta, J; Samra, T; Sarma, P; Sinha, SK; Yadav, TD, 2020)
"Immediately post-IVI, patients in Group 2 reported significantly lower VAS pain scores compared to placebo while no statistically significant difference was found between patients that received topical diclofenac and placebo."9.24Diclofenac for pain associated with intravitreal injections: a prospective, randomized, placebo-controlled study. ( Georgakopoulos, CD; Makri, OE; Pagoulatos, DD; Pharmakakis, N; Tsapardoni, FN, 2017)
"To determine the effectiveness of diclofenac potassium combined with 2% lidocaine gel in reducing the pain of intrauterine device (IUD) insertion."9.22Diclofenac plus lidocaine gel for pain relief during intrauterine device insertion. A randomized, double-blinded, placebo-controlled study. ( Elsetohy, KA; Fouda, UM; Salah Eldin, NM; Shaban, MM; Sobh, SM; Tolba, HA, 2016)
"The results of our study showed that lidocaine puffs provided the best pain relief than the other analgesics used."9.20Effect of paracetamol, dexketoprofen trometamol, lidocaine spray, pethidine & diclofenac sodium application for pain relief during fractional curettage: A randomized controlled trial. ( Acmaz, G; Aksoy, H; Başer, M; Bayraktar, E; Müderris, İİ; Yilmaz, MO, 2015)
"These results show that the recommended daily dose of diclofenac potassium, in three 50 mg doses across the day and evening, offers effective menstrual pain relief across 24 h, compared with placebo, in women with severe primary dysmenorrhea."9.19The 24-h progression of menstrual pain in women with primary dysmenorrhea when given diclofenac potassium: a randomized, double-blinded, placebo-controlled crossover study. ( Avidon, I; Baker, FC; Iacovides, S, 2014)
"The aim of the study is to determine whether dermal scarification is equally effective for treating acute renal colic compared to diclofenac sodium intramuscular therapy."9.19Dermal scarification versus intramuscular diclofenac sodium injection for the treatment of renal colic: a prospective randomized clinical trial. ( Dimitriadis, G; Dimopoulos, P; Gkagkalidis, K; Ioannidis, A; Ioannidis, S; Kampantais, S; Laskaridis, L; Patsialas, C; Toutziaris, C; Vakalopoulos, I, 2014)
"Post-marketing study of combined therapy of OA of different localizations using diclofenac, aescin and original glucosamine sulfate in Russia and Ukraine demonstrated decrease of the pain severity, assessed by numeric rating scale, after 8 weeks of the treatment."9.17[Impact of combined therapy using glucosamine sulfate and anti-inflammatory agent on pain severity in patients with osteoarthritis: prospective, non-controlled postmarketing study]. ( Belen'kiĭ, DA; Borisenko, OV, 2013)
"Diclofenac suppository, a non-steroidal anti-inflammatory drug (NSAID), is used widely in rheumatoid arthritis (RA) patients with severe arthritic pain."9.17A diclofenac suppository-nabumetone combination therapy for arthritic pain relief and a monitoring method for the diclofenac binding capacity of HSA site II in rheumatoid arthritis. ( Arimori, K; Chosa, E; Fujita, K; Kawai, K; Nishio, T; Ogata, K; Setoguchi, N; Takamura, N; Tokunaga, J; Yamamoto, R, 2013)
"The aim of this study was to assess the efficacy of desmopressin nasal spray compared with diclofenac given intramuscularly in patients with acute renal colic caused by urolithiasis."9.15A comparative assessment of the clinical efficacy of intranasal desmopressin spray and diclofenac in the treatment of renal colic. ( Behera, NC; Kumar, S; Mandal, AK; Prasad, S; Sarkar, D; Singh, SK, 2011)
"We assessed the analgesic efficacy of levobupivacaine when administered as an adjuvant to diclofenac sodium in prostate biopsy pain management and effects of prostate biopsy on sexual function."9.14'Multimodal' approach to management of prostate biopsy pain and effects on sexual function: efficacy of levobupivacaine adjuvant to diclofenac sodium - a prospective randomized trial. ( Aktoz, T; Atakan, IH; Inci, O; Kaplan, M; Memis, D; Turan, U, 2010)
"To investigate the extent and time course of pain intensity upon treatment with a topical diclofenac patch compared with placebo in acute traumatic sport injury based on a validated and established end point."9.14Extent and time course of pain intensity upon treatment with a topical diclofenac sodium patch versus placebo in acute traumatic injury based on a validated end point: post hoc analysis of a randomized placebo-controlled trial. ( Kirch, W; Mueller, EA; Reiter, S, 2010)
"This randomized, controlled, double-blind clinical study in parallel groups evaluated the safety and efficacy of an oral combination diclofenac-cholestyramine, nucleotides (uridine and cytidine) and vitamin B12 versus the oral combination of nucleotides and vitamin B12 in the treatment of acute, non-traumatic pain."9.14Treatment of acute, non-traumatic pain using a combination of diclofenac-cholestyramine, uridine triphosphate, cytidine monophosphate, and hydroxycobalamin. ( Bendavit, GG; Cohen, JC; Geller, M; Higashi, R; Mibielli, MA; Nunes, CP; Oliveira, L; Scussel, AB, 2010)
"To compare the efficacy and safety of the COX-2 inhibitor lumiracoxib 400 mg once daily (qd) and naproxen 500 mg twice daily (bid) in patients with acute musculoskeletal pain caused by uncomplicated soft tissue injury."9.13A randomised, double-blind study comparing lumiracoxib with naproxen for acute musculoskeletal pain. ( Adekunle, F; Andrews, C; Ellis, G; Kinch, H; Kyle, C; Zachariah, J, 2008)
"Randomized clinical trials evaluating ultramicronised diclofenac, diclofenac, celecoxib, etodolac and placebo in patients with osteoarthritis were identified."9.12Efficacy of ultramicronised diclofenac in patients with osteoarthritis - systematic review with network meta-analysis. ( Auletta, LL; de Almeida Macedo, E; de Campos, GC; Kummer, AM; Millan Fachi, M; Papaleo Rosim, M, 2021)
"To evaluate the efficacy and upper gastrointestinal (UGI) safety of celecoxib, compared with nonspecific nonsteroidal anti-inflammatory drugs (NSAIDs), among patients with osteoarthritis."9.12Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study. ( Agrawal, NM; Andrade-Ortega, L; Bello, AE; Eisen, GM; Fort, JG; Goldstein, JL; Hanrahan, PS; Levy, RA; Singh, G; Stenson, WF; Triadafilopoulos, G; Wallemark, C, 2006)
"A randomized, controlled, cross-over trial compared single doses of 50 mg diclofenac potassium sachets and tablets with placebo in 328 patients with migraine pain, treating 888 attacks."9.12Efficacy and tolerability of diclofenac potassium sachets in migraine: a randomized, double-blind, cross-over study in comparison with diclofenac potassium tablets and placebo. ( Diener, HC; Edson, K; Gács, G; Lyczak, P; Montagna, P; Mulder, LJ; Schumann, G; Siegel, J; Zöller, B, 2006)
"To compare the efficacy and side effects of transdermal diclofenac patch with eutectic mixture of local anesthetic (EMLA) cream in attenuating venous cannulation pain."9.12Transdermal diclofenac patch vs eutectic mixture of local anesthetics for venous cannulation pain. ( Agarwal, A; Gautam, S; Gupta, D; Singh, U, 2007)
"To compare the time to presentation of the analgetic and anti-inflammatory effects of granulated and tablet nimesulide and sodium diclofenac since the start of therapy for gouty arthritis (GA)."9.12[Comparison of the time to analgetic and anti-inflammatory effect in the treatment of gouty arthritis with nimesulide and sodium diclofenac]. ( Barskova, VG; Eliseev, MS; Kudaeva, FM; Nasonova, VA, 2007)
"It was concluded that diclofenac sodium and paracetamol are effective and well tolerated as a short term treatment alternatives for acute ankle injuries."9.12The efficacy of paracetamol in the treatment of ankle sprains in comparison with diclofenac sodium. ( Agus, H; Kayali, C; Surer, L; Turgut, A, 2007)
"A previously published study comparing the efficacy of comfrey extract to a commercial diclofenac (CAS 78213-16-8) preparation in the treatment of unilateral ankle sprains is critically re-evaluated."9.12Comfrey extract ointment in comparison to diclofenac gel in the treatment of acute unilateral ankle sprains (distortions). ( Bulitta, M; D'Anchise, R; Giannetti, B, 2007)
"To evaluate rectal diclofenac in the relief of perineal pain after trauma during childbirth."9.11Rectal analgesia for the relief of perineal pain after childbirth: a randomised controlled trial of diclofenac suppositories. ( Crowther, CA; Dodd, JM; Hedayati, H; Hotham, N; Pearce, E, 2004)
"Diclofenac is a non-steroidal anti-inflammatory drug used for a variety of painful and inflammatory conditions."9.11Diclofenac systemic exposure is not increased when topical diclofenac is applied to ultraviolet-induced erythema. ( Kienzler, JL; Knops, A; Magnette, JL; Ménart, C; Nollevaux, F; Sallin, D, 2004)
"In a randomized, double-blind, controlled trial, 120 ASA 1 or 2 patients were allocated to receive diclofenac or normal saline as pretreatment to assess their effect on incidence and severity of pain during propofol injection."9.11Effect of diclofenac pretreatment on pain during propofol injection. ( Agarwal, D; Mohta, M; Sandhu, K; Sethi, AK, 2004)
"This double-blind randomized control study was conducted to evaluate whether a nonsteroidal anti-inflammatory drug (NSAID) could act as an effective pain control method during first trimester suction abortion, and whether co-treatment of NSAID with misoprostol will decrease the efficacy of the cervical ripening effect of misoprostol."9.10A study of co-treatment of nonsteroidal anti-inflammatory drugs (NSAIDs) with misoprostol for cervical priming before suction termination of first trimester pregnancy. ( Chan, CP; Ho, PC; Li, CF; Wong, CY, 2003)
"This was a randomized, double-blind, placebo-controlled study designed to compare the antihyperalgesic efficacy of topical (65 mg) and oral (93 mg) diclofenac via estimates of mechanical pain thresholds obtained at the site of induced inflammation with von Frey hairs."9.10Peripheral and central antihyperalgesic effects of diclofenac in a model of human inflammatory pain. ( Burian, M; Geisslinger, G; Seegel, M; Tegeder, I, 2003)
"There was minimal change in the degree of pain in the lidocaine-only and control groups during and after the treatment period."9.09Intrathecal methylprednisolone for intractable postherpetic neuralgia. ( Asai, M; Hashimoto, H; Kimura, F; Kotani, N; Kushikata, T; Matsuki, A; Muraoka, M; Yodono, M, 2000)
" The efficacy of misoprostol and ranitidine in the prevention of gastroduodenal damage in patients taking diclofenac for their cancer pain has been compared in this study."9.08Nonsteroidal antiinflammatory drugs for cancer pain: comparison between misoprostol and ranitidine in prevention of upper gastrointestinal damage. ( Bortolussi, R; Bortoluzzi, F; Cannizzaro, R; Fornasarig, M; Fracasso, A; Grazioli, I; Poletti, M; Sozzi, M; Testa, V; Valentini, M, 1995)
"Sixty female out-patients suffering from moderate to severe primary dysmenorrhea, aged 14-40 years (mean 27 years), entered this randomized, double-blind, 3-period, within-patient study, evaluating the efficacy and tolerability of diclofenac dispersible 46."9.08Comparative efficacy of diclofenac dispersible 50 mg and ibuprofen 400 mg in patients with primary dysmenorrhea. A randomized, double-blind, within-patient, placebo-controlled study. ( Bakshi, R; Fedele, L; Marchini, M; Pistai, R; Tozzi, L, 1995)
"The efficacy and tolerability of aceclofenac, a new non-steroidal anti-inflammatory drug (NSAID) was compared to that of ketoprofen in a multicentre, double-blind, prospective, randomized study of 3-months duration in patients with rheumatoid arthritis."9.08Aceclofenac in comparison to ketoprofen in the treatment of rheumatoid arthritis. ( Ansoleaga, JJ; Gijón-Baños, J; Martín-Mola, E, 1995)
"Topical application, 4 times daily for 2 weeks, of the diclofenac-hyaluronan gel to 59 osteoarthritis patients induced a significantly greater (p = 0."9.08A controlled clinical investigation of 3% diclofenac/2.5% sodium hyaluronate topical gel in the treatment of uncontrolled pain in chronic oral NSAID users with osteoarthritis. ( Roth, SH, 1995)
"To compare the efficacy and tolerability of single doses of diclofenac dispersible and naproxen granular in patients with acute, painful, minor sports injuries."9.08Diclofenac dispersible provides superior analgesia with faster onset of action compared to naproxen granular in patients with acute, painful, minor sports injuries. ( Colombo, G; Giombini, A; Pamich, T; Peruzzi, E; Pisati, R, 1997)
"Efficacy of diclofenac in pain relief after hip alloplasty was investigated in 35 patients aged 61-73 (mean 66)."9.08[Diclofenac for treatment of postoperative pain after hip arthroplasty in older patients]. ( Bohatyrewicz, A; Litke, J; Mikulski, K, 1997)
"A prospective double-blind randomized trial was conducted on 184 cancer patients with moderate to severe chronic pain to evaluate the analgesic efficacy and tolerability of diclofenac alone (50 mg q."9.08Double-blind evaluation of short-term analgesic efficacy of orally administered diclofenac, diclofenac plus codeine, and diclofenac plus imipramine in chronic cancer pain. ( Celani, MG; De Angelis, V; Del Favero, A; Fumi, G; Lupatelli, M; Minotti, V; Monza, G; Pisati, R; Righetti, E; Rossetti, R; Tonato, M, 1998)
"Two hundred and sixty patients with lumbago or sciatic pain participated in a multicenter observer-blind randomized trial to compare the efficacy and tolerability of dipyrone 2."9.07Parenteral dipyrone versus diclofenac and placebo in patients with acute lumbago or sciatic pain: randomized observer-blind multicenter study. ( Babej-Dölle, R; Eckmeyer, J; Freytag, S; Schinzel, S; Schmeider, G; Stankov, G; Zerle, G, 1994)
"The putative central analgesic activity of diclofenac was investigated in a human experimental pain model using intraneural electrical stimulation in the median nerve."9.07Diclofenac evaluated in a human experimental model of central pain. ( Björkman, R; Elam, M, 1993)
"The effect of diclofenac on pain after arthroscopy of the knee joint was investigated in 64 patients."9.07Diclofenac for pain relief after arthroscopy: a comparison of early and delayed treatment. ( Björkman, R; Brodd, B; Sandin, R; Stam, H; Sternlo, JE, 1993)
" as additive treatment to parenteral patient-controlled administration therapy (PCAT) with morphine in cancer pain has been investigated in a double-blind study."9.07Morphine-sparing effect of diclofenac in cancer pain. ( Björkman, R; Hedner, J; Ullman, A, 1993)
"At Helsinki University Central Hospital in Finland, clinical researchers divided 169 women into two groups (group 1: diagnostic laparoscopies; group 2: laparoscopic sterilizations) as part of a study to evaluate the effect of intravenous diclofenac on postoperative pain, nausea, and recovery after outpatient gynecological laparoscopy."9.07Effect of intravenous diclofenac on pain and recovery profile after day-case laparoscopy. ( Hovorka, J; Kallela, H; Korttila, K, 1993)
"In a multicentric, interindividual, double-blind study, the analgesic action, duration of effect, tolerability and side effects of the new combination preparation, Combaren (diclofenac-Na 50 mg+codeine phosphate 50 mg), were compared with those of diclofenac-Na 50 mg (Voltaren 50) in 184 patients with severe tumor-related pain."9.07[Drug therapy in severe tumor pain. Comparative study of a new combination preparation versus diclofenac-Na]. ( Strobel, E, 1992)
"A double-blind, crossover study was undertaken in general practice to compare the efficacy and tolerability of a new controlled-release indomethacin with sustained-release diclofenac sodium in patients with osteoarthritis."9.06Controlled-release indomethacin and sustained-release diclofenac sodium in the treatment of osteoarthritis: a comparative controlled clinical trial in general practice. ( Gostick, N; James, IG; Khong, TK; Miller, AJ; Roy, P; Shepherd, PR, 1990)
"The efficacy and tolerability of a new, controlled-release indomethacin (75 mg) tablet was compared to that of a sustained-release diclofenac sodium (100 mg) tablet in 84 patients with rheumatoid arthritis."9.06Controlled-release indomethacin and sustained-release diclofenac sodium in the treatment of rheumatoid arthritis: a comparative controlled clinical trial. ( Crowley, B; Hamill, JJ; Lyndon, S; McKellican, JF; Miller, AJ; Williams, P, 1990)
"Twenty-four patients with localized myofascial pain were treated with injections, 11 with 2 ml lidocaine 1% and 13 with 2 ml diclofenac (Voltaren) (50 mg) given in the trigger-point."9.06Diclofenac versus lidocaine as injection therapy in myofascial pain. ( Frost, A, 1986)
"The efficacy and tolerability of 100 mg suppositories of diclofenac sodium (Voltaren) and indomethacin were investigated in relieving symptoms of rheumatoid arthritis."9.05Comparison of diclofenac and indomethacin suppositories in rheumatoid arthritis. ( Valindas, E; Wafin, F; Wuolijoki, E, 1984)
"The efficacy of diclofenac sodium was investigated in the painful symptoms of primary dysmenorrhea and in reducing menstrual bleeding."9.05Treatment of primary dysmenorrhea with diclofenac sodium. ( Pulkkinen, MO; Riihiluoma, P; Wuolijoki, E, 1981)
"Diclofenac is commonly used for acute pain in children, but is not licensed for this indication in all age groups."8.85Diclofenac for acute pain in children. ( Pritchard, D; Savage, I; Standing, JF; Waddington, M, 2009)
"Topical diclofenac is widely used in the treatment of pain and inflammation."8.84Topical diclofenac and its role in pain and inflammation: an evidence-based review. ( Altman, R; Bellamy, N; Brühlmann, P; Da Silva, J; Huskisson, E; Taylor, RS; Zacher, J, 2008)
" It has proved as effective as diclofenac, naproxen and piroxicam in patients with osteoarthritis, diclofenac, ketorolac, tenoxicam and indomethacin in patients with rheumatoid arthritis and tenoxicam, naproxen and indomethacin in patients with ankylosing spondylitis."8.82Aceclofenac in the management of inflammatory pain. ( Legrand, E, 2004)
"Trials of 2 to 6 months' duration have shown aceclofenac to be an effective agent in the management of pain and rheumatic disease."8.81Aceclofenac: a reappraisal of its use in the management of pain and rheumatic disease. ( Dooley, M; Dunn, CJ; Spencer, CM, 2001)
"The aim of this article is to critically review the potential role of aceclofenac in the treatment of inflammatory pain and chronic osteoarticular disorder, based on its activity on the mediators of inflammation, its effect on cartilage remodeling and on the results of clinical studies comparing aceclofenac with other NSAIDs in these disorders."8.81[What is the role of aceclofenac in the therapeutic arsenal against chronic osteoarthritis pathologies?]. ( Henrotin, Y; Paul, I; Reginster, JY, 2001)
"A meta-analysis was done with the final data from three trials that provided the first results relating to efficacy and safety of the new sustained-release (SR) formulation of etodolac versus established nonsteroidal anti-inflammatory drugs (NSAIDs) in the treatment of osteoarthritis (OA) of the knee."8.78Meta-analysis of three double-blind comparative trials with sustained-release etodolac in the treatment of osteoarthritis of the knee. ( Porzio, F, 1993)
" Published data indicate that diclofenac 75 to 150mg daily (25 to 50mg 3 times daily) is comparable in efficacy with ordinary aspirin 3 to 5g daily and indomethacin 75 to 150mg daily in rheumatoid arthritis and with indomethacin in osteoarthritis."8.76Diclofenac sodium: a review of its pharmacological properties and therapeutic use in rheumatic diseases and pain of varying origin. ( Avery, GS; Brogden, RN; Heel, RC; Pakes, GE; Speight, TM, 1980)
"Joint pain decreased after 2 weeks of therapy in all patients during treatment with Voltaren Emulgel 2% (diclofenac diethylamine 2%) in both groups."8.02[Evaluation of topical therapy of patients with osteoarthritis of small joints of the hands with Voltaren® Emulgel® 2% (diclofenac diethylamine 2%)]. ( Gromova, MA; Tsurko, VV, 2021)
"Using diclofenac mouthwash, 9/10 patients experienced pain score reduction from day 0 (mean score 6."7.96Diclofenac Mouthwash as a potential therapy for reducing pain and discomfort in chemo-radiotherapy-induced oral mucositis. ( Alam, P; Brennan, PA; Donnelly, O; Fedele, S; Gomez, RS; Lewthwaite, R; McGuigan, S; Sakthithasan, P, 2020)
" The goal of this study was to determine the impact of administration of the non-selective NSAID diclofenac in the inflammatory phase of bone repair in mice with or without lipopolysaccharide-induced systemic inflammation."7.91Defective bone repair in diclofenac treated C57Bl6 mice with and without lipopolysaccharide induced systemic inflammation. ( Abou-Rjeili, M; Akoury, E; Al-Saran, Y; Awlia, A; Chan, D; Henderson, JE; Lemarié, CA; Martineau, PA; Ouellet, S; Ramirez-Garcia-Luna, JL; Wong, TH, 2019)
"In this work, we propose a surgical suture that can sustainably release diclofenac (DF) for the local pain relief of surgical wounds."7.85Surgical suture braided with a diclofenac-loaded strand of poly(lactic-co-glycolic acid) for local, sustained pain mitigation. ( Choy, YB; Heo, CY; Huh, BK; Kim, BH; Kim, KR; Kim, SN; Lee, SH; Park, CG, 2017)
"To determine the frequency of perineal pain after childbirth after a single dose of diclofenac rectal suppository."7.83Diclofenac rectal suppository: an effective modality for perineal pain. ( Baloch, R; Memon, NY; Naz, S; Sattar, A, 2016)
"Topical diclofenac, with and without dimethyl sulfoxide (DMSO), modestly improves pain and function scores (by 4%-8%) for as long as 12 weeks in patients with osteoarthritis (OA) of the knee."7.81Clinical inquiry: does topical diclofenac relieve osteoarthritis pain? ( Hodge, B; Skolnik, D, 2015)
" In the present study, we compared the effects of crocin, safranal and diclofenac on local inflammation and its induced pain in rats."7.79Comparison of the effects of crocin, safranal and diclofenac on local inflammation and inflammatory pain responses induced by carrageenan in rats. ( Eghdami, K; Erfanparast, A; Farshid, AA; Samadi, F; Tamaddonfard, E, 2013)
"A pan-European study involving 23407 patients with pain due to various inflammatory or degenerative rheumatic diseases was undertaken in Austria, Belgium, Germany and Greece, to evaluate overall pain relief and satisfaction with aceclofenac therapy."7.71Patient and physician satisfaction with aceclofenac: results of the European Observational Cohort Study (experience with aceclofenac for inflammatory pain in daily practice). Aceclofenac is the treatment of choice for patients and physicians in the manage ( Aslanidis, S; De Bast, J; Leeb, B; Lemmel, EM, 2002)
"This study determines the effects of dexamethasone versus co-administered dexamethasone and diclofenac, on carrageenan-evoked spinal c-Fos expression and peripheral oedema in the freely moving rat."7.69Enhanced effects of co-administered dexamethasone and diclofenac on inflammatory pain processing and associated spinal c-Fos expression in the rat. ( Besson, JM; Buritova, J; Chapman, V; Honoré, P, 1996)
"The effects of combined single oral treatments with non-steroidal anti-inflammatory drugs (NSAIDs) and the non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist dextromethorphan (DM) on arthritic pain were examined in a rat model of adjuvant-induced arthritis."7.69Effects of the combined oral administration of NSAIDs and dextromethorphan on behavioral symptoms indicative of arthritic pain in rats. ( Caruso, FS; Frenk, H; Lu, J; Mao, J; Mayer, DJ; Price, DD, 1996)
"Adhesive capsulitis or frozen shoulder is a common condition characterized by shoulder pain and stiffness in which conservative methods of treatment such as glucocorticosteroids, anti-inflammatory drugs, and physiotherapy play a significant part."6.73Pain relieving effect of short-course, pulse prednisolone in managing frozen shoulder. ( Haghighi, MH; Hemmati, AA; Saeidian, SR, 2007)
"At day 3, pain was reduced by -20."6.71Analgesic efficacy of a lecithin-vehiculated diclofenac epolamine gel in shoulder periarthritis and lateral epicondylitis: a placebo-controlled, multicenter, randomized, double-blind clinical trial. ( Cacchio, A; Forgács, A; Monteforte, P; Rovetta, G; Spacca, G, 2005)
"Population pharmacokinetics of a fast release diclofenac were assessed with special focus on pharmacodynamic implications."6.69Population pharmacokinetics of fast release oral diclofenac in healthy volunteers: relation to pharmacodynamics in an experimental pain model. ( Brune, K; Drover, D; Geisslinger, G; Kettenmann, B; Kobal, G; Lötsch, J; Renner, B, 2000)
"Diclofenac patch was superior to placebo patch in relieving pain."6.69Topical diclofenac patch relieves minor sports injury pain: results of a multicenter controlled clinical trial. ( Devers, A; Friedman, E; Galer, BS; Perander, J; Rowbotham, M, 2000)
"Ibuprofen was also better tolerated than diclofenac sodium (100 mg/day), the latter being associated with gastrointestinal side effects in a significant proportion of patients."6.68Ibuprofen and diclofenac sodium in the treatment of osteoarthritis: a comparative trial of two once-daily sustained-release NSAID formulations. ( Baumgartner, H; Blum, W; Bruhin, A; Gallachi, G; Goldinger, G; Saxer, M; Schwarz, HA; Trost, H, 1996)
" After achieving adequate analgesia with regular dosing of oral methadone (T1), patient-controlled analgesia with methadone was administered for 3 days (T2)."6.68Opioid-sparing effect of diclofenac in cancer pain. ( Barresi, L; Caligara, M; Dardanoni, G; Mercadante, S; Sapio, M; Serretta, R, 1997)
"Codeine 60 mg was significantly superior to placebo in all pain measures."6.66Experimental pain induced by electrical and thermal stimulation of the skin in healthy man: sensitivity to 75 and 150 mg diclofenac sodium in comparison with 60 mg codeine and placebo. ( Gaupmann, G; Mittelbach, G; Schneider, S; Stacher, G; Steinringer, H; Winklehner, S, 1986)
"Diclofenac HPβCD was generally well tolerated in clinical trials, with injection-site reactions among the most commonly reported adverse events."6.52Diclofenac sodium injection (akis(®), dicloin (®)): a review of its use in the management of pain. ( Blair, HA; Plosker, GL, 2015)
"Many types of acute pain have been managed with traditional oral non-steroidal anti-inflammatory drugs (NSAIDs) and selective cyclooxygenase-2 inhibitors (coxibs)."6.46Topical diclofenac epolamine patch 1.3% for treatment of acute pain caused by soft tissue injury. ( Argoff, CE; McCarberg, BH, 2010)
" The incidence of adverse events in patients taking single or multiple doses of diclofenac potassium is similar to that of ibuprofen and placebo."6.44Diclofenac potassium 12.5mg tablets for mild to moderate pain and fever: a review of its pharmacology, clinical efficacy and safety. ( Moore, N, 2007)
" The chronic use of diclofenac sodium can lead to adverse gastrointestinal problems."6.43The use of topical diclofenac for pain in osteoarthritis of the knee: a review. ( Banning, M, 2006)
"Aceclofenac is a phenylacetic acid derivative with anti-inflammatory and analgesic properties similar to those of diclofenac."6.39Aceclofenac. A review of its pharmacodynamic properties and therapeutic potential in the treatment of rheumatic disorders and in pain management. ( Brogden, RN; Wiseman, LR, 1996)
" This results in an increase in the rate of absorption of the active compound and, consequently, in an earlier onset of analgesic action."6.38Piroxicam-beta-cyclodextrin in the treatment of acute pain of rheumatic disease. ( Franchimont, P; Reginster, JY, 1993)
"Diclofenac is a non-steroidal anti-inflammatory drug (NSAID) advocated for use in painful and inflammatory rheumatic and certain non-rheumatic conditions."6.16Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. ( Sorkin, EM; Todd, PA, 1988)
"Dry needling on latent and active MTrPs combined with stretching and oral diclofenac combined with stretching can effectively relieve pain, improve function, and restore knee ROM affected by KOA."5.69Dry needling on latent and active myofascial trigger points versus oral diclofenac in patients with knee osteoarthritis: a randomized controlled trial. ( Dong, YL; Huang, QM; Ma, YT; Wang, B; Xie, WP; Zheng, YJ, 2023)
"Non-inferiority of SFPP to diclofenac gel was demonstrated in the efficacy for pain on rising from a chair."5.51Efficacy and safety of S-flurbiprofen plaster in knee osteoarthritis patients: A 2-week randomized controlled Phase III clinical trial compared to diclofenac gel. ( Fuady, A; Matsumoto, H; Tomatsu, K; Yasuda, S, 2022)
"To evaluate the efficacy and safety of intra-articular injection of diclofenac etalhyaluronate (DF-HA) in patients with osteoarthritis (OA) of the hip, ankle, shoulder, or elbow."5.51Diclofenac-hyaluronate conjugate (diclofenac etalhyaluronate) intra-articular injection for hip, ankle, shoulder, and elbow osteoarthritis: a randomized controlled trial. ( Ikegami, H; Kano, K; Kubo, T; Kumai, T; Nishii, M; Seo, T, 2022)
"These findings suggest that acupuncture plus intramuscular injection of diclofenac is safe and provides fast and substantial pain relief for patients with renal colic compared with sham acupuncture in the emergency setting."5.51Effect of Adjunctive Acupuncture on Pain Relief Among Emergency Department Patients With Acute Renal Colic Due to Urolithiasis: A Randomized Clinical Trial. ( Cao, Y; Jia, LC; Li, HW; Liu, BL; Liu, CZ; Pei, XL; Qu, ZC; Shi, GX; Tu, JF; Wang, LQ; Yan, SY; Yang, JW; Yao, WH, 2022)
"There is a strong correlation between treatment resistant depression and increase in inflammatory cytokines in plasma and cerebrospinal fluid."5.48Population scale retrospective analysis reveals distinctive antidepressant and anxiolytic effects of diclofenac, ketoprofen and naproxen in patients with pain. ( Abagyan, R; Cohen, IV; Lee, KC; Makunts, T, 2018)
" Both 27 and 48 demonstrated robust activity in the acute rat monoiodoacetate-induced osteoarthritis model of pain, and subchronic dosing of 48 showed a shift to a lower EC50 over 7 days."5.43Substituted Indazoles as Nav1.7 Blockers for the Treatment of Pain. ( Daanen, JF; DeGoey, DA; El-Kouhen, OF; Fricano, MM; Frost, JM; Ghoreishi-Haack, N; Gum, RJ; Hsieh, GC; Kort, ME; Lundgaard, GL; Matulenko, MA; Neelands, T; Pai, M; Shi, L; Zhan, C; Zhang, XF, 2016)
"Aceclofenac (ACE) is a systematically designed drug, developed to circumvent the concerns associated with diclofenac."5.43Novel elastic membrane vesicles (EMVs) and ethosomes-mediated effective topical delivery of aceclofenac: a new therapeutic approach for pain and inflammation. ( Goyal, H; Katare, OP; Raza, K; Sharma, G; Thakur, K, 2016)
"The mechanical hyperalgesia was assessed by the Randall Selitto paw pressure test, which determines the paw withdrawal thresholds."5.43Association of terpinolene and diclofenac presents antinociceptive and anti-inflammatory synergistic effects in a model of chronic inflammation. ( Almeida, FR; Cunha, FV; Lopes, EM; Macedo, EM; Oliveira, FA; Piauilino, CA; Santos, WC; Sousa, BP; Sousa, DP, 2016)
"To compare the efficacy and safety of ketoprofen plasters and diclofenac plasters after 3 weeks of administration in patients with osteoarthritis-related knee pain."5.41Comparison of the Efficacy and Safety of Ketoprofen Plaster and Diclofenac Plaster for Osteoarthritis-Related Knee Pain: A Multicenter, Randomized, Active-Controlled, Open-Label, Parallel-Group, Phase III Clinical Trial. ( Cha, JE; Ershova, O; Hyun, BJ; Kastanayan, A; Krechikova, D; Nikulenkova, N; Polyakova, S; Shvarts, Y; Vinogradova, I; Yakushin, S, 2021)
"To compare the effectiveness of suppository diclofenac (100mg), cervical lidocaine 25mg -prilocaine 25mg cream (5% EMLA) and placebo in pain relief for hysterosalpingography."5.41Pain Relief for Hysterosalpingography: A Randomized Controlled, Double Blinded Trial Comparing Suppository Diclofenac, Prilocaine/Lignocaine (EMLA) Cream And Placebo. ( Agboghoroma, OC; Babandi, RM; Durojaiye, KW; Essiet, EA; Jimoh, KO, 2021)
" Indomethacin was superior to celecoxib for pain score at rest at 8-12 h and celecoxib + parecoxib, diclofenac, and ketorolac for pain score on movement at 48 h."5.41Comparison of different nonsteroidal anti-inflammatory drugs for cesarean section: a systematic review and network meta-analysis. ( Blake, L; Carvalho, B; Carver, AL; Desai, N; Murdoch, I; O'Carroll, JE; Onwochei, DN; Sultan, P, 2023)
"The application of topical diclofenac has been suggested as a possible treatment for Achilles tendinopathy."5.41Topical diclofenac vs placebo for the treatment of chronic Achilles tendinopathy: A randomized controlled clinical trial. ( Bovard, J; Bussin, E; Cairns, B; Fredericson, M; Gerschman, T; Scott, A, 2021)
"6 h, oral bioavailability of 37% and 90%) with anti-inflammatory activity (ED 50 = 37 micromol/kg, mouse) and efficacy in pain models (thermal hyperalgesia, ED 50 = 72 micromol/kg, rat)."5.35Rotationally constrained 2,4-diamino-5,6-disubstituted pyrimidines: a new class of histamine H4 receptor antagonists with improved druglikeness and in vivo efficacy in pain and inflammation models. ( Adair, RM; Altenbach, RJ; Bettencourt, BM; Brioni, JD; Cowart, MD; Drizin, I; Esbenshade, TA; Fix-Stenzel, SR; Honore, P; Hsieh, GC; Liu, H; Marsh, KC; McPherson, MJ; Milicic, I; Miller, TR; Sullivan, JP; Wetter, JM; Wishart, N; Witte, DG, 2008)
"Both diclofenac and tramadol are equally effective in controlling pain in AP with similar safety profile."5.34Comparison of efficacy of diclofenac and tramadol in relieving pain in patients of acute pancreatitis: A randomized parallel group double blind active controlled pilot study. ( Dhaka, N; Gupta, V; Kochhar, R; Kumar, NS; Muktesh, G; Samanta, J; Samra, T; Sarma, P; Sinha, SK; Yadav, TD, 2020)
" An open, randomized, prospective, longitudinal, comparative, and experimental clinical study was conducted to evaluate the efficacy of subcostal nerve block with lidocaine, comparing it in combination with tramadol or diclofenac for pain control during ESWL."5.27Comparison of three analgesic drug regimens with twelfth subcostal nerve block for pain control during extracorporeal shock wave lithotripsy. ( Del Rosario-Santiago, M; Garduño-Arteaga, LM; Jaspersen-Gastelum, J; Maldonado-Avila, M; Rios-Davila, V; Vela-Mollinedo, RA; Virgen-Gutierrez, F, 2018)
"Immediately post-IVI, patients in Group 2 reported significantly lower VAS pain scores compared to placebo while no statistically significant difference was found between patients that received topical diclofenac and placebo."5.24Diclofenac for pain associated with intravitreal injections: a prospective, randomized, placebo-controlled study. ( Georgakopoulos, CD; Makri, OE; Pagoulatos, DD; Pharmakakis, N; Tsapardoni, FN, 2017)
"This review was designated to evaluate the efficacy of parenteral ketorolac in treating acute migraine headache."5.22Efficacy of ketorolac in the treatment of acute migraine attack: A systematic review and meta-analysis. ( Abu Bakar, MA; Baharuddin, KA; Norhayati, MN; Nurathirah, MN; Yazid, MB, 2022)
"A phase II, 4 week, randomized, double-blind, parallel-group, two-arm, vehicle-controlled study compared pain relief with diclofenac sodium 2% topical solution versus control (vehicle only) in patients aged 40 to 85 years with radiographically confirmed primary OA of the knee."5.22Efficacy and safety of diclofenac sodium 2% topical solution for osteoarthritis of the knee: a randomized, double-blind, vehicle-controlled, 4 week study. ( Holt, RJ; Kent, JD; Wadsworth, LT, 2016)
"To determine the effectiveness of diclofenac potassium combined with 2% lidocaine gel in reducing the pain of intrauterine device (IUD) insertion."5.22Diclofenac plus lidocaine gel for pain relief during intrauterine device insertion. A randomized, double-blinded, placebo-controlled study. ( Elsetohy, KA; Fouda, UM; Salah Eldin, NM; Shaban, MM; Sobh, SM; Tolba, HA, 2016)
"The combination of ibuprofen/paracetamol, taken immediately after initial endodontic therapy and root canal preparation in teeth with irreversible pulpitis, reduced post-endodontic pain (ClinicalTrials."5.22Double-blind Randomized Placebo-controlled Clinical Trial of Efficiency of Nonsteroidal Anti-inflammatory Drugs in the Control of Post-endodontic Pain. ( Abubakr, NH; Elzaki, WM; Ibrahim, YE; Ziada, HM, 2016)
"Patients with knee OA (n = 35) were compared on QST responses to a demographically-matched pain-free control group (n = 39), after which patients completed a month-long treatment study of diclofenac sodium topical gel (1 %), applied up to 4 times daily."5.22Variability in conditioned pain modulation predicts response to NSAID treatment in patients with knee osteoarthritis. ( Cornelius, M; Dolman, AJ; Edwards, RR; Finan, PH; Lazaridou, A; Martel, MO; Wasan, AD, 2016)
"The results of our study showed that lidocaine puffs provided the best pain relief than the other analgesics used."5.20Effect of paracetamol, dexketoprofen trometamol, lidocaine spray, pethidine & diclofenac sodium application for pain relief during fractional curettage: A randomized controlled trial. ( Acmaz, G; Aksoy, H; Başer, M; Bayraktar, E; Müderris, İİ; Yilmaz, MO, 2015)
"These results show that the recommended daily dose of diclofenac potassium, in three 50 mg doses across the day and evening, offers effective menstrual pain relief across 24 h, compared with placebo, in women with severe primary dysmenorrhea."5.19The 24-h progression of menstrual pain in women with primary dysmenorrhea when given diclofenac potassium: a randomized, double-blinded, placebo-controlled crossover study. ( Avidon, I; Baker, FC; Iacovides, S, 2014)
"The aim of the study is to determine whether dermal scarification is equally effective for treating acute renal colic compared to diclofenac sodium intramuscular therapy."5.19Dermal scarification versus intramuscular diclofenac sodium injection for the treatment of renal colic: a prospective randomized clinical trial. ( Dimitriadis, G; Dimopoulos, P; Gkagkalidis, K; Ioannidis, A; Ioannidis, S; Kampantais, S; Laskaridis, L; Patsialas, C; Toutziaris, C; Vakalopoulos, I, 2014)
"To investigate whether sublingual misoprostol administered one hour before intrauterine device (IUD) insertion reduces failed insertions, insertion-related complications and pain in parous women delivered only by elective caesarean section (CS)."5.17Sublingual misoprostol prior to insertion of a T380A intrauterine device in women with no previous vaginal delivery. ( Ibrahim, ZM; Sayed Ahmed, WA, 2013)
"Diclofenac 4% spray gel rapidly relieves pain and improves mobility in patients with acute, uncomplicated ankle sprain and is well tolerated."5.17A randomized, double-blind, placebo-controlled multicentre study to evaluate the efficacy and safety of diclofenac 4% spray gel in the treatment of acute uncomplicated ankle sprain. ( Giannetti, B; Menke, G; Novellini, R; Predel, HG; Seigfried, B, 2013)
"To compare the clinical efficacy between locally applied diclofenac diethylamine gel, EMLA cream and systemically given diclofenac sodium for the pain relief during extracorporeal shock wave lithotripsy (SWL) using Dornier Delta Compact Lithotripter."5.17Comparative study between three analgesic agents for the pain management during extracorporeal shock wave lithotripsy. ( Liu, J; Zang, YJ, 2013)
"Post-marketing study of combined therapy of OA of different localizations using diclofenac, aescin and original glucosamine sulfate in Russia and Ukraine demonstrated decrease of the pain severity, assessed by numeric rating scale, after 8 weeks of the treatment."5.17[Impact of combined therapy using glucosamine sulfate and anti-inflammatory agent on pain severity in patients with osteoarthritis: prospective, non-controlled postmarketing study]. ( Belen'kiĭ, DA; Borisenko, OV, 2013)
"Diclofenac suppository, a non-steroidal anti-inflammatory drug (NSAID), is used widely in rheumatoid arthritis (RA) patients with severe arthritic pain."5.17A diclofenac suppository-nabumetone combination therapy for arthritic pain relief and a monitoring method for the diclofenac binding capacity of HSA site II in rheumatoid arthritis. ( Arimori, K; Chosa, E; Fujita, K; Kawai, K; Nishio, T; Ogata, K; Setoguchi, N; Takamura, N; Tokunaga, J; Yamamoto, R, 2013)
"Hyaluronic acid alone and in combination with sodium clodronate or diclofenac sodium produced a significant improvement in mean VAS pain score at 3 and 6-month follow-up."5.17Preliminary study of highly cross-linked hyaluronic acid-based combination therapy for management of knee osteoarthritis-related pain. ( Iannitti, T; Palmieri, B; Rottigni, V, 2013)
"To investigate if the 180-mg diclofenac epolamine and heparin sodium 5600 IU medicated plaster (DHEP-heparin) is more effective for pain reduction in mild-to-moderate contusions than the reference diclofenac epolamine 180 mg plaster (DHEP)."5.16Efficacy and tolerability of DHEP-heparin plaster in reducing pain in mild-to-moderate muscle contusions: a double-blind, randomized trial. ( Gugliotta, B; Hoffmann, P; Kopačka, P; Rovati, S, 2012)
"The aim of this study was to assess the efficacy of desmopressin nasal spray compared with diclofenac given intramuscularly in patients with acute renal colic caused by urolithiasis."5.15A comparative assessment of the clinical efficacy of intranasal desmopressin spray and diclofenac in the treatment of renal colic. ( Behera, NC; Kumar, S; Mandal, AK; Prasad, S; Sarkar, D; Singh, SK, 2011)
"To assess the spontaneous passage rate for patients being treated with alfuzosin 10mg daily after presenting with an acute ureteral stone compared with a control group, and to assess the respective pain control status."5.15Medical expulsive therapy using alfuzosin for patient presenting with ureteral stone less than 10mm: a prospective randomized controlled trial. ( Chau, LH; Fan, CW; Fung, BT; Li, JC; Li, MK; Tai, DC, 2011)
"The objective of this study was to evaluate the benefit of a seven-day buprenorphine transdermal patch for patients with chronic musculoskeletal pain previously receiving long-term treatment with ibuprofen or diclofenac alone."5.15[Application of a seven-day buprenorphine transdermal patch in multimorbid patients on long-term ibuprofen or diclofenac]. ( Böhme, K; Heckes, B; Thomitzek, K, 2011)
"In this prospective and randomized study, we aimed to compare the efficacy of a eutectic mixture of local anesthetics (EMLA) cream, diclofenac sodium (DS) and EMLA in combination with DS (EMLA+DS) for pain management during extracorporeal shock wave lithotripsy (ESWL)."5.14Comparison of three analgesic treatment protocols for pain management during extracorporeal shock wave lithotripsy. ( Eryildirim, B; Faydaci, G; Kuyumcuoğlu, U; Tarhan, F; Uruç, F, 2009)
"We assessed the analgesic efficacy of levobupivacaine when administered as an adjuvant to diclofenac sodium in prostate biopsy pain management and effects of prostate biopsy on sexual function."5.14'Multimodal' approach to management of prostate biopsy pain and effects on sexual function: efficacy of levobupivacaine adjuvant to diclofenac sodium - a prospective randomized trial. ( Aktoz, T; Atakan, IH; Inci, O; Kaplan, M; Memis, D; Turan, U, 2010)
"To investigate the extent and time course of pain intensity upon treatment with a topical diclofenac patch compared with placebo in acute traumatic sport injury based on a validated and established end point."5.14Extent and time course of pain intensity upon treatment with a topical diclofenac sodium patch versus placebo in acute traumatic injury based on a validated end point: post hoc analysis of a randomized placebo-controlled trial. ( Kirch, W; Mueller, EA; Reiter, S, 2010)
"The severity of SWL-related pain was significantly better tolerated with dexketoprofen trometamol."5.14Comparison of the analgesic effects of dexketoprofen and diclofenac during shockwave lithotripsy: a randomized, double-blind clinical trial. ( Akduman, B; Erol, B; Hanci, V; Mungan, A; Tokgoz, H; Turksoy, O; Yurtlu, S, 2010)
"This randomized, controlled, double-blind clinical study in parallel groups evaluated the safety and efficacy of an oral combination diclofenac-cholestyramine, nucleotides (uridine and cytidine) and vitamin B12 versus the oral combination of nucleotides and vitamin B12 in the treatment of acute, non-traumatic pain."5.14Treatment of acute, non-traumatic pain using a combination of diclofenac-cholestyramine, uridine triphosphate, cytidine monophosphate, and hydroxycobalamin. ( Bendavit, GG; Cohen, JC; Geller, M; Higashi, R; Mibielli, MA; Nunes, CP; Oliveira, L; Scussel, AB, 2010)
"to prospectively evaluate degree of pain during transrectal ultrasound-guided prostate biopsy after receiving analgesics treatment of oral morphine sulphate compared to suppository sodium diclofenac."5.13Comparison of efficacy between oral morphine sulphate and diclofenac suppository for analgesia during transrectal ultrasound-guided prostate biopsy. ( Haswir, H; Umbas, R, 2008)
"To compare the efficacy and safety of the COX-2 inhibitor lumiracoxib 400 mg once daily (qd) and naproxen 500 mg twice daily (bid) in patients with acute musculoskeletal pain caused by uncomplicated soft tissue injury."5.13A randomised, double-blind study comparing lumiracoxib with naproxen for acute musculoskeletal pain. ( Adekunle, F; Andrews, C; Ellis, G; Kinch, H; Kyle, C; Zachariah, J, 2008)
"Randomized clinical trials evaluating ultramicronised diclofenac, diclofenac, celecoxib, etodolac and placebo in patients with osteoarthritis were identified."5.12Efficacy of ultramicronised diclofenac in patients with osteoarthritis - systematic review with network meta-analysis. ( Auletta, LL; de Almeida Macedo, E; de Campos, GC; Kummer, AM; Millan Fachi, M; Papaleo Rosim, M, 2021)
" The meta-analysis indicated that celecoxib reduced pain more effectively than diclofenac sodium in patients with KOA, as evaluated by the VAS score."5.12Meta-analysis Comparing Celecoxib with Diclofenac Sodium in Patients with Knee Osteoarthritis. ( Hou, S; Huang, H; Liang, G; Liang, H; Liu, J; Luo, M; Pan, J; Yang, W; Zeng, L; Zhao, J, 2021)
"Topical diclofenac and ketoprofen are the most rigorously studied topical NSAIDs in the treatment of knee OA and have demonstrated the most significant reduction in pain and improvement of function."5.12Topical nonsteroidal anti-inflammatory drugs in the treatment of knee osteoarthritis: a systematic review and meta-analysis. ( Brown, SM; Christophersen, C; Mulcahey, MK; Wolff, DG, 2021)
"To evaluate the efficacy and upper gastrointestinal (UGI) safety of celecoxib, compared with nonspecific nonsteroidal anti-inflammatory drugs (NSAIDs), among patients with osteoarthritis."5.12Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study. ( Agrawal, NM; Andrade-Ortega, L; Bello, AE; Eisen, GM; Fort, JG; Goldstein, JL; Hanrahan, PS; Levy, RA; Singh, G; Stenson, WF; Triadafilopoulos, G; Wallemark, C, 2006)
"A randomized, controlled, cross-over trial compared single doses of 50 mg diclofenac potassium sachets and tablets with placebo in 328 patients with migraine pain, treating 888 attacks."5.12Efficacy and tolerability of diclofenac potassium sachets in migraine: a randomized, double-blind, cross-over study in comparison with diclofenac potassium tablets and placebo. ( Diener, HC; Edson, K; Gács, G; Lyczak, P; Montagna, P; Mulder, LJ; Schumann, G; Siegel, J; Zöller, B, 2006)
"To compare the ketoprofen TDS patch with diclofenac gel in the treatment of traumatic acute pain in benign sport-related soft-tissue injuries."5.12Topical ketoprofen TDS patch versus diclofenac gel: efficacy and tolerability in benign sport related soft-tissue injuries. ( Cobián, C; Esparza, F; García-Cota, JJ; Jiménez, JF; Maestro, A; Sánchez, C, 2007)
"To compare the efficacy and side effects of transdermal diclofenac patch with eutectic mixture of local anesthetic (EMLA) cream in attenuating venous cannulation pain."5.12Transdermal diclofenac patch vs eutectic mixture of local anesthetics for venous cannulation pain. ( Agarwal, A; Gautam, S; Gupta, D; Singh, U, 2007)
"The mean pain scores for the three groups were: diclofenac and paracervical block 5."5.12A randomized comparison of different methods of analgesia in abortion using manual vacuum aspiration. ( López, JC; Ruiz, E; Vega-Malek, JC; Vergara, V; Vigil-De Gracia, P, 2007)
"To compare the time to presentation of the analgetic and anti-inflammatory effects of granulated and tablet nimesulide and sodium diclofenac since the start of therapy for gouty arthritis (GA)."5.12[Comparison of the time to analgetic and anti-inflammatory effect in the treatment of gouty arthritis with nimesulide and sodium diclofenac]. ( Barskova, VG; Eliseev, MS; Kudaeva, FM; Nasonova, VA, 2007)
"It was concluded that diclofenac sodium and paracetamol are effective and well tolerated as a short term treatment alternatives for acute ankle injuries."5.12The efficacy of paracetamol in the treatment of ankle sprains in comparison with diclofenac sodium. ( Agus, H; Kayali, C; Surer, L; Turgut, A, 2007)
"A previously published study comparing the efficacy of comfrey extract to a commercial diclofenac (CAS 78213-16-8) preparation in the treatment of unilateral ankle sprains is critically re-evaluated."5.12Comfrey extract ointment in comparison to diclofenac gel in the treatment of acute unilateral ankle sprains (distortions). ( Bulitta, M; D'Anchise, R; Giannetti, B, 2007)
"Patients given diclofenac had significantly lower pain scores than those given placebo (2."5.11Diclofenac suppository analgesia for transrectal ultrasound guided biopsies of the prostate: a double-blind, randomized controlled trial. ( Donaldson, PJ; Habib, MR; Haq, A; Parry, JR; Patel, HR, 2004)
"To evaluate rectal diclofenac in the relief of perineal pain after trauma during childbirth."5.11Rectal analgesia for the relief of perineal pain after childbirth: a randomised controlled trial of diclofenac suppositories. ( Crowther, CA; Dodd, JM; Hedayati, H; Hotham, N; Pearce, E, 2004)
"Diclofenac is a non-steroidal anti-inflammatory drug used for a variety of painful and inflammatory conditions."5.11Diclofenac systemic exposure is not increased when topical diclofenac is applied to ultraviolet-induced erythema. ( Kienzler, JL; Knops, A; Magnette, JL; Ménart, C; Nollevaux, F; Sallin, D, 2004)
" In well designed clinical trials of 1-52 weeks' duration in patients with osteoarthritis (OA) or rheumatoid arthritis, the efficacy of oral lumiracoxib 100-400 mg/day in decreasing pain intensity and improving functional status was greater than that with placebo and similar to those with nonselective NSAIDs or celecoxib 200mg once daily."5.11Lumiracoxib. ( Curran, MP; Lyseng-Williamson, KA, 2004)
"To analyse the efficacy of acupuncture as a complementary therapy to the pharmacological treatment of osteoarthritis of the knee, with respect to pain relief, reduction of stiffness, and increased physical function during treatment; modifications in the consumption of diclofenac during treatment; and changes in the patient's quality of life."5.11Acupuncture as a complementary therapy to the pharmacological treatment of osteoarthritis of the knee: randomised controlled trial. ( Aguilar, I; Borge, MA; Gaspar, O; Jurado, R; León, JM; Méndez, C; Panadero, MD; Perea-Milla, E; Sánchez-Rodríguez, F; Vas, J; Vega, E, 2004)
"STUDY OF HEALTHY VOLUNTEERS: This double blind study (bioadhesive plaster of diclofenac epolamine versus placebo), showed that the application of diclofenac epolamine for 24 hours induced a selective hypoanalgesic effect on the muscle, proportional to the degree of hypersensitivity to the pain observed in baseline conditions."5.11[Proof of the pharmacodynamic activity of Flector Plaster in healthy volunteers and patients suffering from osteo-arthritis of the knee]. ( Solignac, M, 2004)
" In the first few weeks of treatment, the mean changes in some variables (VAS, which assessed walking pain, standing pain and stiffness, as well as Lequesne's functional index) of the DJW group were significantly lower than those of the diclofenac group."5.11Chinese herbal recipe versus diclofenac in symptomatic treatment of osteoarthritis of the knee: a randomized controlled trial [ISRCTN70292892]. ( Kunanusorn, P; Lhieochaiphunt, S; Pojchamarnwiputh, S; Pruksakorn, S; Rojanasthien, N; Sananpanich, K; Teekachunhatean, S, 2004)
"In a randomized, double-blind, controlled trial, 120 ASA 1 or 2 patients were allocated to receive diclofenac or normal saline as pretreatment to assess their effect on incidence and severity of pain during propofol injection."5.11Effect of diclofenac pretreatment on pain during propofol injection. ( Agarwal, D; Mohta, M; Sandhu, K; Sethi, AK, 2004)
"The aim of this study was to investigate the analgesic efficacy of Neodolpasse, a fixed-dose combination of orphenadrine and diclofenac, compared with those of its single active ingredients in a human pain model."5.11Comparison of the analgesic effects of a fixed-dose combination of orphenadrine and diclofenac (Neodolpasse) with its single active ingredients diclofenac and orphenadrine: a placebo-controlled study using laser-induced somatosensory-evoked potentials fro ( Eggenreich, U; Gschanes, A; Reitmeir, P; Schaffler, K, 2005)
"The topical diclofenac group had a significantly greater mean change in score (final minus baseline) compared to the vehicle control group for pain (-5."5.11Treatment of osteoarthritis of the knee with a topical diclofenac solution: a randomised controlled, 6-week trial [ISRCTN53366886]. ( Baer, PA; Shainhouse, Z; Thomas, LM, 2005)
"There was no statistical difference in the mean reduction in pain score between any of the combinations at any point, although combination therapy was the first to reach a clinically significant reduction in pain score (<13 mm), and diclofenac-paracetamol combinations consistently produced a greater reduction in mean pain score than either nonsteroidal antiinflammatory drugs or paracetamol alone."5.11Randomized double-blind trial comparing oral paracetamol and oral nonsteroidal antiinflammatory drugs for treating pain after musculoskeletal injury. ( Lam, PK; Man, SY; Rainer, TH; Woo, WW, 2005)
"Intrarectal diclofenac suppository administration is a simple, safe, and effective procedure to reduce pain and improve patients' tolerance of transrectal ultrasound-guided prostate biopsy."5.11Diclofenac suppository administration in conjunction with lidocaine gel during transrectal ultrasound-guided prostate biopsy: prospective, randomized, placebo-controlled study. ( Aslan, G; Celebi, I; Goktay, Y; Gulcu, A; Irer, B, 2005)
"This double-blind randomized control study was conducted to evaluate whether a nonsteroidal anti-inflammatory drug (NSAID) could act as an effective pain control method during first trimester suction abortion, and whether co-treatment of NSAID with misoprostol will decrease the efficacy of the cervical ripening effect of misoprostol."5.10A study of co-treatment of nonsteroidal anti-inflammatory drugs (NSAIDs) with misoprostol for cervical priming before suction termination of first trimester pregnancy. ( Chan, CP; Ho, PC; Li, CF; Wong, CY, 2003)
"This was a randomized, double-blind, placebo-controlled study designed to compare the antihyperalgesic efficacy of topical (65 mg) and oral (93 mg) diclofenac via estimates of mechanical pain thresholds obtained at the site of induced inflammation with von Frey hairs."5.10Peripheral and central antihyperalgesic effects of diclofenac in a model of human inflammatory pain. ( Burian, M; Geisslinger, G; Seegel, M; Tegeder, I, 2003)
"Patients who fitted the study criteria were given either 25 mg oral dexketoprofen trometamol or 50 mg sodium diclofenac immediately after triage; baseline and 15 minute pain scores were then recorded for one hour."5.10Randomised controlled trial of the onset of analgesic efficacy of dexketoprofen and diclofenac in lower limb injury. ( Herington, J; Kapadia, Y; Leman, P, 2003)
"Tamsulosin used as a spasmolytic drug during renal colic due to juxtavesical calculi increased the stone expulsion rate and decreased expulsion time, the need for hospitalization and endoscopic procedures, and provided particularly good control of colic pain."5.10Efficacy of tamsulosin in the medical management of juxtavesical ureteral stones. ( Dellabella, M; Milanese, G; Muzzonigro, G, 2003)
"Visual analog scale (VAS), verbal pain score (VPS), sedation score, frequency of opioid side effects, and morphine consumption were recorded every 4 hours."5.10Comparison of the morphine-sparing effects of diclofenac sodium and ketorolac tromethamine after major orthopedic surgery. ( Alexander, R; El-Moalem, HE; Gan, TJ, 2002)
"This study was undertaken to determine whether a special postoperative pain administration of tramadol and diclofenac provides any benefits in patients who underwent microsurgical lumbar discectomy."5.09Postoperative pain therapy after lumbar disc surgery. ( Filippi, R; Jage, J; Laun, J; Perneczky, A, 1999)
"There was minimal change in the degree of pain in the lidocaine-only and control groups during and after the treatment period."5.09Intrathecal methylprednisolone for intractable postherpetic neuralgia. ( Asai, M; Hashimoto, H; Kimura, F; Kotani, N; Kushikata, T; Matsuki, A; Muraoka, M; Yodono, M, 2000)
" The efficacy of misoprostol and ranitidine in the prevention of gastroduodenal damage in patients taking diclofenac for their cancer pain has been compared in this study."5.08Nonsteroidal antiinflammatory drugs for cancer pain: comparison between misoprostol and ranitidine in prevention of upper gastrointestinal damage. ( Bortolussi, R; Bortoluzzi, F; Cannizzaro, R; Fornasarig, M; Fracasso, A; Grazioli, I; Poletti, M; Sozzi, M; Testa, V; Valentini, M, 1995)
"Sixty female out-patients suffering from moderate to severe primary dysmenorrhea, aged 14-40 years (mean 27 years), entered this randomized, double-blind, 3-period, within-patient study, evaluating the efficacy and tolerability of diclofenac dispersible 46."5.08Comparative efficacy of diclofenac dispersible 50 mg and ibuprofen 400 mg in patients with primary dysmenorrhea. A randomized, double-blind, within-patient, placebo-controlled study. ( Bakshi, R; Fedele, L; Marchini, M; Pistai, R; Tozzi, L, 1995)
"The efficacy and tolerability of aceclofenac, a new non-steroidal anti-inflammatory drug (NSAID) was compared to that of ketoprofen in a multicentre, double-blind, prospective, randomized study of 3-months duration in patients with rheumatoid arthritis."5.08Aceclofenac in comparison to ketoprofen in the treatment of rheumatoid arthritis. ( Ansoleaga, JJ; Gijón-Baños, J; Martín-Mola, E, 1995)
"Topical application, 4 times daily for 2 weeks, of the diclofenac-hyaluronan gel to 59 osteoarthritis patients induced a significantly greater (p = 0."5.08A controlled clinical investigation of 3% diclofenac/2.5% sodium hyaluronate topical gel in the treatment of uncontrolled pain in chronic oral NSAID users with osteoarthritis. ( Roth, SH, 1995)
"The clinical efficacy of the two topical analgesics, ketoprofen hydroalcoholic gel (Fastum gel) and diclofenac emulgel, for osteoarthritis of the knee was studied."5.08Topical analgesics for knee arthrosis: a parallel study of ketoprofen gel and diclofenac emulgel. ( Boonsanong, W; Penkitti, P; Soparat, K; Waikakul, S, 1997)
"To compare the efficacy and tolerability of single doses of diclofenac dispersible and naproxen granular in patients with acute, painful, minor sports injuries."5.08Diclofenac dispersible provides superior analgesia with faster onset of action compared to naproxen granular in patients with acute, painful, minor sports injuries. ( Colombo, G; Giombini, A; Pamich, T; Peruzzi, E; Pisati, R, 1997)
"Efficacy of diclofenac in pain relief after hip alloplasty was investigated in 35 patients aged 61-73 (mean 66)."5.08[Diclofenac for treatment of postoperative pain after hip arthroplasty in older patients]. ( Bohatyrewicz, A; Litke, J; Mikulski, K, 1997)
"A prospective double-blind randomized trial was conducted on 184 cancer patients with moderate to severe chronic pain to evaluate the analgesic efficacy and tolerability of diclofenac alone (50 mg q."5.08Double-blind evaluation of short-term analgesic efficacy of orally administered diclofenac, diclofenac plus codeine, and diclofenac plus imipramine in chronic cancer pain. ( Celani, MG; De Angelis, V; Del Favero, A; Fumi, G; Lupatelli, M; Minotti, V; Monza, G; Pisati, R; Righetti, E; Rossetti, R; Tonato, M, 1998)
"The gastric tolerability of nimesulide, a new nonsteroidal anti-inflammatory drug (NSAID), was compared with diclofenac, an established NSAID for the treatment of osteoarthritis (OA)."5.07Double-blind study evaluating by endoscopy the tolerability of nimesulide and diclofenac on the gastric mucosa in osteoarthritic patients. ( Almeida, H; Cunha, MJ; Macciocchi, A; Porto, A, 1994)
"Two hundred and sixty patients with lumbago or sciatic pain participated in a multicenter observer-blind randomized trial to compare the efficacy and tolerability of dipyrone 2."5.07Parenteral dipyrone versus diclofenac and placebo in patients with acute lumbago or sciatic pain: randomized observer-blind multicenter study. ( Babej-Dölle, R; Eckmeyer, J; Freytag, S; Schinzel, S; Schmeider, G; Stankov, G; Zerle, G, 1994)
"The putative central analgesic activity of diclofenac was investigated in a human experimental pain model using intraneural electrical stimulation in the median nerve."5.07Diclofenac evaluated in a human experimental model of central pain. ( Björkman, R; Elam, M, 1993)
"The effect of diclofenac on pain after arthroscopy of the knee joint was investigated in 64 patients."5.07Diclofenac for pain relief after arthroscopy: a comparison of early and delayed treatment. ( Björkman, R; Brodd, B; Sandin, R; Stam, H; Sternlo, JE, 1993)
" as additive treatment to parenteral patient-controlled administration therapy (PCAT) with morphine in cancer pain has been investigated in a double-blind study."5.07Morphine-sparing effect of diclofenac in cancer pain. ( Björkman, R; Hedner, J; Ullman, A, 1993)
"At Helsinki University Central Hospital in Finland, clinical researchers divided 169 women into two groups (group 1: diagnostic laparoscopies; group 2: laparoscopic sterilizations) as part of a study to evaluate the effect of intravenous diclofenac on postoperative pain, nausea, and recovery after outpatient gynecological laparoscopy."5.07Effect of intravenous diclofenac on pain and recovery profile after day-case laparoscopy. ( Hovorka, J; Kallela, H; Korttila, K, 1993)
" Ninety-six patients with rheumatoid arthritis took single daily doses of controlled release naproxen (N), diclofenac S."5.07Four commonly prescribed non-steroidal anti-inflammatory drugs for rheumatoid arthritis. ( Huskisson, EC, 1991)
"In a multicentric, interindividual, double-blind study, the analgesic action, duration of effect, tolerability and side effects of the new combination preparation, Combaren (diclofenac-Na 50 mg+codeine phosphate 50 mg), were compared with those of diclofenac-Na 50 mg (Voltaren 50) in 184 patients with severe tumor-related pain."5.07[Drug therapy in severe tumor pain. Comparative study of a new combination preparation versus diclofenac-Na]. ( Strobel, E, 1992)
"A double-blind, crossover study was undertaken in general practice to compare the efficacy and tolerability of a new controlled-release indomethacin with sustained-release diclofenac sodium in patients with osteoarthritis."5.06Controlled-release indomethacin and sustained-release diclofenac sodium in the treatment of osteoarthritis: a comparative controlled clinical trial in general practice. ( Gostick, N; James, IG; Khong, TK; Miller, AJ; Roy, P; Shepherd, PR, 1990)
"The efficacy and tolerability of a new, controlled-release indomethacin (75 mg) tablet was compared to that of a sustained-release diclofenac sodium (100 mg) tablet in 84 patients with rheumatoid arthritis."5.06Controlled-release indomethacin and sustained-release diclofenac sodium in the treatment of rheumatoid arthritis: a comparative controlled clinical trial. ( Crowley, B; Hamill, JJ; Lyndon, S; McKellican, JF; Miller, AJ; Williams, P, 1990)
" Eight hundred and forty-six patients with pain in one or two joints of the hip, knee, ankle or wrist participated in a randomised double-blind trial to compare the efficacy, tolerability and effect on quality of life of diclofenac sodium slow release (DSR) 100 mg daily and a combination of dextropropoxyphene 180 mg and paracetamol 1."5.06Joint pain and quality of life; results of a randomised trial. ( Bulpitt, CJ; Darekar, B; Fletcher, A; Parr, G, 1989)
" In clinical conditions marked by acute or chronic pain and inflammation, such as oral surgery, dysmenorrhea, low back pain, renal colic, and biliary colic, as well as in post-traumatic and postoperative conditions, diclofenac sodium, a nonsteroidal anti-inflammatory drug with potent prostaglandin synthetase inhibition, has been shown to be an effective analgesic agent."5.06Use of diclofenac in analgesia. ( Kantor, TG, 1986)
"Twenty-four patients with localized myofascial pain were treated with injections, 11 with 2 ml lidocaine 1% and 13 with 2 ml diclofenac (Voltaren) (50 mg) given in the trigger-point."5.06Diclofenac versus lidocaine as injection therapy in myofascial pain. ( Frost, A, 1986)
"The efficacy and tolerability of 100 mg suppositories of diclofenac sodium (Voltaren) and indomethacin were investigated in relieving symptoms of rheumatoid arthritis."5.05Comparison of diclofenac and indomethacin suppositories in rheumatoid arthritis. ( Valindas, E; Wafin, F; Wuolijoki, E, 1984)
"The efficacy of diclofenac sodium was investigated in the painful symptoms of primary dysmenorrhea and in reducing menstrual bleeding."5.05Treatment of primary dysmenorrhea with diclofenac sodium. ( Pulkkinen, MO; Riihiluoma, P; Wuolijoki, E, 1981)
"The nonsteroidal anti-inflammatory drug (NSAID) diclofenac epolamine (DHEP) formulated as a topical patch has demonstrated efficacy and safety in the localized treatment of acute pain from minor strains, sprains and contusions, and for epicondylitis and knee osteoarthritis."5.01Rationale and evidence for the incorporation of heparin into the diclofenac epolamine medicated plaster. ( Jones, C; Nencioni, A; Rainsford, KD; Roberts, MS, 2019)
" It was suggested that the new diclofenac/HPβCD formulation gives a rapid and effective response to acute pain and, furthermore, has pharmacokinetic and efficacy/safety profiles comparable to other medicinal products not containing cyclodextrins."4.93Efficacy and Safety Profile of Diclofenac/Cyclodextrin and Progesterone/Cyclodextrin Formulations: A Review of the Literature Data. ( Bonagura, AC; Cenami, R; Cimmaruta, D; Fiorentino, S; Fossati, T; Rossi, F; Scavone, C; Torella, M, 2016)
" All treatments except acetaminophen showed clinically significant improvement from baseline pain."4.91Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysis. ( Bannuru, RR; Kent, DM; McAlindon, TE; Schmid, CH; Vaysbrot, EE; Wong, JB, 2015)
"The non-opioid analgesic diclofenac is used worldwide for musculoskeletal and perioperative pain therapy."4.90[Diclofenac up2date - Part 1: Pharmacology and comparison with other drugs]. ( Bolbrinker, J; Bushuven, S; Heise, D, 2014)
"Diclofenac and other non-steroidal anti-inflammatory drugs (NSAIDs) are widely used in the treatment of inflammation and pain."4.88Insights into the effects of diclofenac and other non-steroidal anti-inflammatory agents on ion channels. ( Gwanyanya, A; Macianskiene, R; Mubagwa, K, 2012)
"Diclofenac is a proven, commonly prescribed nonsteroidal anti-inflammatory drug (NSAID) that has analgesic, anti-inflammatory, and antipyretic properties, and has been shown to be effective in treating a variety of acute and chronic pain and inflammatory conditions."4.86Diclofenac: an update on its mechanism of action and safety profile. ( Gan, TJ, 2010)
"Diclofenac is commonly used for acute pain in children, but is not licensed for this indication in all age groups."4.85Diclofenac for acute pain in children. ( Pritchard, D; Savage, I; Standing, JF; Waddington, M, 2009)
"Topical formulations of non-steroidal anti-inflammatory drugs (NSAIDs), in particular diclofenac (DI), have become popular for treating various acute and chronic painful inflammatory conditions."4.84Review of the pharmaceutical properties and clinical effects of the topical NSAID formulation, diclofenac epolamine. ( Ehrlich, GE; Kean, WF; Rainsford, KD, 2008)
"Topical diclofenac is widely used in the treatment of pain and inflammation."4.84Topical diclofenac and its role in pain and inflammation: an evidence-based review. ( Altman, R; Bellamy, N; Brühlmann, P; Da Silva, J; Huskisson, E; Taylor, RS; Zacher, J, 2008)
" It has proved as effective as diclofenac, naproxen and piroxicam in patients with osteoarthritis, diclofenac, ketorolac, tenoxicam and indomethacin in patients with rheumatoid arthritis and tenoxicam, naproxen and indomethacin in patients with ankylosing spondylitis."4.82Aceclofenac in the management of inflammatory pain. ( Legrand, E, 2004)
"Trials of 2 to 6 months' duration have shown aceclofenac to be an effective agent in the management of pain and rheumatic disease."4.81Aceclofenac: a reappraisal of its use in the management of pain and rheumatic disease. ( Dooley, M; Dunn, CJ; Spencer, CM, 2001)
"The aim of this article is to critically review the potential role of aceclofenac in the treatment of inflammatory pain and chronic osteoarticular disorder, based on its activity on the mediators of inflammation, its effect on cartilage remodeling and on the results of clinical studies comparing aceclofenac with other NSAIDs in these disorders."4.81[What is the role of aceclofenac in the therapeutic arsenal against chronic osteoarthritis pathologies?]. ( Henrotin, Y; Paul, I; Reginster, JY, 2001)
"Celecoxib is the first COX-2-specific inhibitor approved for relief of the signs and symptoms of osteoarthritis (OA) and rheumatoid arthritis (RA), as well as for treatment of familial adenomatous polyposis."4.80Celecoxib clinical profile. ( Tive, L, 2000)
"Injections of diclofenac induced antinociception in visceral pain models (writhing test, colorectal distension test), but not in two models of somatosensory pain (tail-flick and hot-plate test)."4.79Central antinociceptive effects of non-steroidal anti-inflammatory drugs and paracetamol. Experimental studies in the rat. ( Björkman, R, 1995)
"Hyaluronan (HA) in combination with diclofenac is currently undergoing clinical trials as a topical preparation in the management of osteoarthritic pain, basal-cell carcinoma and actinic keratosis."4.79Hyaluronan as a drug delivery system for diclofenac: a hypothesis for mode of action. ( Moore, AR; Willoughby, DA, 1995)
"A meta-analysis was done with the final data from three trials that provided the first results relating to efficacy and safety of the new sustained-release (SR) formulation of etodolac versus established nonsteroidal anti-inflammatory drugs (NSAIDs) in the treatment of osteoarthritis (OA) of the knee."4.78Meta-analysis of three double-blind comparative trials with sustained-release etodolac in the treatment of osteoarthritis of the knee. ( Porzio, F, 1993)
" Published data indicate that diclofenac 75 to 150mg daily (25 to 50mg 3 times daily) is comparable in efficacy with ordinary aspirin 3 to 5g daily and indomethacin 75 to 150mg daily in rheumatoid arthritis and with indomethacin in osteoarthritis."4.76Diclofenac sodium: a review of its pharmacological properties and therapeutic use in rheumatic diseases and pain of varying origin. ( Avery, GS; Brogden, RN; Heel, RC; Pakes, GE; Speight, TM, 1980)
"Diclofenac sodium is an anti-inflammatory drug commonly used to cure pain in various treatments."4.31Development of zinc ferrite nanoparticles with enhanced photocatalytic performance for remediation of environmentally toxic pharmaceutical waste diclofenac sodium from wastewater. ( Bilal, M; Hussain, N; Imran, M; Javaid, A; Jesionowski, T; Latif, S; Liaqat, A, 2023)
"Joint pain decreased after 2 weeks of therapy in all patients during treatment with Voltaren Emulgel 2% (diclofenac diethylamine 2%) in both groups."4.02[Evaluation of topical therapy of patients with osteoarthritis of small joints of the hands with Voltaren® Emulgel® 2% (diclofenac diethylamine 2%)]. ( Gromova, MA; Tsurko, VV, 2021)
" The acetylcholinesterase inhibitor (ACHEI); neostigmine, is known clinically for its analgesic effect in the perioperative phases proving high efficacy; besides possessing anti-inflammatory properties controlling immune cells and cytokine level."4.02The effective interplay of (non-) selective NSAIDs with neostigmine in animal models of analgesia and inflammation. ( Abdel-Bary, A; El-Tahan, RA; Gowayed, MA, 2021)
"Using diclofenac mouthwash, 9/10 patients experienced pain score reduction from day 0 (mean score 6."3.96Diclofenac Mouthwash as a potential therapy for reducing pain and discomfort in chemo-radiotherapy-induced oral mucositis. ( Alam, P; Brennan, PA; Donnelly, O; Fedele, S; Gomez, RS; Lewthwaite, R; McGuigan, S; Sakthithasan, P, 2020)
" platensis on different types of pain and inflammation in comparison to diclofenac sodium."3.96Effects of Spirulina platensis on pain and inflammation in long Evans rats. ( Akhter, S; Ali, T; Nipa, NS; Rafiq, K, 2020)
" The goal of this study was to determine the impact of administration of the non-selective NSAID diclofenac in the inflammatory phase of bone repair in mice with or without lipopolysaccharide-induced systemic inflammation."3.91Defective bone repair in diclofenac treated C57Bl6 mice with and without lipopolysaccharide induced systemic inflammation. ( Abou-Rjeili, M; Akoury, E; Al-Saran, Y; Awlia, A; Chan, D; Henderson, JE; Lemarié, CA; Martineau, PA; Ouellet, S; Ramirez-Garcia-Luna, JL; Wong, TH, 2019)
"In this work, we propose a surgical suture that can sustainably release diclofenac (DF) for the local pain relief of surgical wounds."3.85Surgical suture braided with a diclofenac-loaded strand of poly(lactic-co-glycolic acid) for local, sustained pain mitigation. ( Choy, YB; Heo, CY; Huh, BK; Kim, BH; Kim, KR; Kim, SN; Lee, SH; Park, CG, 2017)
"To determine the frequency of perineal pain after childbirth after a single dose of diclofenac rectal suppository."3.83Diclofenac rectal suppository: an effective modality for perineal pain. ( Baloch, R; Memon, NY; Naz, S; Sattar, A, 2016)
"Topical diclofenac, with and without dimethyl sulfoxide (DMSO), modestly improves pain and function scores (by 4%-8%) for as long as 12 weeks in patients with osteoarthritis (OA) of the knee."3.81Clinical inquiry: does topical diclofenac relieve osteoarthritis pain? ( Hodge, B; Skolnik, D, 2015)
"This study showed that TS has anti-visceral pain properties comparable with those of rofecoxib (a cyclooxygenase-2 inhibitor) and diclofenac, which suggests promise for the treatment of intractable visceral pain in humans."3.81Toona sinensis leaf extract has antinociceptive effect comparable with non-steroidal anti-inflammatory agents in mouse writhing test. ( Chan, TF; Hsu, HK; Hwang, SL; Lee, KS; Lieu, AS; Lin, CL; Su, YF; Yang, YC, 2015)
"This study investigated the effects of Phα1β, pregabalin and diclofenac using an animal model of fibromyalgia (FM)."3.80The effects of Phα1β, a spider toxin, calcium channel blocker, in a mouse fibromyalgia model. ( Castro, CJ; da Costa Lopes, AM; da Silva, CA; da Silva, JF; de Souza, AH; Ferreira, J; Gomez, MV; Klein, CP; Pereira, EM, 2014)
" Both pretreatment and post-treatment with the opioid antagonist naloxone into the DH significantly reduced the antinociceptive effect of NSAIDs in both pain models."3.80Antinociceptive tolerance to NSAIDs microinjected into dorsal hippocampus. ( Gurtskaia, G; Nebieridze, M; Nozadze, I; Tsagareli, MG; Tsiklauri, N, 2014)
" In the present study, we compared the effects of crocin, safranal and diclofenac on local inflammation and its induced pain in rats."3.79Comparison of the effects of crocin, safranal and diclofenac on local inflammation and inflammatory pain responses induced by carrageenan in rats. ( Eghdami, K; Erfanparast, A; Farshid, AA; Samadi, F; Tamaddonfard, E, 2013)
"05) and dosedependent anti-inflammatory activity in carrageenan induced paw oedema models of inflammation and the result was comparable with the standard drug diclofenac."3.79Evaluation of antinociceptive and anti-inflammatory activity of hydromethanol extract of Cocos nucifera L. ( Gupta, M; Haldar, PK; Mazumder, UK; Naskar, S; Pramanik, G; Saha, P, 2013)
"The anti-edematous and anti-allodynic effects of JZL184 were compared to those of PF-3845, an inhibitor of fatty acid amide hydrolase (FAAH), and diclofenac, a non-selective cyclooxygenase inhibitor."3.79The monoacylglycerol lipase inhibitor JZL184 suppresses inflammatory pain in the mouse carrageenan model. ( Chen, Y; Cravatt, BF; Ghosh, S; Gujjar, R; Lichtman, AH; Mahadevan, A; Wise, LE, 2013)
" Carrageenan induced paw edema model was used for anti-inflammatory and acetic acid induced model used for analgesic activity."3.78Anti-inflammatory and analgesic potential of a novel steroidal derivative from Bryophyllum pinnatum. ( Afzal, M; Afzal, O; Alam, J; Anwar, F; Gupta, G; Gupta, R; Hakeem, KR; Kazmi, I; Pravez, M; Rahman, M, 2012)
"The aim of the present study was to investigate the preemptive analgesic effects of intraperitoneally administrated midazolam and diclofenac, before acute and inflammatory induced pain in rat model."3.77Preemptive analgesic effects of midazolam and diclofenac in rat model. ( Hasani, A; Jakupi, M; Soljakova, M; Ustalar-Ozgen, S, 2011)
" The five most commonly reported adverse events were abdominal pain by 23."3.77Overall safety of Arthrotec. ( Geis, GS, 1992)
" First, validate PEAP with Complete Freund's Adjuvant (CFA)-induced inflammation for the assessment of the affective component of pain using the reference analgesics celecoxib, diclofenac and duloxetine; fluoxetine and scopolamine were tested as negative controls."3.76Comparison of mechanical allodynia and the affective component of inflammatory pain in rats. ( Baker, SJ; Boyce-Rustay, JM; Decker, MW; Honore, P; Kohnken, R; Simler, GH; Wensink, EJ; Zhong, C, 2010)
" The blueberry extract produced a significant decrease in constrictions induced by acetic acid and caused graded inhibition of the second phase of formalin-induced pain."3.76Preliminary studies on the antinociceptive activity of Vaccinium ashei berry in experimental animal models. ( Barros, DM; de Castro, MR; de Souza, MM; Dickel, OE; Guterres, L; Henriques, AT; Ramirez, MR, 2010)
"The aim of this study was to investigate the type of common (occurring in >1% of patients) adverse reactions caused by diclofenac when given to children for acute pain."3.75Prospective observational study of adverse drug reactions to diclofenac in children. ( Howard, RF; Keady, S; Ooi, K; Savage, I; Standing, JF; Wong, IC, 2009)
" EtCD at the dose of 300 mg/kg produced significant decrease in paw volume and pain when compared with reference drug diclofenac and morphine, respectively."3.75Antioxidant, anti-inflammatory and analgesic potential of the Citrus decumana L. peel extract. ( Arora, B; Arora, R; Bali, M; Bansal, S; Gill, NS; Muthuraman, A; Sharma, PD; Sood, S, 2009)
" In the acute phase, violent colic pain is treated with diclophenac or morphine."3.74[Summary of the practice guideline 'Urolithiasis' (first revision) from the Dutch College of General Practitioners]. ( Boukes, FS; Goudswaard, AN; van Koningsbruggen, PJ; van Lieshout, J, 2008)
"To evaluate the efficacy of intramuscular injection of 75 mg diclofenac sodium and periprostatic nerve block (PPNB) with 1% lignocaine in controlling pain during transrectal ultrasound (TRUS)-guided prostate biopsy."3.74Control of pain during transrectal ultrasound-guided prostate biopsy: a prospective study comparing two methods. ( Bhomi, KK; Consigliere, DT; Lim, HH; Tiong, HY, 2007)
" The antiinflammatory property of the aqueous leaf extract was investigated in rats, using fresh egg albumin-induced pedal (paw) edema, while the analgesic effect of the plant extract was evaluated by the "hot-plate" and "acetic acid" test models of pain in mice."3.73Antiinflammatory and analgesic effects of Psidium guajava Linn. (Myrtaceae) leaf aqueous extract in rats and mice. ( Ojewole, JA, 2006)
"5, 5 and 10 mg kg (-1)) was investigated and compared with diclofenac sodium (5 mg kg (-1)) using the formalin-, histamine-, and carrageenan-induced paw oedema and cotton pellet granuloma tests."3.71Anti-inflammatory and antinociceptive properties of dantrolene sodium in rats and mice. ( Büyükokuroğlu, ME, 2002)
"The peripheral antinociceptive effect of the selective COX-2 inhibitor celecoxib in the formalin-induced inflammatory pain was compared with that of resveratrol (COX-1 inhibitor) and diclofenac (non-selective COX inhibitor)."3.71Comparison of the antinociceptive effect of celecoxib, diclofenac and resveratrol in the formalin test. ( Alonso-López, R; Asomoza-Espinosa, R; Castañeda-Hernández, G; Granados-Soto, V; Ortiz, MI; Torres-López, JE, 2002)
" The effect of the extracts against acute inflammation was studied by acetic acid increased vascular permeability and xylene-induced ear edema in mice."3.71Antinociceptive, anti-inflammatory and acute toxicity effects of Zhumeria majdae extracts in mice and rats. ( Fadishei, M; Hosseinzadeh, H; Mahmoudi, M; Ramezani, M, 2002)
"A pan-European study involving 23407 patients with pain due to various inflammatory or degenerative rheumatic diseases was undertaken in Austria, Belgium, Germany and Greece, to evaluate overall pain relief and satisfaction with aceclofenac therapy."3.71Patient and physician satisfaction with aceclofenac: results of the European Observational Cohort Study (experience with aceclofenac for inflammatory pain in daily practice). Aceclofenac is the treatment of choice for patients and physicians in the manage ( Aslanidis, S; De Bast, J; Leeb, B; Lemmel, EM, 2002)
"Narcotics and topical diclofenac were used to control pain in a patient who developed a corneal ulcer after abusing topical anesthetics."3.70Topical diclofenac sodium in the management of anesthetic abuse keratopathy. ( Dornic, DI; Lass, JH; Thomas, JM, 1998)
"The present study shows that meloxicam dose-dependently exhibited systemic antinociceptive action when assessed against neurogenic and inflammatory pain caused by acetic acid, formalin and capsaicin models."3.70Antinociceptive effect of meloxicam, in neurogenic and inflammatory nociceptive models in mice. ( De Freitas, GA; Santos, AR; Vedana, EM, 1998)
" Both etodolac and bromelain inhibited the inflammatory pain in concanavalin A-treated paws of rats in a dose-dependent manner, but indomethacin did not."3.69Effect of etodolac on prostaglandin E2 biosynthesis, active oxygen generation and bradykinin formation. ( Dainaka, J; Hashii, H; Inoue, K; Kimura, K; Motonaga, A; Nishimura, T; Ueda, F; Yamate, K, 1994)
"The antinociceptive activity of intramuscular 6-methoxy-2-naphthylacetic acid (6-MNA), the active metabolite of nabumetone, was examined in a rat model of unilateral hindpaw inflammation/hyperalgesia and compared with that of three other non-steroidal anti-inflammatory drugs (NSAIDs)--diclofenac, naproxen and piroxicam."3.69Antinociceptive effects of non-steroidal anti-inflammatory drugs in a rat model of unilateral hindpaw inflammation. ( Clarke, GD; MacPherson, IS; Petrone, G; Spangler, RS, 1994)
"Due to pain from infected 12 per cent TBSA flame injuries a 71-year-old female was treated with a non-steroidal antiinflammatory drug (diclofenac), thereby inhibiting the synthesis of prostaglandins, and developed transient impairment of renal function."3.69Impairment of renal function after treatment of a burn patient with diclofenac, a non-steroidal antiinflammatory drug. ( Ericsson, F; Jonsson, CE, 1995)
"This study determines the effects of dexamethasone versus co-administered dexamethasone and diclofenac, on carrageenan-evoked spinal c-Fos expression and peripheral oedema in the freely moving rat."3.69Enhanced effects of co-administered dexamethasone and diclofenac on inflammatory pain processing and associated spinal c-Fos expression in the rat. ( Besson, JM; Buritova, J; Chapman, V; Honoré, P, 1996)
"The effects of combined single oral treatments with non-steroidal anti-inflammatory drugs (NSAIDs) and the non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist dextromethorphan (DM) on arthritic pain were examined in a rat model of adjuvant-induced arthritis."3.69Effects of the combined oral administration of NSAIDs and dextromethorphan on behavioral symptoms indicative of arthritic pain in rats. ( Caruso, FS; Frenk, H; Lu, J; Mao, J; Mayer, DJ; Price, DD, 1996)
" The anti-inflammatory potency of NS-398 in rat carrageenin-induced edema was as potent as that of indomethacin and 8 times more potent than diclofenac."3.68NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions. ( Arai, I; Futaki, N; Hamasaka, Y; Higuchi, S; Iizuka, H; Otomo, S; Yoshikawa, K, 1993)
"In this trial, 20 patients suffering from bone metastasis pain received diclofenac, a non-steroid anti-inflammatory agent, by continuous IV infusion."3.67[Efficacy of diclofenac continuous perfusion in hyperalgic bone metastases. Apropos of 20 cases treated at Gustave Roussy Institute]. ( Ammarguellat, H; Benahmed, M; Court, B; Kple Faget, P; Pichard, E; Wibault, P, 1988)
"The pre-treatment pain severity of the groups was similar (p = 0."3.30The efficacy of intradermal sterile water application in severe renal colic: a randomised clinical trial. ( Ak, R; Aykanat, MC; Cimilli Öztürk, T; Kılıç, M; Ustaalioğlu, İ, 2023)
" No difference in adverse events was observed between the two groups."2.87Efficacy and safety of adalimumab by intra-articular injection for moderate to severe knee osteoarthritis: An open-label randomized controlled trial. ( Wang, J, 2018)
"Diclofenac alone was not better than double-placebo."2.84Side effects can enhance treatment response through expectancy effects: an experimental analgesic randomized controlled trial. ( Berna, C; Edwards, RR; Jensen, KB; Kaptchuk, TJ; Kirsch, I; Lee, YC; Sadler, P; Zion, SR, 2017)
" Adverse drug reactions may be renal, gastrointestinal, hematological, or immunologic."2.82Efficacy and Safety of NSAIDs in Infants: A Comprehensive Review of the Literature of the Past 20 Years. ( Gorenflo, M; Saur, P; van den Anker, JN; van Dyk, M; Welzel, T; Ziesenitz, VC, 2022)
" The incidence of adverse events of abnormal peripheral sensation was lower than in previous tanezumab trials."2.79Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial. ( Balanescu, AR; Brown, MT; Davignon, I; Feist, E; Smith, MD; West, CR; Wolfram, G, 2014)
"Aceclofenac was better tolerated in terms of incidence and severity of GI AEs and GPA requirement and was as efficacious as diclofenac."2.78Comparison of gastrointestinal safety and tolerability of aceclofenac with diclofenac: a multicenter, randomized, double-blind study in patients with knee osteoarthritis. ( Chandurkar, N; Pareek, A, 2013)
" Both the study medications were well tolerated with no incidence of serious adverse events."2.76Zaltoprofen, a noninferior alternative to diclofenac for the treatment of primary knee osteoarthritis -- a comparative evaluation of efficacy and safety in a 4-week, multicentric, randomized, double-blind, double-dummy trial. ( Ambade, RE; Chandurkar, NB; Gupta, AK; Jesalpura, BH; Pareek, A; Sirsikar, AD; Swamy, AP, 2011)
" The most common adverse events were treatment site related (n=16, 7."2.76Analgesic efficacy and safety of the diclofenac epolamine topical patch 1.3% (DETP) in minor soft tissue injury. ( Carr, W; Kuehl, K; Magelli, M; Rovati, S; Yanchick, J, 2011)
"Electroacupuncture can treat effectively hip osteoarthritis, relieve joint pain and improve joint function."2.75[Comparative observation on hip osteoarthritis treated with electroacupuncture and medication]. ( Fan, TY; Sheng, XP, 2010)
"Adhesive capsulitis or frozen shoulder is a common condition characterized by shoulder pain and stiffness in which conservative methods of treatment such as glucocorticosteroids, anti-inflammatory drugs, and physiotherapy play a significant part."2.73Pain relieving effect of short-course, pulse prednisolone in managing frozen shoulder. ( Haghighi, MH; Hemmati, AA; Saeidian, SR, 2007)
"Aceclofenac is a phenylacetic acid derivative with analgesic and anti-inflammatory properties and an improved gastrointestinal tolerance compared with other NSAIDs, such as diclofenac."2.73Bioequivalence and pharmacokinetic evaluation of two branded formulations of aceclofenac 100 mg: a single-dose, randomized, open-label, two-period crossover comparison in healthy Korean adult volunteers. ( Kang, JS; Lee, MH; Park, JH; Park, YS; Rhim, SY; Shaw, LM, 2008)
"Diclofenac-K was superior to placebo (P < 0."2.71A multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled, parallel-group comparison of diclofenac-K and ibuprofen for the treatment of adults with influenza-like symptoms. ( Frank, WO; Gold, MS; Grebe, W; Ionescu, E; Liu, JM, 2003)
" Efficacy assessments included overall joint pain intensity and Western Ontario and McMaster Universities Osteoarthritis Index subscales; tolerability was evaluated by adverse event and physician reporting."2.71Efficacy and safety of four doses of lumiracoxib versus diclofenac in patients with knee or hip primary osteoarthritis: a phase II, four-week, multicenter, randomized, double-blind, placebo-controlled trial. ( Beier, J; Geusens, P; Gitton, X; Hasler, P; Moore, A; Patel, SK; Poór, G; Schnitzer, TJ; Senftleber, I; Sloan, VS, 2004)
"Forty healthy volunteers instilled Dicloabak in the randomised eye and thiomersal-preserved diclofenac in the other eye, according to a strictly identical dosing regimen, for 28 days."2.71[Ocular tolerance of a new formulation of nonpreserved diclofenac]. ( Chiambaretta, F; Creuzot-Garcher, C; Dubray, C; Pilon, F; Pouliquen, P; Rebika, H; Rigal, D, 2004)
"At day 3, pain was reduced by -20."2.71Analgesic efficacy of a lecithin-vehiculated diclofenac epolamine gel in shoulder periarthritis and lateral epicondylitis: a placebo-controlled, multicenter, randomized, double-blind clinical trial. ( Cacchio, A; Forgács, A; Monteforte, P; Rovetta, G; Spacca, G, 2005)
"Diclofenac gel was effective and safe for relief of symptoms of OA of the knee over 3 weeks of dosing."2.71Efficacy of topical diclofenac diethylamine gel in osteoarthritis of the knee. ( Albrecht, HH; Elkik, F; Gold, MS; Liu, JM; Niethard, FU; Solomon, GS; Unkauf, M, 2005)
"Population pharmacokinetics of a fast release diclofenac were assessed with special focus on pharmacodynamic implications."2.69Population pharmacokinetics of fast release oral diclofenac in healthy volunteers: relation to pharmacodynamics in an experimental pain model. ( Brune, K; Drover, D; Geisslinger, G; Kettenmann, B; Kobal, G; Lötsch, J; Renner, B, 2000)
"Diclofenac patch was superior to placebo patch in relieving pain."2.69Topical diclofenac patch relieves minor sports injury pain: results of a multicenter controlled clinical trial. ( Devers, A; Friedman, E; Galer, BS; Perander, J; Rowbotham, M, 2000)
"Ibuprofen was also better tolerated than diclofenac sodium (100 mg/day), the latter being associated with gastrointestinal side effects in a significant proportion of patients."2.68Ibuprofen and diclofenac sodium in the treatment of osteoarthritis: a comparative trial of two once-daily sustained-release NSAID formulations. ( Baumgartner, H; Blum, W; Bruhin, A; Gallachi, G; Goldinger, G; Saxer, M; Schwarz, HA; Trost, H, 1996)
" After achieving adequate analgesia with regular dosing of oral methadone (T1), patient-controlled analgesia with methadone was administered for 3 days (T2)."2.68Opioid-sparing effect of diclofenac in cancer pain. ( Barresi, L; Caligara, M; Dardanoni, G; Mercadante, S; Sapio, M; Serretta, R, 1997)
"Diclofenac is a non-steroidal anti-inflammatory drug available in an ophthalmic preparation."2.68The effectiveness of topical diclofenac in relieving discomfort following traumatic corneal abrasions. ( Andrews, RM; Dayan, M; Fitt, AW; Griffiths, PG; Jayamanne, DG; Mitchell, KW, 1997)
"Ankylosing spondylitis is a systemic rheumatic disorder characterized by inflammation of the spine, sacroiliac, and large peripheral joints."2.66Efficacy of diclofenac in ankylosing spondylitis. ( Calabro, JJ, 1986)
"Diclofenac was preferred to naproxen, aspirin and indomethacin, while piroxicam and placebo were preferred only to aspirin."2.66Double-blind preference and compliance multicentre study in osteoarthritis: once-a-day treatment. ( Bassi, GP; Borghi, C; Camarri, E; Cocco, F; Francucci, BM; Giannini, R; Giordano, N; Marcolongo, R; Mordini, M; Neri, D, 1985)
"Codeine 60 mg was significantly superior to placebo in all pain measures."2.66Experimental pain induced by electrical and thermal stimulation of the skin in healthy man: sensitivity to 75 and 150 mg diclofenac sodium in comparison with 60 mg codeine and placebo. ( Gaupmann, G; Mittelbach, G; Schneider, S; Stacher, G; Steinringer, H; Winklehner, S, 1986)
"Diclofenac HPβCD was generally well tolerated in clinical trials, with injection-site reactions among the most commonly reported adverse events."2.52Diclofenac sodium injection (akis(®), dicloin (®)): a review of its use in the management of pain. ( Blair, HA; Plosker, GL, 2015)
"Commonly used approaches that are effective to minimise pain or discomfort include intravenous sedoanalgesia, inhalational agents and periprostatic infiltration of local anaesthetic."2.50Current methods of analgesia for transrectal ultrasonography (TRUS)-guided prostate biopsy -- a systematic review. ( Lee, C; Woo, HH, 2014)
" The combination of diclofenac sodium and metamizole sodium is acceptable, although, at a lower dosage of metamizole, the duration of analgesia is shortened."2.46Evidence-based intravenous pain treatment with analgesic infusion regimens. ( Cihal, P; Kamyar, MR; Lemmens-Gruber, R; Nemec, K; Timin, E, 2010)
"Many types of acute pain have been managed with traditional oral non-steroidal anti-inflammatory drugs (NSAIDs) and selective cyclooxygenase-2 inhibitors (coxibs)."2.46Topical diclofenac epolamine patch 1.3% for treatment of acute pain caused by soft tissue injury. ( Argoff, CE; McCarberg, BH, 2010)
" The bioavailability in terms of systemic exposure from the patch compared with oral intake (75 mg/day) is in the order of 1%."2.45Diclofenac epolamine (Flector) patch: evidence for topical activity. ( Petersen, B; Rovati, S, 2009)
" The incidence of adverse events in patients taking single or multiple doses of diclofenac potassium is similar to that of ibuprofen and placebo."2.44Diclofenac potassium 12.5mg tablets for mild to moderate pain and fever: a review of its pharmacology, clinical efficacy and safety. ( Moore, N, 2007)
"Pain is a common symptom experienced by people with osteoarthritis and rheumatoid arthritis and impacts upon mobility and quality of life."2.44Pain relief in osteoarthritis and rheumatoid arthritis: TENS. ( While, A; Ying, KN, 2007)
" Following oral administration, the less lipophilic celecoxib has a lower bioavailability (20-40%) than the other two coxibs (74-100%)."2.44Clinical use and pharmacological properties of selective COX-2 inhibitors. ( Klotz, U; Shi, S, 2008)
" The chronic use of diclofenac sodium can lead to adverse gastrointestinal problems."2.43The use of topical diclofenac for pain in osteoarthritis of the knee: a review. ( Banning, M, 2006)
" The usual oral dosage of aceclofenac is 100 mg twice daily in adults."2.40[Pharma-clinics. The drug of the month. Aceclofenac (Biofenac)]. ( Scheen, AJ, 1999)
"Aceclofenac is a phenylacetic acid derivative with anti-inflammatory and analgesic properties similar to those of diclofenac."2.39Aceclofenac. A review of its pharmacodynamic properties and therapeutic potential in the treatment of rheumatic disorders and in pain management. ( Brogden, RN; Wiseman, LR, 1996)
" This results in an increase in the rate of absorption of the active compound and, consequently, in an earlier onset of analgesic action."2.38Piroxicam-beta-cyclodextrin in the treatment of acute pain of rheumatic disease. ( Franchimont, P; Reginster, JY, 1993)
"BACKGROUND Peyronie's disease is a chronic inflammatory disease involving the tunica albuginea of the penile corpora cavernosa."1.72Complete Plaque Regression in Patients with Peyronie's Disease After Multimodal Treatment with Antioxidants: A Report of 2 Cases. ( De Giorgio, G; Paulis, G, 2022)
"Non-steroidal anti-inflammatory drugs (NSAIDs) are one of the most frequently used medications for pain, even though they increase the risk for adverse cardiovascular events."1.72Reduced risk of NSAID-Induced adverse events with concomitant use of misoprostol (MICRO study). ( Cheung, AK; Munger, MA; Nelson, SD; Sauer, BC; Teng, CC, 2022)
"Conservative medical approaches encompass oral, topical, and physical treatment."1.72Patients with Peyronie's disease achieve complete plaque regression after multimodal treatment with antioxidants: a case series. ( De Giorgio, G; Paulis, G, 2022)
"Pain is a major problem that burdens the health and economy of societies worldwide."1.72Preclinical comparison of antinociceptive effects between ibuprofen, diclofenac, naproxen, and acetaminophen on acid-stimulated body stretching and acid-depressed feeding behaviors in rats. ( Al-Mousa, AA; Alsalem, MI; Altarifi, AA; Neubert, JK; Nuseir, KQ; Qaoud, AK; Younis, BA, 2022)
"There is a strong correlation between treatment resistant depression and increase in inflammatory cytokines in plasma and cerebrospinal fluid."1.48Population scale retrospective analysis reveals distinctive antidepressant and anxiolytic effects of diclofenac, ketoprofen and naproxen in patients with pain. ( Abagyan, R; Cohen, IV; Lee, KC; Makunts, T, 2018)
"Current therapeutic approaches to depression fail for millions of patients due to lag in clinical response and non-adherence."1.46Population scale data reveals the antidepressant effects of ketamine and other therapeutics approved for non-psychiatric indications. ( Abagyan, R; Atayee, R; Cohen, IV; Makunts, T, 2017)
" In the pyridine series, compound 7a was found to be a highly potent and selective EP4 antagonist, with suitable rat and dog pharmacokinetic profiles."1.43Discovery of potent aryl-substituted 3-[(3-methylpyridine-2-carbonyl) amino]-2,4-dimethyl-benzoic acid EP4 antagonists with improved pharmacokinetic profile. ( Blanco, MJ; Chambers, M; Chandrasekhar, S; Fisher, MJ; Harvey, A; Lin, C; Mudra, D; Oskins, J; Vetman, T; Wang, XS; Warshawsky, AM; Yu, XP, 2016)
" Both 27 and 48 demonstrated robust activity in the acute rat monoiodoacetate-induced osteoarthritis model of pain, and subchronic dosing of 48 showed a shift to a lower EC50 over 7 days."1.43Substituted Indazoles as Nav1.7 Blockers for the Treatment of Pain. ( Daanen, JF; DeGoey, DA; El-Kouhen, OF; Fricano, MM; Frost, JM; Ghoreishi-Haack, N; Gum, RJ; Hsieh, GC; Kort, ME; Lundgaard, GL; Matulenko, MA; Neelands, T; Pai, M; Shi, L; Zhan, C; Zhang, XF, 2016)
"Aceclofenac (ACE) is a systematically designed drug, developed to circumvent the concerns associated with diclofenac."1.43Novel elastic membrane vesicles (EMVs) and ethosomes-mediated effective topical delivery of aceclofenac: a new therapeutic approach for pain and inflammation. ( Goyal, H; Katare, OP; Raza, K; Sharma, G; Thakur, K, 2016)
"The mechanical hyperalgesia was assessed by the Randall Selitto paw pressure test, which determines the paw withdrawal thresholds."1.43Association of terpinolene and diclofenac presents antinociceptive and anti-inflammatory synergistic effects in a model of chronic inflammation. ( Almeida, FR; Cunha, FV; Lopes, EM; Macedo, EM; Oliveira, FA; Piauilino, CA; Santos, WC; Sousa, BP; Sousa, DP, 2016)
" Worldwide health authorities, including the European Medicines Agency, Health Canada, and the US Food and Drug Administration, have advised that NSAIDs be prescribed at the lowest effective dosage and for the shortest duration."1.43Cost-effectiveness of Low-dose Submicron Diclofenac Compared With Generic Diclofenac. ( Miles, L; Mladsi, D; Odom, D; Ronquest, N; Saag, K, 2016)
"Diclofenac is a nonsteroidal anti-inflammatory drug (NSAID) that exhibits anti-inflammatory, antinociceptive, and antipyretic activities."1.42Evaluation of antinociceptive activity of nanoliposome-encapsulated and free-form diclofenac in rats and mice. ( Chiong, HS; Goh, JZ; Hakim, MN; Tang, SN; Yong, YK; Zuraini, A, 2015)
"Diclofenac treatment produced dose-related reversal of CRANE at 0."1.42Complete Freund's adjuvant-induced reduction of exploratory activity in a novel environment as an objective nociceptive endpoint for sub-acute inflammatory pain model in rats. ( Bannon, AW; Joshi, SK; Zhu, CZ, 2015)
"Cancer-induced bone pain is described as dull, aching ongoing pain."1.42Behavioral and neurochemical analysis of ongoing bone cancer pain in rats. ( King, T; Navratilova, E; Okun, A; Porreca, F; Remeniuk, B; Sukhtankar, D; Xie, JY, 2015)
"Valdecoxib has highest similarity to analogs 8, 19, 21, 22, 23, 26, 27, and 28."1.40Drug analogs of COX-2 selective inhibitors lumiracoxib and valdecoxib derived from in silico search and optimization. ( Bartzatt, R, 2014)
"A major concern in the treatment of acute pain/inflammation is the potential for drug-drug interactions resulting from P-gp induction by therapeutic agents co-administered with opioids."1.40P-glycoprotein modulates morphine uptake into the CNS: a role for the non-steroidal anti-inflammatory drug diclofenac. ( Davis, TP; DeMarco, KM; Laracuente, ML; Ronaldson, PT; Sanchez-Covarrubias, L; Slosky, LM; Thompson, BJ; Zhang, Y, 2014)
" To determine the possibility of a pharmacokinetic interaction, the oral bioavailability of diclofenac (10 mg/kg) was studied in presence and the absence of curcumin (31 mg/kg)."1.40Synergistic effect of the interaction between curcumin and diclofenac on the formalin test in rats. ( Castañeda-Hernández, G; Chávez Piña, AE; De Paz-Campos, MA; Ortiz, MI; Zazueta-Beltrán, L, 2014)
"Cancer pain is one of the most severe types of chronic pain, and the most common cancer pain is bone cancer pain."1.38Targeting A-type K(+) channels in primary sensory neurons for bone cancer pain in a rat model. ( Duan, KZ; Mei, YA; Xu, Q; Zhang, XM; Zhang, YQ; Zhao, ZQ, 2012)
"Two patients experienced oral numbness and intractable tongue pain, and 1 patient required endotracheal intubation because of upper respiratory tract obstruction."1.37Toxicities of raw Alocasia odora. ( Chun, BJ; Lee, BK; Moon, JM, 2011)
"Inflammation was induced in one hind paw of rats by intraplantar injection of carrageenan (250 μg)."1.36Is the sulphonamide radical in the celecoxib molecule essential for its analgesic activity? ( Bakhle, YS; de Francischi, JN; dos Reis, WG; Ferreira-Alves, DL; Gassani, BC; Paiva-Lima, P; Rezende, RM, 2010)
"6 h, oral bioavailability of 37% and 90%) with anti-inflammatory activity (ED 50 = 37 micromol/kg, mouse) and efficacy in pain models (thermal hyperalgesia, ED 50 = 72 micromol/kg, rat)."1.35Rotationally constrained 2,4-diamino-5,6-disubstituted pyrimidines: a new class of histamine H4 receptor antagonists with improved druglikeness and in vivo efficacy in pain and inflammation models. ( Adair, RM; Altenbach, RJ; Bettencourt, BM; Brioni, JD; Cowart, MD; Drizin, I; Esbenshade, TA; Fix-Stenzel, SR; Honore, P; Hsieh, GC; Liu, H; Marsh, KC; McPherson, MJ; Milicic, I; Miller, TR; Sullivan, JP; Wetter, JM; Wishart, N; Witte, DG, 2008)
" The purpose of this work was to examine in the rat if such interaction involves pharmacokinetic mechanisms or is solely limited to the pharmacodynamic level."1.35Pharmacokinetics and pharmacodynamics of diclofenac in the presence and absence of glibenclamide in the rat. ( Castañeda-Hernández, G; León-Reyes, MR; Ortiz, MI, 2008)
"Thermal hyperalgesia was also decreased by intraplantar treatment with morphine (10 microg) or diclofenac (100 microg)."1.35Effects of analgesics on the plantar incision-induced drop of the noxious heat threshold measured with an increasing-temperature water bath in the rat. ( Bölcskei, K; Füredi, R; Petho, G; Szolcsányi, J, 2009)
" Therefore, in view of the vast clinical uses and interactions of NSAIDs with commonly used therapeutic agents, the interaction of the NSAID diclofenac and glibenclamide was investigated about pharmacokinetic profile and antinociceptive effect in rats."1.35Pharmacokinetic of diclofenac in the presence and absence of glibenclamide in the rat. ( Castañeda-Hernández, G; León-Reyes, MR; Ortiz, MI, 2009)
"Pain was inferred from impairment of gait and stance."1.34Spontaneous nociceptive behaviour in female mice with Freund's complete adjuvant- and carrageenan-induced monoarthritis. ( Arborelius, L; Berge, OG; Brodin, E; Heilborn, U, 2007)
"Carrageenan induced significant mechanical allodynia, thermal hyperalgesia and paw oedema at 6 h post-carrageenan, while paw incision surgery induced significant mechanical allodynia and thermal hyperalgesia at 6 and 24 h post-surgery."1.34Oral administration of Ginkgo biloba extract, EGb-761 inhibits thermal hyperalgesia in rodent models of inflammatory and post-surgical pain. ( Biddlestone, L; Corbett, AD; Dolan, S, 2007)
"Naloxone pretreatment had no effect on the antinociceptive effects of intradermal diclofenac, ketorolac, lysine acetyl salicylate, and sodium salicylate."1.34The local antinociceptive actions of nonsteroidal antiinflammatory drugs in the mouse radiant heat tail-flick test. ( Deveci, MS; Dogrul, A; Gul, H; Gülmez, SE; Ossipov, MH; Porreca, F; Tulunay, FC, 2007)
"Thermal hyperalgesia was induced by mild heat injury (51 degrees C water for 20 s) which led to a 7-8 degrees C decrease of the noxious heat threshold."1.34Heat injury-induced drop of the noxious heat threshold measured with an increasing-temperature water bath: a novel rat thermal hyperalgesia model. ( Bölcskei, K; Horváth, D; Petho, G; Szolcsányi, J, 2007)
" Etoricoxib is partly metabolised by the cytochrome P450 isoenzyme CYP 3A4 and increases the bioavailability of ethinylestradiol."1.34Etoricoxib: new drug. Avoid using cox-2 inhibitors for pain. ( , 2007)
"Diclofenac iontophoresis was performed by varying either the current density (0."1.32The antinociceptive effect of iontophoretic direct application of diclofenac to arthritic knee-joints of rats. ( Borges Junior, NG; da Fonseca, JC; Motta, AF; Tonussi, CR, 2003)
"Chronic pain resulting from metastatic bone cancer remains poorly understood and resistant to treatment."1.32Anti-hyperalgesic activity of the cox-2 inhibitor lumiracoxib in a model of bone cancer pain in the rat. ( Bevan, S; Courade, JP; Dawson, J; Fox, A; Glatt, M; Gonzalez, I; Medhurst, S; Urban, L, 2004)
"Patients with renal colic are usually treated in emergency care units or by their family doctors and require immediate diagnosis and treatment."1.32[Rational therapy of urolithiasis in every-day practice]. ( Gschwend, JE; Hautmann, RE; Rinnab, L; Straub, M, 2004)
" We evaluated the antinociceptive effects of chronic administration of Delta(9)-tetrahydrocannabinol (Delta(9)-THC), anandamide (an endogenous cannabinoid), arachadonic acid, ethanolamine, and methanandamide on several NSAIDs via p."1.31Decrease in efficacy and potency of nonsteroidal anti-inflammatory drugs by chronic delta(9)-tetrahydrocannabinol administration. ( Anikwue, R; Huffman, JW; Martin, ZL; Welch, SP, 2002)
"Allodynia and hyperalgesia appeared on day 5 post-inoculation."1.31Pharmacological and immunohistochemical characterization of a mouse model of acute herpetic pain. ( Andoh, T; Kuraishi, Y; Nemoto, H; Nitta, M; Nojima, H; Shiraki, K; Takahata, H; Takasaki, I, 2000)
" The aim of the present study was to evaluate the comparative efficacy of intramuscularly injected nimesulide with that of diclofenac and to elucidate the pharmacokinetic profile of this formulation."1.30Comparative analgesic activity of nimesulide and diclofenac by intramuscular route: correlation with pharmacokinetic profile of nimesulide. ( Gupta, SK; Mathur, P; Sengupta, S; Velpandian, T, 1998)
"Diclofenac was the NSAID of choice for 69."1.30Analgesia in soft-tissue injury: current practice in Auckland is not supported by the available evidence. ( Jones, PG, 1999)
"Meclofenamic acid is an analgesic endowed with anti-inflammatory properties."1.28Clinical experiences in the treatment of pain in rheumatology. ( Pellegrini, P, 1991)

Research

Studies (429)

TimeframeStudies, this research(%)All Research%
pre-199030 (6.99)18.7374
1990's85 (19.81)18.2507
2000's143 (33.33)29.6817
2010's124 (28.90)24.3611
2020's47 (10.96)2.80

Authors

AuthorsStudies
Alagarsamy, V2
Raja Solomon, V1
Dhanabal, K1
Cowart, MD1
Altenbach, RJ1
Liu, H1
Hsieh, GC2
Drizin, I1
Milicic, I1
Miller, TR1
Witte, DG1
Wishart, N1
Fix-Stenzel, SR1
McPherson, MJ1
Adair, RM1
Wetter, JM1
Bettencourt, BM1
Marsh, KC1
Sullivan, JP1
Honore, P3
Esbenshade, TA1
Brioni, JD1
Sujith, KV1
Rao, JN1
Shetty, P1
Kalluraya, B1
Hollinshead, SP1
Astles, PC1
Chambers, MG1
Johnson, MP1
Palmer, J1
Tidwell, MW1
Singh, A2
Kaur, M1
Sharma, S1
Bhatti, R1
Singh, P2
Vivier, D1
Bennis, K1
Lesage, F1
Ducki, S1
Blanco, MJ1
Vetman, T1
Chandrasekhar, S1
Fisher, MJ1
Harvey, A1
Chambers, M1
Lin, C1
Mudra, D1
Oskins, J1
Wang, XS1
Yu, XP1
Warshawsky, AM1
Frost, JM1
DeGoey, DA1
Shi, L1
Gum, RJ1
Fricano, MM1
Lundgaard, GL1
El-Kouhen, OF1
Neelands, T1
Matulenko, MA1
Daanen, JF1
Pai, M1
Ghoreishi-Haack, N1
Zhan, C1
Zhang, XF1
Kort, ME1
Bua, S1
Lucarini, L1
Micheli, L1
Menicatti, M1
Bartolucci, G1
Selleri, S1
Di Cesare Mannelli, L1
Ghelardini, C1
Masini, E1
Carta, F1
Gratteri, P1
Nocentini, A1
Supuran, CT1
Yakushin, S1
Polyakova, S1
Shvarts, Y1
Kastanayan, A1
Krechikova, D1
Ershova, O1
Nikulenkova, N1
Vinogradova, I1
Hyun, BJ1
Cha, JE1
de Campos, GC1
de Almeida Macedo, E1
Kummer, AM1
Papaleo Rosim, M1
Millan Fachi, M1
Auletta, LL1
Mohan, T1
Ajdnik, U1
Nagaraj, C1
Lackner, F1
Dobaj Štiglic, A1
Palani, T1
Amornkitbamrung, L1
Gradišnik, L2
Maver, U2
Kargl, R1
Stana Kleinschek, K1
Babandi, RM1
Agboghoroma, OC1
Durojaiye, KW1
Jimoh, KO1
Essiet, EA1
Nurathirah, MN1
Yazid, MB1
Norhayati, MN1
Baharuddin, KA1
Abu Bakar, MA1
Tomatsu, K1
Yasuda, S1
Fuady, A1
Matsumoto, H1
Paulis, G2
De Giorgio, G2
Kubo, T1
Kumai, T1
Ikegami, H1
Kano, K1
Nishii, M1
Seo, T1
Ribeiro, H1
Rodrigues, I1
Napoleão, L1
Lira, L1
Marques, D1
Veríssimo, M1
Andrade, JP1
Dourado, M1
Lee, N1
Mårtensson, LB1
Hashemi, SMH1
Enayatifard, R1
Akbari, J1
Saeedi, M1
Seyedabadi, M1
Morteza-Semnani, K1
Babaei, A1
Asare-Addo, K1
Nokhodchi, A1
Munger, MA1
Nelson, SD1
Teng, CC1
Cheung, AK1
Sauer, BC1
Chobpenthai, T1
Arunwatthanangkul, P1
Mahikul, W1
Tu, JF1
Cao, Y2
Wang, LQ1
Shi, GX1
Jia, LC1
Liu, BL1
Yao, WH1
Pei, XL1
Li, HW1
Yan, SY1
Yang, JW1
Qu, ZC1
Liu, CZ1
Li, T1
Guo, M1
Zhang, W2
Ziesenitz, VC1
Welzel, T1
van Dyk, M1
Saur, P1
Gorenflo, M1
van den Anker, JN1
Altarifi, AA1
Younis, BA1
Nuseir, KQ1
Al-Mousa, AA1
Qaoud, AK1
Alsalem, MI1
Neubert, JK1
Latif, S1
Liaqat, A1
Imran, M1
Javaid, A1
Hussain, N1
Jesionowski, T1
Bilal, M1
Tsurko, VV1
Gromova, MA1
Arai, T1
Suzuki-Narita, M1
Takeuchi, J1
Tajiri, I1
Inage, K1
Kawarai, Y1
Eguchi, Y1
Shiga, Y1
Hozumi, T1
Kim, G1
Tsuchiya, R1
Otagiri, T1
Mukaihata, T1
Hishiya, T1
Toshi, N1
Okuyama, K1
Tokeshi, S1
Furuya, T1
Maki, S1
Matsuura, Y1
Suzuki, T1
Nakamura, J1
Hagiwara, S1
Ohtori, S1
Orita, S1
Yin, F1
Ma, J1
Xiao, H1
Ao, R1
Zhang, F1
Li, W1
Wang, W1
Zeng, P1
Lu, T1
Revel, FB1
Araga, M1
Patel, S1
Moreira, S1
Zhang, J1
Ma, YT1
Dong, YL1
Wang, B1
Xie, WP1
Huang, QM1
Zheng, YJ1
Murdoch, I1
Carver, AL1
Sultan, P1
O'Carroll, JE1
Blake, L1
Carvalho, B1
Onwochei, DN1
Desai, N1
Karami, Z1
Zanjani, MS1
Andalib, S1
Babaie, H1
Aminoroaia, P1
Hamdi, BA1
Amin, ZA1
Shareef, AMY1
Al-Bustany, HA1
Aykanat, MC1
Kılıç, M1
Cimilli Öztürk, T1
Ustaalioğlu, İ1
Ak, R1
Kumar, NS1
Muktesh, G1
Samra, T1
Sarma, P1
Samanta, J1
Sinha, SK1
Dhaka, N1
Yadav, TD1
Gupta, V1
Kochhar, R1
Brennan, PA1
Lewthwaite, R1
Sakthithasan, P1
McGuigan, S1
Donnelly, O1
Alam, P1
Gomez, RS1
Fedele, S1
Gromova, OA1
Torshin, IY1
Putilina, MV1
Stakhovskaia, LV1
Rudakov, KV1
Moussa, M2
Papatsoris, AG2
Chakra, MA2
Golcuk, Y1
Demir, A1
Yıldırım, B1
Acar, E1
Ailincai, D1
Mititelu-Tartau, L1
Marin, L1
Aras, B2
Uruç, F3
Huang, H1
Luo, M1
Liang, H1
Pan, J1
Yang, W1
Zeng, L1
Liang, G1
Hou, S1
Zhao, J1
Liu, J2
Zarro, M1
Tamberrino, K1
Bane, EM1
Bihlet, AR1
Byrjalsen, I1
Simon, LS1
Carrara, D1
Delpy, L1
Derne, C1
Ivelik, HI1
Kopečná, M1
Kováčik, A1
Novák, P1
Boncheva Bettex, M1
Vávrová, K1
Wolff, DG1
Christophersen, C1
Brown, SM1
Mulcahey, MK1
Bussin, E1
Cairns, B1
Gerschman, T1
Fredericson, M1
Bovard, J1
Scott, A1
Nipa, NS1
Ali, T1
Akhter, S1
Rafiq, K1
Gowayed, MA1
Abdel-Bary, A1
El-Tahan, RA1
Mishra, NR1
Kumar, R1
Tripathy, SK1
Lai, PM1
Collaku, A1
Reed, K1
Cohen, IV2
Makunts, T2
Atayee, R1
Abagyan, R2
Makri, OE1
Tsapardoni, FN1
Pagoulatos, DD1
Pharmakakis, N1
Georgakopoulos, CD1
Huh, BK1
Kim, BH1
Kim, SN1
Park, CG1
Lee, SH1
Kim, KR1
Heo, CY1
Choy, YB1
Maver, T1
Kurečič, M1
Hribernik, S1
Smrke, DM1
Kleinschek, KS1
Wang, J1
Breivik, H2
Maldonado-Avila, M1
Garduño-Arteaga, LM1
Vela-Mollinedo, RA1
Jaspersen-Gastelum, J1
Virgen-Gutierrez, F1
Del Rosario-Santiago, M1
Rios-Davila, V1
Tsiklauri, N2
Pirkulashvili, N1
Nozadze, I2
Nebieridze, M2
Gurtskaia, G2
Abzianidze, E1
Tsagareli, MG2
Lee, KC1
Kreutzkamp, B1
Ogawa, S1
Natsume, T1
Takamatsu, H1
Ramirez-Garcia-Luna, JL1
Wong, TH1
Chan, D1
Al-Saran, Y1
Awlia, A1
Abou-Rjeili, M1
Ouellet, S1
Akoury, E1
Lemarié, CA1
Henderson, JE1
Martineau, PA1
Şahin, M1
Eşer, İ1
Rainsford, KD2
Roberts, MS1
Nencioni, A1
Jones, C1
Andreev, YA1
Osmakov, DI1
Koshelev, SG1
Maleeva, EE1
Logashina, YA1
Palikov, VA1
Palikova, YA1
Dyachenko, IA1
Kozlov, SA1
Karateev, AE1
Pogozheva, EY1
Filatova, EA1
Amirjanova, VN1
Lila, AM1
Antipova, OV1
Babaeva, AR1
Volkorezova, AV1
Davydova, AF1
Davtyan, VG1
Zonova, EV1
Ivanova, ON1
Kalinina, NN1
Kiseleva, NI1
Knyazeva, LA1
Kulikov, AI1
Nesmeyanova, OB1
Mazurov, VI1
Masneva, LV1
Menshikova, LV1
Obuhova, IV1
Otteva, EN1
Salnikova, TS1
Shсhendrygin, IN1
Yakupova, SP1
Wade, AG1
Crawford, GM1
Young, D1
Corson, S1
Brown, C1
Pareek, A2
Chandurkar, N1
Gu, LJ1
Qiu, XD1
Zhao, Y1
Qin, WK1
Dong, FH1
Ibrahim, ZM1
Sayed Ahmed, WA1
Balanescu, AR1
Feist, E1
Wolfram, G1
Davignon, I1
Smith, MD1
Brown, MT1
West, CR1
Predel, HG2
Giannetti, B3
Seigfried, B1
Novellini, R1
Menke, G1
de Knegt, NC1
Evenhuis, HM1
Lobbezoo, F1
Schuengel, C1
Scherder, EJ1
Bartzatt, R1
Sifferlin, A1
Lee, C2
Woo, HH1
Zang, YJ1
Borisenko, OV1
Belen'kiĭ, DA1
Iacovides, S1
Baker, FC1
Avidon, I1
Inal, S1
Kabay, S1
Cayci, MK1
Kuru, HI1
Altikat, S1
Akkas, G1
Deger, A1
Tamaddonfard, E1
Farshid, AA1
Eghdami, K1
Samadi, F1
Erfanparast, A1
de Souza, AH1
da Costa Lopes, AM1
Castro, CJ1
Pereira, EM1
Klein, CP1
da Silva, CA1
da Silva, JF1
Ferreira, J1
Gomez, MV1
Sanchez-Covarrubias, L1
Slosky, LM1
Thompson, BJ1
Zhang, Y1
Laracuente, ML1
DeMarco, KM1
Ronaldson, PT1
Davis, TP2
Maulvi, FA1
Thakkar, VT1
Soni, TG1
Gandhi, TR1
Kara, D1
Yapucu Güneş, Ü1
Ioannidis, S1
Kampantais, S1
Ioannidis, A1
Gkagkalidis, K1
Vakalopoulos, I1
Toutziaris, C1
Patsialas, C1
Laskaridis, L1
Dimopoulos, P1
Dimitriadis, G1
Bushuven, S1
Heise, D1
Bolbrinker, J1
Dhokchawle, BV1
Bhandari, AB1
De Paz-Campos, MA1
Ortiz, MI6
Chávez Piña, AE1
Zazueta-Beltrán, L1
Castañeda-Hernández, G7
Bannuru, RR1
Schmid, CH1
Kent, DM1
Vaysbrot, EE1
Wong, JB1
McAlindon, TE1
Hodge, B1
Skolnik, D1
Goh, JZ1
Tang, SN1
Chiong, HS1
Yong, YK1
Zuraini, A1
Hakim, MN1
Zhu, CZ1
Bannon, AW1
Joshi, SK1
Datar, PA1
Limaye, SA1
Su, YF1
Yang, YC1
Hsu, HK1
Hwang, SL1
Lee, KS1
Lieu, AS1
Chan, TF1
Lin, CL1
Colak, S1
Kutlucan, L1
Erdogan, MO1
Afacan, MA1
Saritas, A1
Kandis, H1
Remeniuk, B1
Sukhtankar, D1
Okun, A1
Navratilova, E1
Xie, JY1
King, T1
Porreca, F2
Ilango, K1
Valentina, P1
Kumar, G1
Dixit, D1
Nilewar, S1
Kathiravan, MK1
Blair, HA1
Plosker, GL1
Standing, JF3
Savage, I3
Pritchard, D2
Waddington, M2
Paull, DR1
Small, AH1
Labeur, L1
Colditz, IG1
Sarganas, G1
Buttery, AK1
Zhuang, W1
Wolf, IK1
Grams, D1
Rosario, AS1
Scheidt-Nave, C1
Knopf, H1
Wadsworth, LT1
Kent, JD1
Holt, RJ1
Acmaz, G1
Bayraktar, E1
Aksoy, H1
Başer, M1
Yilmaz, MO1
Müderris, İİ1
Han, YM1
Woo, SU1
Choi, MS1
Park, YN1
Kim, SH1
Yim, H1
Yoo, HH1
Fouda, UM1
Salah Eldin, NM1
Elsetohy, KA1
Tolba, HA1
Shaban, MM1
Sobh, SM1
Scavone, C1
Bonagura, AC1
Fiorentino, S1
Cimmaruta, D1
Cenami, R1
Torella, M1
Fossati, T1
Rossi, F1
Sharma, G1
Goyal, H1
Thakur, K1
Raza, K1
Katare, OP1
Elzaki, WM1
Abubakr, NH1
Ziada, HM1
Ibrahim, YE1
Macedo, EM1
Santos, WC1
Sousa, BP1
Lopes, EM1
Piauilino, CA1
Cunha, FV1
Sousa, DP1
Oliveira, FA1
Almeida, FR1
Edwards, RR2
Dolman, AJ1
Martel, MO1
Finan, PH1
Lazaridou, A1
Cornelius, M1
Wasan, AD1
Schattner, A1
Naz, S1
Memon, NY1
Sattar, A1
Baloch, R1
Sen, H1
Erturhan, S1
Sadioglu, E1
Bayrak, O1
Seckiner, İ1
Mladsi, D1
Ronquest, N1
Odom, D1
Miles, L1
Saag, K1
Goh, CF1
Craig, DQ1
Hadgraft, J1
Lane, ME1
Iannitti, T2
McDermott, MF1
Laurino, C1
Malagoli, A1
Palmieri, B2
Raison, N1
Ahmed, K1
Brunckhorst, O1
Dasgupta, P1
Krügel, U1
Straub, I1
Beckmann, H1
Schaefer, M1
Berna, C1
Kirsch, I1
Zion, SR1
Lee, YC1
Jensen, KB1
Sadler, P1
Kaptchuk, TJ1
Hosni, HM1
Abdulla, MM1
León-Reyes, MR2
Kean, WF2
Ehrlich, GE1
Haswir, H1
Umbas, R1
Kampitak, T1
van Lieshout, J1
van Koningsbruggen, PJ1
Boukes, FS1
Goudswaard, AN1
Petersen, B1
Rovati, S5
Pourmorad, F1
Ebrahimzadeh, MA1
Mahmoudi, M2
Yasini, S1
Naidu, PS1
Booker, L1
Cravatt, BF2
Lichtman, AH2
Kyle, C1
Zachariah, J1
Kinch, H1
Ellis, G1
Andrews, C1
Adekunle, F1
Füredi, R1
Bölcskei, K3
Szolcsányi, J3
Petho, G3
Woodson, SA1
Faaij, RA1
Ziere, G1
Zietse, R1
Van der Cammen, TJ1
Harris, D1
Pease, N1
Eryildirim, B1
Kuyumcuoğlu, U1
Tarhan, F1
Faydaci, G1
Niazi, J1
Bansal, Y1
Goel, RK1
Dolan, S2
Gunn, MD1
Biddlestone, L2
Nolan, AM1
Ooi, K1
Keady, S1
Howard, RF1
Wong, IC1
Boyce-Rustay, JM1
Zhong, C1
Kohnken, R1
Baker, SJ1
Simler, GH1
Wensink, EJ1
Decker, MW1
Schuelert, N1
McDougall, JJ1
Sood, S1
Arora, B1
Bansal, S1
Muthuraman, A1
Gill, NS1
Arora, R1
Bali, M1
Sharma, PD1
Moen, MD1
Rahimi, M1
Makarem, J1
Goharrizi, AG1
Barthel, HR1
Peniston, JH1
Clark, MB1
Gold, MS3
Altman, RD1
Aktoz, T1
Kaplan, M1
Turan, U1
Memis, D1
Atakan, IH1
Inci, O1
Mueller, EA1
Kirch, W1
Reiter, S1
Ramirez, MR1
Guterres, L1
Dickel, OE1
de Castro, MR1
Henriques, AT1
de Souza, MM1
Barros, DM1
Hiros, M1
Selimovic, M1
Spahovic, H1
Sadovic, S1
Spuzic-Celic, E1
Ahmad, NS1
Waheed, A1
Farman, M1
Qayyum, A1
Tokgoz, H1
Yurtlu, S1
Hanci, V1
Turksoy, O1
Erol, B2
Akduman, B1
Mungan, A1
Gan, TJ2
Joshi, RS1
Mandhane, PG1
Diwakar, SD1
Dabhade, SK1
Gill, CH1
Nemec, K1
Cihal, P1
Timin, E1
Kamyar, MR1
Lemmens-Gruber, R1
Kapoor, S1
Yanchick, J2
Magelli, M3
Bodie, J1
Sjogren, J1
Gassani, BC1
Rezende, RM1
Paiva-Lima, P1
Ferreira-Alves, DL1
dos Reis, WG1
Bakhle, YS1
de Francischi, JN1
Kuehl, KS1
McCarberg, BH1
Argoff, CE1
Resorlu, B1
Bozkurt, OF1
Senocak, C1
Unsal, A1
Böttcher, A1
Guder, E1
Just, T1
Moon, JM1
Lee, BK1
Chun, BJ1
Ağaç, E1
Güneş, UY1
Kumar, S1
Behera, NC1
Sarkar, D1
Prasad, S1
Mandal, AK1
Singh, SK1
Sheng, XP1
Fan, TY1
Taha, HM1
Rehmani, RS1
Gupta, AK1
Chandurkar, NB1
Sirsikar, AD1
Ambade, RE1
Jesalpura, BH1
Swamy, AP1
Kuehl, K1
Carr, W1
Chau, LH1
Tai, DC1
Fung, BT1
Li, JC1
Fan, CW1
Li, MK1
Böhme, K1
Heckes, B1
Thomitzek, K1
Schnitzer, TJ2
Dattani, ID1
Seriolo, B1
Schneider, H1
Moore, A2
Tseng, L1
Sallstig, P1
Rebuli, R1
Maxwell, T1
Hasani, A1
Soljakova, M1
Jakupi, M1
Ustalar-Ozgen, S1
Brewer, AR1
Pierchala, LA1
Yanchick, JK1
Moisseiev, E1
Varssano, D1
Lende, AB1
Kshirsagar, AD1
Deshpande, AD1
Muley, MM1
Patil, RR1
Bafna, PA1
Naik, SR1
Mibielli, MA1
Nunes, CP1
Cohen, JC1
Scussel, AB1
Higashi, R1
Bendavit, GG1
Oliveira, L1
Geller, M1
Duan, KZ1
Xu, Q1
Zhang, XM1
Zhao, ZQ1
Mei, YA1
Zhang, YQ1
Das, S1
Haldar, PK2
Pramanik, G2
Panda, SP1
Bera, S1
Kumar, A2
Lohan, P1
Aneja, DK1
Gupta, GK1
Kaushik, D1
Prakash, O1
Afzal, M1
Gupta, G1
Kazmi, I1
Rahman, M1
Afzal, O1
Alam, J1
Hakeem, KR1
Pravez, M1
Gupta, R1
Anwar, F1
Hamelsky, S1
Gold, M1
Naskar, S1
Mazumder, UK1
Saha, P1
Gupta, M1
Ghosh, S1
Wise, LE1
Chen, Y1
Gujjar, R1
Mahadevan, A1
Hoffmann, P1
Kopačka, P1
Gugliotta, B1
Gwanyanya, A1
Macianskiene, R1
Mubagwa, K1
Vélez de Mendizábal, N1
Vásquez-Bahena, D1
Jiménez-Andrade, JM1
Trocóniz, IF1
Setoguchi, N1
Takamura, N1
Fujita, K1
Ogata, K1
Tokunaga, J1
Nishio, T1
Chosa, E1
Arimori, K1
Kawai, K1
Yamamoto, R1
Rottigni, V1
Büyükokuroğlu, ME1
Labenz, J1
Blum, AL2
Bolten, WW1
Dragosics, B1
Rösch, W1
Stolte, M2
Koelz, HR1
Gottesdiener, K1
Schnitzer, T1
Fisher, C1
Bockow, B1
Markenson, J1
Ko, A1
DeTora, L1
Curtis, S1
Geissler, L1
Gertz, BJ1
Kohase, H1
Miyamoto, T1
Umino, M1
Anikwue, R1
Huffman, JW1
Martin, ZL1
Welch, SP1
Okuyama, M1
Shibata, T1
Morita, T1
Kitada, M1
Tukahara, Y1
Fukushima, Y1
Ikeda, K1
Fuzita, J1
Shimano, T1
Weaver, CS1
Terrell, KM1
Li, CF1
Wong, CY1
Chan, CP1
Ho, PC1
Colak, T1
Ipek, T1
Kanik, A1
Ogetman, Z1
Aydin, S1
Almási, R1
Grebe, W1
Ionescu, E1
Liu, JM2
Frank, WO1
Lázaro, C1
Caseras, X1
Torrubia, R1
Baños, JE1
Burian, M2
Tegeder, I2
Seegel, M1
Geisslinger, G4
Motta, AF1
Borges Junior, NG1
da Fonseca, JC1
Tonussi, CR1
Tallarida, RJ1
Cowan, A1
Raffa, RB1
Michalsen, A1
Klotz, S1
Lüdtke, R1
Moebus, S1
Spahn, G1
Dobos, GJ1
Leman, P1
Kapadia, Y1
Herington, J1
Patil, CS1
Jain, NK1
Kulkarni, SK1
Dellabella, M1
Milanese, G1
Muzzonigro, G1
Murugananthan, G1
Venkateshperumal, R1
Fox, A1
Medhurst, S1
Courade, JP1
Glatt, M1
Dawson, J1
Urban, L1
Bevan, S1
Gonzalez, I1
Haq, A1
Patel, HR1
Habib, MR1
Donaldson, PJ1
Parry, JR1
Legrand, E1
Amir, M1
Shikha, K1
Ukhal', MI1
Melenevskiĭ, DA1
Sørensen, OG1
Hansen, TB1
Akhtar, NM1
Naseer, R1
Farooqi, AZ1
Aziz, W1
Nazir, M1
Mysler, E1
Beier, J1
Geusens, P1
Hasler, P1
Patel, SK1
Senftleber, I1
Gitton, X1
Sloan, VS2
Poór, G1
Bezer, M1
Gökkuş, K1
Kocaoğlu, B1
Güven, O1
Dodd, JM1
Hedayati, H1
Pearce, E1
Hotham, N1
Crowther, CA1
Adler, S1
Schostak, M1
Haas, H1
Walz, J1
Magnette, JL1
Kienzler, JL1
Sallin, D1
Ménart, C1
Nollevaux, F1
Knops, A1
Lyseng-Williamson, KA1
Curran, MP1
Vas, J1
Méndez, C1
Perea-Milla, E1
Vega, E1
Panadero, MD1
León, JM1
Borge, MA1
Gaspar, O1
Sánchez-Rodríguez, F1
Aguilar, I1
Jurado, R1
Rinnab, L1
Gschwend, JE1
Hautmann, RE1
Straub, M1
Chiambaretta, F1
Creuzot-Garcher, C1
Pilon, F1
Pouliquen, P1
Rebika, H1
Dubray, C1
Rigal, D1
Solignac, M2
Jones, NG1
Slater, R1
Cadiou, H1
McNaughton, P1
McMahon, SB1
Khan, MS1
Akhter, M1
Teekachunhatean, S1
Kunanusorn, P1
Rojanasthien, N1
Sananpanich, K1
Pojchamarnwiputh, S1
Lhieochaiphunt, S1
Pruksakorn, S1
Mohta, M1
Agarwal, D1
Sethi, AK1
Sandhu, K1
Christidis, N1
Kopp, S1
Ernberg, M1
Bierma-Zeinstra, SM1
Belo, JN1
Thomas, S1
Di Rienzo Businco, L1
Di Rienzo Businco, A1
D'Emilia, M1
Lauriello, M1
Coen Tirelli, G1
Lozano-Cuenca, J1
Granados-Soto, V5
Schaffler, K1
Reitmeir, P1
Gschanes, A1
Eggenreich, U1
Baer, PA1
Thomas, LM1
Shainhouse, Z1
Wright, GA1
Fleischmann, R1
Sheldon, E1
Maldonado-Cocco, J1
Dutta, D1
Yu, S1
Woo, WW1
Man, SY1
Lam, PK1
Rainer, TH1
Spacca, G1
Cacchio, A1
Forgács, A1
Monteforte, P1
Rovetta, G1
Irer, B1
Gulcu, A1
Aslan, G1
Goktay, Y1
Celebi, I1
Niethard, FU1
Solomon, GS1
Unkauf, M1
Albrecht, HH1
Elkik, F1
Kim, JS1
Hwang, JM1
Singh, G1
Fort, JG1
Goldstein, JL1
Levy, RA1
Hanrahan, PS1
Bello, AE1
Andrade-Ortega, L1
Wallemark, C1
Agrawal, NM1
Eisen, GM1
Stenson, WF1
Triadafilopoulos, G1
Zochling, J1
Bohl-Bühler, MH1
Baraliakos, X1
Feldtkeller, E1
Braun, J1
Agarwal, A2
Dhiraaj, S1
Singhal, V1
Singh, U2
Diener, HC1
Montagna, P1
Gács, G1
Lyczak, P1
Schumann, G1
Zöller, B1
Mulder, LJ1
Siegel, J1
Edson, K1
Gøtzsche, PC1
Ericsson, E1
Wadsby, M1
Hultcrantz, E1
Ojewole, JA2
Esparza, F1
Cobián, C1
Jiménez, JF1
García-Cota, JJ1
Sánchez, C1
Maestro, A1
Banning, M1
Parker, AG1
Peraza, GG1
Sena, J1
Silva, ES1
Soares, MC1
Vaz, MR1
Furlong, EB1
Muccillo-Baisch, AL1
Moore, N1
Heilborn, U1
Berge, OG1
Arborelius, L1
Brodin, E1
Gautam, S1
Gupta, D1
Mutalik, S1
Naha, A1
Usha, AN1
Ranjith, AK1
Musmade, P1
Manoj, K1
Anju, P1
Prasanna, S1
Corbett, AD1
Dogrul, A1
Gülmez, SE1
Deveci, MS1
Gul, H1
Ossipov, MH1
Tulunay, FC1
Horváth, D1
Saeidian, SR1
Hemmati, AA1
Haghighi, MH1
Orssaud, C1
Roche, O1
El Dirani, H1
Allali, J1
Dufier, JL1
López, JC1
Vigil-De Gracia, P1
Vega-Malek, JC1
Ruiz, E1
Vergara, V1
Bannwarth, B1
Bérenbaum, F1
Kudaeva, FM1
Eliseev, MS1
Barskova, VG1
Nasonova, VA1
Azevedo, AO1
Campos, JJ1
Galdino, GS1
Braga, FC1
Duarte, ID1
Perez, AC1
Ying, KN1
While, A1
Duh, D1
Vandevijver, A1
Shi, S1
Klotz, U1
Bhomi, KK1
Lim, HH1
Consigliere, DT1
Tiong, HY1
Kayali, C1
Agus, H1
Surer, L1
Turgut, A1
D'Anchise, R1
Bulitta, M1
Zacher, J1
Altman, R1
Bellamy, N2
Brühlmann, P1
Da Silva, J1
Huskisson, E1
Taylor, RS1
Brooks, TA1
Nametz, N1
Charles, R1
Rhim, SY1
Park, JH1
Park, YS1
Lee, MH1
Shaw, LM1
Kang, JS1
Baroni, L2
Borghi, C2
Trombetta, N2
Marcolongo, R3
Giordano, N2
Mattara, L1
Leardini, G1
Lavezzari, M1
Gruni, G1
Mandelli, V1
Wafin, F1
Valindas, E1
Wuolijoki, E2
Grossi, E2
Brogden, RN2
Heel, RC1
Pakes, GE1
Speight, TM1
Avery, GS1
Riihiluoma, P1
Pulkkinen, MO1
Muriel-Villoria, C1
Zungri-Telo, E1
Díaz-Curiel, M1
Fernández-Guerrero, M1
Moreno, J1
Puerta, J1
Ortiz, P1
Haddad, FS1
Williams, RL1
Valentini, M1
Cannizzaro, R1
Poletti, M1
Bortolussi, R1
Fracasso, A1
Testa, V1
Sozzi, M1
Fornasarig, M1
Bortoluzzi, F1
Grazioli, I1
Porto, A1
Almeida, H1
Cunha, MJ1
Macciocchi, A1
Bakshi, R2
Ezzet, N1
Frey, L1
Lasry, D1
Salliere, D1
Inoue, K1
Motonaga, A1
Dainaka, J1
Nishimura, T1
Hashii, H1
Yamate, K1
Ueda, F1
Kimura, K1
Björkman, R4
Bombardier, C1
Peloso, PM1
Goldsmith, CH1
Reginster, JY2
Franchimont, P1
Benoit, R1
Blanchi, A1
Roubin, C1
Chapeau, MC1
Ardia, A1
Franchini, S1
Baggio, A1
Cornelli, U1
Barr, S1
Buchanan, WW1
Chalmers, A1
Ford, PM1
Kraag, GR1
Gerecz-Simon, E1
Campbell, J1
March, L1
Irwig, L1
Schwarz, J1
Simpson, J1
Chock, C1
Brooks, P1
Dawson, C1
Vale, JA1
Corry, DA1
Cohen, NP1
Gallagher, J1
Nockler, IB1
Whitfield, HN1
Babej-Dölle, R1
Freytag, S1
Eckmeyer, J1
Zerle, G1
Schinzel, S1
Schmeider, G1
Stankov, G1
Frey, W1
Wassmer, P1
Frey-Rindova, P1
Braun, D1
Schwarz, F1
Arnold, M1
Piguet, A1
Villiger, B1
Clarke, GD1
MacPherson, IS1
Petrone, G1
Spangler, RS1
Dolenska, S1
Kahraman, S1
Ercan, S1
Aypar, U1
Erdem, K1
Porzio, F1
Bacon, P1
Elam, M1
Sandin, R1
Sternlo, JE1
Stam, H1
Brodd, B1
Ullman, A1
Hedner, J2
Hovorka, J1
Kallela, H1
Korttila, K1
Futaki, N1
Yoshikawa, K1
Hamasaka, Y1
Arai, I1
Higuchi, S1
Iizuka, H1
Otomo, S1
Nunez, J1
Lake, AP1
Marchini, M1
Tozzi, L1
Pistai, R1
Fedele, L1
Jonsson, CE1
Ericsson, F1
Martín-Mola, E1
Gijón-Baños, J1
Ansoleaga, JJ1
Buritova, J1
Chapman, V1
Besson, JM1
Wiseman, LR1
Roth, SH1
Moore, AR1
Willoughby, DA1
Tankó, A1
Tamás, G1
Baumgartner, H1
Schwarz, HA1
Blum, W1
Bruhin, A1
Gallachi, G1
Goldinger, G1
Saxer, M1
Trost, H1
Winters, JC1
Sobel, JS1
Groenier, KH1
Arendzen, JH1
Meyboom-de Jong, B1
Graham, MJ1
Kent, JE1
Molony, V1
Somwanshi, M1
Tripathi, A1
Singh, B1
Mercadante, S1
Sapio, M1
Caligara, M1
Serretta, R1
Dardanoni, G1
Barresi, L1
Jayamanne, DG1
Fitt, AW1
Dayan, M1
Andrews, RM1
Mitchell, KW1
Griffiths, PG1
Price, DD1
Mao, J1
Lu, J1
Caruso, FS1
Frenk, H1
Mayer, DJ1
Chen, X1
Gallar, J1
Belmonte, C1
Gans, RO1
Stehouwer, CD1
Saxen, MA1
Ambrosius, WT1
Russell, AL1
Eckert, GJ1
Waikakul, S1
Penkitti, P1
Soparat, K1
Boonsanong, W1
Gehling, M1
Colombo, G1
Giombini, A1
Pamich, T1
Peruzzi, E1
Pisati, R2
Le Loët, X1
Dreiser, RL1
Le Gros, V1
Febvre, N1
Litke, J1
Bohatyrewicz, A1
Mikulski, K1
Polati, E1
Finco, G1
Gottin, L1
Bassi, C1
Pederzoli, P1
Ischia, S1
Minotti, V2
De Angelis, V1
Righetti, E1
Celani, MG1
Rossetti, R1
Lupatelli, M1
Tonato, M2
Monza, G1
Fumi, G1
Del Favero, A2
Gupta, SK1
Velpandian, T1
Mathur, P1
Sengupta, S1
Dornic, DI1
Thomas, JM1
Lass, JH1
Euchenhofer, C1
Maihófner, C1
Brune, K2
Santos, AR1
Vedana, EM1
De Freitas, GA1
Reyes, G2
Medina, R2
Castillo, EF1
Herrera, JE1
Tinajero, J1
Chaves, F1
Valdes, B1
Scheen, AJ1
Matambo, J1
Moodley, J1
Chigumadzi, P1
Gordon, A1
Bartlett, JD1
Lin, M1
Akpinar, F1
Aydinlioğlu, A1
Tosun, N1
Fioravanti, A1
Cicero, MR1
Nerucci, F1
Manopulo, R1
Jones, PG1
Zgradie, I1
Lötsch, J1
Kettenmann, B1
Renner, B1
Drover, D1
Kobal, G1
Edwards, SR1
Mather, LE1
Lin, Y1
Power, I2
Cousins, MJ1
Galer, BS1
Rowbotham, M1
Perander, J1
Devers, A1
Friedman, E1
Filippi, R1
Laun, J1
Jage, J1
Perneczky, A1
Takasaki, I1
Andoh, T1
Nitta, M1
Takahata, H1
Nemoto, H1
Shiraki, K1
Nojima, H1
Kuraishi, Y1
Castillo, C1
Rodríguez, J1
Mateos, E1
Terán, F1
Kotani, N1
Kushikata, T1
Hashimoto, H1
Kimura, F1
Muraoka, M1
Yodono, M1
Asai, M1
Matsuki, A1
Hoogewijs, J1
Diltoer, MW1
Hubloue, I1
Spapen, HD1
Camu, F1
Corne, L1
Huyghens, LP1
Tive, L1
Asomoza-Espinosa, R3
Alonso-López, R3
Mixcoatl-Zecuatl, T1
Aguirre-Bañuelos, P1
Torres-López, JE3
Kakar, S1
Jeffery, JA1
Bentley, G1
Mahé, I1
Mouly, S1
Mahé, E1
Diemer, M1
Knellwolf, AL1
Simoneau, G1
Caulin, C1
Bergmann, JF1
Dooley, M1
Spencer, CM1
Dunn, CJ1
Paul, I1
Henrotin, Y1
Rufino, MO1
Gomes-Lopes, LD1
Ferreira, SH1
Jurna, I1
Rosas, R1
Vidal-Cantú, GC1
Miranda, HF1
Sierralta, F1
Pinardi, G1
Hosseinzadeh, H1
Ramezani, M1
Fadishei, M1
Alexander, R1
El-Moalem, HE1
Lemmel, EM1
Leeb, B1
De Bast, J1
Aslanidis, S1
Goch, JH1
Adamska-Dyniewska, H1
Vigneron, JR1
Thys, R1
Huskisson, EC1
Corts Giner, JR1
García Borrás, JJ1
Strobel, E1
Björkman, RL1
Hedner, T1
Hallman, KM1
Henning, M1
Geis, GS1
Loew, D1
Schuster, O1
Schneider, B1
Biehl, J1
De Conno, F1
Ripamonti, C1
Bianchi, M1
Ventafridda, V1
Panerai, AE1
Fainsinger, RL1
Miller, MJ1
Bruera, E1
Berenfeld, A1
Bessing, WD1
Bisplinghoff, U1
Bittner, G1
Matthiesen, HO1
Tilscher, H1
Ramm, S1
Ebeling, L1
Schmitz, H1
Wiesenberg-Boettcher, I1
Pfeilschifter, J1
Schweizer, A4
Sallmann, A1
Wenk, P1
Pellegrini, P1
Grau, M1
Guasch, J1
Montero, JL1
Felipe, A1
Carrasco, E1
Juliá, S1
Stiefel, F1
Morant, R1
Stadler, P1
Armstrong, D1
Margalith, D1
Saraga, E1
Lualdi, P1
Mautone, G1
Morán, M1
Sanahuja, J1
Corbera, G1
Garau, J1
Plá, R1
Carmen Carré, M1
McGalliard, J1
Bell, AL1
Gostick, N1
James, IG1
Khong, TK1
Roy, P1
Shepherd, PR1
Miller, AJ2
Crowley, B1
Hamill, JJ1
Lyndon, S1
McKellican, JF1
Williams, P1
Patoia, L1
Roila, F1
Basurto, C1
Pasqualucci, V1
Maresca, V1
Parr, G1
Darekar, B1
Fletcher, A1
Bulpitt, CJ1
Kromann-Andersen, B1
Sommer, P1
Finnerup, B1
Lendorf, A1
Lyngdorf, P1
Mouritsen, AL1
Møller, P1
Rasmussen, F1
Kantor, TG1
Rossi, PC1
Giudicelli, N1
Parenti, G1
Pacetti, E1
Scholer, DW1
Ku, EC1
Boettcher, I1
Khalifa, MS1
Sharkawi, MA1
Attal, N1
Kayser, V1
Eschalier, A1
Benoist, JM1
Guilbaud, G1
Bremerich, A1
Wiegel, W1
Faigle, JW1
Böttcher, I1
Godbillon, J1
Kriemler, HP1
Schlumpf, E1
Schneider, W1
Stierlin, H1
Winkler, T1
Todd, PA1
Sorkin, EM1
Donnelly, AE1
McCormick, K1
Maughan, RJ1
Whiting, PH1
Clarkson, PM1
Benahmed, M1
Wibault, P1
Court, B1
Kple Faget, P1
Ammarguellat, H1
Pichard, E1
Calabro, JJ1
Garagiola, U1
Marconi, A1
Broggini, M1
Frost, A1
Bassi, GP1
Giannini, R1
Francucci, BM1
Camarri, E1
Mordini, M1
Cocco, F1
Neri, D1
Stacher, G1
Steinringer, H1
Schneider, S1
Mittelbach, G1
Winklehner, S1
Gaupmann, G1
Brom, R1
Caldwell, JR1
Khan, MA1
Machtey, I1

Clinical Trials (38)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
"Clinical Study on Pain Control of Cervical Dilation by Lidocaine Solution Injected Into a Single-use Micro-non-invasive Injection Cervical Dilator"[NCT05955768]74 participants (Anticipated)Interventional2023-07-21Enrolling by invitation
A Clinical Study to Assess the Efficacy and Onset of Pain Relief of Topical MFC51123 Diclofenac-Menthol Gel Versus Controls in Ankle Sprain[NCT02100670]Phase 3385 participants (Actual)Interventional2013-11-01Completed
Comparison of Topical 1% Diclofenac and Topical 2.5% Hydrocortisone for TMJ Arthralgia[NCT05816226]Phase 390 participants (Anticipated)Interventional2023-06-01Recruiting
Double-blind, Randomized, Placebo-controlled Study on the Effect of Multimodal Analgesia on Pain With Insertion of Levonorgestrel-releasing Intrauterine System[NCT02799641]61 participants (Actual)Interventional2016-07-31Completed
A PHASE 3, RANDOMIZED, DOUBLE BLIND, CONTROLLED, MULTI CENTER STUDY OF THE ANALGESIC EFFICACY AND SAFETY OF TANEZUMAB ADDED ON TO DICLOFENAC SR IN PATIENTS WITH OSTEOARTHRITIS OF THE KNEE OR HIP[NCT00864097]Phase 3607 participants (Actual)Interventional2009-08-11Terminated (stopped due to See termination reason in detailed description.)
Anorectal Application of 5% Lidocaine Cream Reduces Pain Prior to Periprostatic Nerve Block During Transrectal Ultrasound Guided Biopsy: Randomized, Prospective Controlled Study[NCT04064047]284 participants (Actual)Interventional2016-12-31Completed
Comparison of Dexketoprofen, Paracetamol and Ibuprofen in the Treatment of Primary Dysmenorrhea[NCT03697746]300 participants (Anticipated)Interventional2018-10-01Not yet recruiting
"Efficacy of the Combination of Z-track and Airlock Techniques During Intramuscular Injection of Haloperidol Decanoate in Adult Patients With Schizophrenic or Related Disorder : A Multicenter Randomized Controlled Trial"[NCT05995457]84 participants (Anticipated)Interventional2023-09-01Not yet recruiting
Pilot, Open Non-controled Trial to Assess the Feasibility of Implementing Objective Parameters as Primary Endpoints in a Clinical Trial With Patients Affected by Knee Osteoarthritis[NCT03421054]8 participants (Actual)Interventional2018-03-19Completed
Double Blind, Placebo Controlled Trial to Evaluate the Effects of a Nutraceutical Containing High-Molecular-Weight Hyaluronic Acid (HA) and Acetyl-11-Keto-Beta-Boswellic Acid (AKBA) in Patients Affected by Knee Osteoarthritis[NCT03612986]72 participants (Actual)Interventional2018-08-22Completed
A Phase 2, Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Clinical Study to Evaluate the Safety and Efficacy of PENNSAID Gel in the Symptomatic Treatment of Osteoarthritis of the Knee[NCT01119898]Phase 2260 participants (Actual)Interventional2010-08-02Completed
[NCT01993589]144 participants (Actual)Interventional2012-11-30Completed
Diclofenac Plus Lidocaine Gel for Pain Relief During Intrauterine Device (IUD) Insertion. A Randomized Double Blinded Placebo-controlled Study[NCT02332057]Phase 290 participants (Actual)Interventional2015-02-28Completed
Efficacy of Pain Control Following Root Canal Treatment Using Paracetamol Alone and in Combination With Three Different Non-Steroidal Anti-Inflammatory Analgesics[NCT02417337]Phase 2170 participants (Actual)Interventional2012-08-31Completed
Effect of Preoperative, Single-dose Diclofenac Potassium on Postoperative Endodontic Pain in Patients With Symptomatic Irreversible Pulpitis: A Double Blind Randomized Controlled Trial[NCT03341260]Phase 2/Phase 370 participants (Actual)Interventional2016-12-31Completed
Investigating Brain Abnormalities in People With Knee Osteoarthritis Using MRI: a Nociplastic Pain Mechanism Based Assessment[NCT05986513]66 participants (Anticipated)Interventional2023-09-01Not yet recruiting
The Efficacy of Diclofenac Gel for Breakthrough Pain and the Neuropathic Components of Pain in Knee Osteoarthritis[NCT01383954]Phase 452 participants (Actual)Interventional2011-06-30Completed
Potential for Improved Analgesia From Combined Medication for Superficial Pain[NCT02194088]Phase 3100 participants (Actual)Interventional2014-04-30Completed
A 7-Day Multicenter Randomized Double-Blind, Double-Dummy Parallel Group Trial to Assess the Safety and Efficacy of 400 mg Lumiracoxib Once Daily Versus 500 mg Naproxen Twice Daily in Patients With Acute Musculoskeletal Pain Due to Uncomplicated Soft Tiss[NCT00170898]Phase 4419 participants Interventional2004-11-30Completed
Efficacy of PENNSAID® for Pain Management in the Emergency Department[NCT01350622]0 participants (Actual)Interventional2011-12-31Withdrawn (stopped due to Study never initiated)
Efficacy and Safety of Diclofenac Sodium Gel in Hand Osteoarthritis[NCT00171652]Phase 3360 participants Interventional2005-05-31Completed
Efficacy and Safety of Diclofenac Sodium Gel in Hand Osteoarthritis[NCT00171665]Phase 3360 participants Interventional2005-05-31Completed
A 13-week, Multicenter, Randomized, Double-blind, Double-dummy, Placebo-controlled, Parallel Group Trial of Lumiracoxib (COX189) 100 mg o.d. in Patients With Primary Hip Osteoarthritis Using Celecoxib (200 mg o.d.) as a Positive Control[NCT00154219]Phase 31,200 participants Interventional2004-11-30Completed
A Placebo-Controlled, Parallel-Group, Double-Blind Study to Assess Safety and to Define the Clinically Effective Dose Range of MK0663 in Patients With Osteoarthritis of the Knee, Followed by a Double-Blind, Active-Comparator-Controlled Extension.[NCT00242489]Phase 21,167 participants (Actual)Interventional1998-06-30Completed
Single and Repeated Leech Therapy for the Treatment of Late Stage Knee Osteoarthritis. A Randomized, Placebo Controlled Comparative Trial[NCT00435773]Phase 2118 participants Interventional2004-02-29Completed
[NCT00451061]Phase 4120 participants (Anticipated)Interventional2007-04-30Not yet recruiting
Diclofenac Suppository As a Preemptive Analgesia in Ultrasound Guided Biopsy of Prostate: Randomized Controlled Trial[NCT01939743]Phase 2100 participants (Actual)Interventional2011-10-31Completed
External Validation of a Clinical Scoring System to Predict Microscopic Colitis in Patients With Chronic Watery Diarrhoea[NCT06031064]200 participants (Anticipated)Observational2022-05-15Recruiting
Efficacy of Tramadol Hcl in the Treatment of Renal Colic[NCT00310908]Phase 4100 participants (Anticipated)Interventional2006-09-30Completed
Randomized, Double-Blind, Placebo-Controlled Trial, Parallel Design Used To Evaluate Pain, Endocrinologic Variations, Life Quality And Medication Use, After Electro-Acupuncture Treatment In Patients With Osteoarthritis Of The Knee[NCT02299713]160 participants (Actual)Interventional2015-01-31Completed
The Serotonin Receptor Type 3 Antagonist Granisetron as a New Treatment Approach for Patients With Chronic Myofascial Pain in the Orofacial Muscles[NCT02230371]Phase 440 participants (Actual)Interventional2007-03-31Completed
The Use of Cannabinoid Patch for Knee Osteoarthritis[NCT04412837]Phase 20 participants (Actual)Interventional2022-10-31Withdrawn (stopped due to Inadequate funding)
IM Ketorolac vs Diclofenac Potassium Powder for Oral Solution (Cambia) for the Acute Treatment of Severe Migraine[NCT02664116]Phase 440 participants (Anticipated)Interventional2016-01-31Recruiting
An Evaluation of the Paracervical Block for Pain Control in First Trimester Surgical Abortion[NCT01094366]Phase 4121 participants (Actual)Interventional2010-04-30Completed
Trial of Ultrasound Guided Femoral Nerve Block on Isolated Femur Fracture Using Echo Friendly Needles[NCT02046317]Phase 412 participants (Actual)Interventional2011-05-31Terminated (stopped due to No further enrolled patients, Primary researcher left the institution)
Regulation of Nitric Oxide Bioavailability in Chronic Obstructive Pulmonary Disease: A Mechanistic Approach[NCT01398943]60 participants (Actual)Interventional2010-09-30Completed
Does Repetitive Peripheral Nerve Blocks Vs Single Peripheral Nerve Block Vs Standard Medical Treatment Provide a Better Pain Relief on Zoster Pain at the Acute Phase and Reduce the Risk of Post Herpetic Neuralgia?[NCT04133142]0 participants (Actual)Interventional2020-05-15Withdrawn (stopped due to No enrollement and covid)
Double-blind, Prospective Comparison of Medications Used in Trigger Point Injections - Ketorolac, Lidocaine, or Dexamethasone[NCT03028012]Phase 410 participants (Actual)Interventional2017-05-02Terminated (stopped due to Poor enrollment.)
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Area Under the Curve From Day 1 to Day 3 (AUC1-3 Days) of Pain Intensity(PI) on Movement for Diclofenac/Methanol Gel and Placebo Gel

AUC of PI on movement was measured by a numerical rating scale (NRS) during the 48 hour time interval from Day 1 to 3. AUC1-3 day was calculated based on trapezoidal method. Pain intensity was measured in NRS scale from 0 (no pain) to 10 (extreme pain). Participants assessed the severity of ankle pain using the NRS scale at baseline (prior to treatment) and at 10, 30 minutes and 1, 4, 6, 12, 18 and 24 hours after the first dose of treatment and twice daily after dosing. (NCT02100670)
Timeframe: up to 72 hours

InterventionNRS Score (0 - 10 scale) * hrs (Mean)
1% Diclofenac Sodium Plus (+) 3% Menthol276.97
Placebo282.88

AUC1-3 Days of PI on Movement for Diclofenac Sodium + Methanol, Diclofenac, Methanol and Placebo

AUC of PI on movement was measured by a numerical rating scale (NRS) during the 48 hour time interval from Day 1 to 3. AUC1-3 day was calculated based on trapezoidal method. Pain intensity was measured in NRS scale from 0 (no pain) to 10 (extreme pain). Participants assessed the severity of ankle pain using the NRS scale at baseline (prior to treatment) and at 10, 30 minutes and 1, 4, 6, 12, 18 and 24 hours after the first dose of treatment and twice daily after dosing. (NCT02100670)
Timeframe: up to 72 hours

InterventionNRS Score (0 - 10 scale) * hrs (Mean)
1% Diclofenac Sodium+3% Menthol276.97
1% Diclofenac Sodium261.11
3% Menthol272.65
Placebo282.88

Time of Onset of Cooling Sensation (TOCS)

"Time of onset of cooling sensation measured by time when subjects reported to have a 'cooling effect as an enhancement of pain relief'. To assess this endpoint, participants were asked at 10, 30 minutes and at 1, 4, 6 hours post first dose Do you feel a cooling sensation at the injured ankle from the study gel?" (NCT02100670)
Timeframe: up to 6 hours

InterventionHours (Median)
1% Diclofenac Sodium+3% Menthol0.17
1% Diclofenac Sodium0.17
3% Menthol0.17
Placebo0.17

Time of Onset of Meaningful Pain Relief (TOMR)

"TOMR was measured by time when participants reported PRS ≥ 2, i.e. some or meaningful pain relief" (NCT02100670)
Timeframe: up to 10 days (end of study)

InterventionHours (Median)
1% Diclofenac Sodium+3% Menthol92.50
1% Diclofenac Sodium76.83
3% Menthol72.00
Placebo93.50

Time of Onset of Pain Relief (TOPR)

"TOPR was measured by time when participants reported PRS ≥ 1, i.e. a little or perceptible pain relief'." (NCT02100670)
Timeframe: Baseline to 10 days (end of study)

InterventionHours (Median)
1% Diclofenac Sodium+3% Menthol1.03
1% Diclofenac Sodium4.00
3% Menthol1.00
Placebo4.00

Time to Complete Recovery

Time to complete recovery measured as the day with complete relief of ankle pain (Participant-rated NRS scores were 0 for pain intensity at rest and pain) and swelling (Participants did not have any apparent swelling nor experience any pain or limitation of movement of the injured ankle as determined by the Principal Investigator or designee during the course of an ankle exam). (NCT02100670)
Timeframe: up to 240 hours

InterventionHours (Median)
1% Diclofenac Sodium+3% Menthol240.00
1% Diclofenac Sodium240.00
3% Menthol240.00
Placebo240.00

Ankle Swelling

"Ankle swelling measured by figure of eight method of injured ankle." (NCT02100670)
Timeframe: Day 1 (baseline), 3, and 7

,,,
InterventionMillimeters (Mean)
At Day 1At Day 3At Day 7
1% Diclofenac Sodium573.6566.9558.8
1% Diclofenac Sodium+3% Menthol573.9566.2558.3
3% Menthol577.1567.0558.4
Placebo576.1565.4557.0

Pain Intensity Difference (PID) on Movement

"PID on movement, calculated as PI at a given time 't' (after walking 5 steps on a flat surface) subtracted by the PI at baseline.~Participants assessed the severity of ankle pain (PI) using the NRS scale from 0 (no pain) to 10 (extreme pain). PI was measured at baseline (prior to treatment) and at 10, 30 minutes (min.) and 1, 4, 6, 12, 18 and 24 hours after the first dose of treatment and twice daily after dosing." (NCT02100670)
Timeframe: Baseline to 10 days

,,,
Interventionscore on scale (Mean)
PI at Baseline (n=117, 112, 77, 75)PID at 10 min. (n=117, 112, 77, 75)PID at 30 min. (n=117, 112, 77, 75)PID at 1 hour (n=117, 112, 77, 75)PID at 4 hour (n=117, 112, 77, 75)PID at 6 hour (n=117, 112, 77, 75)PID at 12 hour (n= 117, 112, 77, 75)PID at 18 hour (n=117, 112, 77, 75)PID at 24 hour (n=117, 112, 77, 75)PID at 36 hour (n=117, 112, 77, 75)PID at 48 hour (n=117, 112, 77, 75)PID at 60 hour (n=117, 112, 77, 75)PID at 72 hour (n=117, 112, 77, 75)PID at 84 hour (n=113, 107, 75, 75)PID at 96 hour (n=112, 107, 75, 74)PID at 108 hour (n=112, 107, 75, 74)PID at 120 hour (n=111, 107, 74, 74)PID at 132 hour (n=110, 107, 74, 74)PID at 144 hour (n=110, 107, 74, 74)PID at 156 hour (n=109, 107, 74, 74)PID at 168 hour (n=105, 104, 73, 74)PID at 180 hour (n=105, 104, 73, 72)PID at 192 hour (n=101, 102, 71, 72)PID at 204 hour (n=101, 100, 71, 72)PID at 216 hour (n=95, 100, 69, 72)PID at 228 hour (n=95, 100, 69, 72)PID at 240 hour (n=32, 43, 22, 42)
1% Diclofenac Sodium7.40.190.360.500.480.670.991.321.581.652.012.262.422.682.783.013.173.533.784.054.114.454.594.945.215.625.44
1% Diclofenac Sodium+3% Menthol7.80.230.440.560.710.790.841.191.621.591.912.412.552.843.103.343.383.703.764.174.264.584.555.175.285.715.56
3% Menthol7.80.290.490.640.790.911.171.441.751.552.042.562.553.083.033.483.353.723.683.953.904.374.214.874.875.285.41
Placebo7.70.320.550.640.690.870.951.161.531.321.922.052.282.682.783.183.143.473.593.883.954.084.224.564.785.015.60

Pain Relief Score (PRS)

Pain relief was measured at each time point using a 5-point Pain Relief Scale ranging from 0-4 while at rest (Where: 0- No pain relief; 1- A little or perceptible pain relief; 2- Meaningful pain relief; 3- A lot of relief; 4- Complete relief). Participants assessed the degree of ankle pain relief using the PRS scores at 10, 30 minutes and 1, 4, 6, 12, 18 and 24 hours after the first dose of treatment and twice daily after the first day of treatment. (NCT02100670)
Timeframe: Day 1 to Day 7

,,,
Interventionscore on a scale (Mean)
At 10 min. (n= 117, 111, 77, 74)At 30 min. (n=117, 111, 77, 75)At 1 hour (n=116, 112, 77, 75)At 4 hour (n= 115, 110, 74, 71)At 6 hour (n= 109, 105, 70, 69)At 12 hour (n= 77, 89, 53, 58)At 18 hour (n= 76, 78, 53, 57)At 24 hour (n= 111, 105, 72, 72)At 36 hour (n= 116, 112, 77, 74)At 48 hour (n= 116, 112, 77, 75)At 60 hour (n=115, 111, 77, 75)At 72 hour (n= 114, 109, 75, 74)At 84 hour (n= 113, 106, 75, 75)At 96 hour (n= 112, 106, 75, 74)At 108 hour (n= 111, 105, 75, 74)At 120 hour (n= 111, 107, 74, 72)At 132 hour (n= 110, 107, 73, 74)At 144 hour (n= 110, 107, 74, 73)At 156 hour (n= 109, 106, 74, 74)At 168 hour (n= 105, 103, 73, 73)
1% Diclofenac Sodium0.290.360.460.450.540.720.730.740.840.841.001.061.001.031.131.141.241.211.301.31
1% Diclofenac Sodium+3% Menthol0.330.440.480.470.500.600.710.790.840.901.070.931.071.091.181.111.341.211.411.41
3% Menthol0.320.490.570.510.630.740.830.900.880.991.161.161.251.011.281.241.341.301.471.34
Placebo0.360.440.400.490.450.620.700.810.780.990.960.971.111.091.151.101.301.271.321.40

Patient's Global Assessment in Response to Treatment (PGART)

PGART was measured at the end of study in a scale from 0-4 (Where: 0- Poor; 1- Fair; 2- Good; 3- Very Good; 4- Excellent) (NCT02100670)
Timeframe: up to Day 10

,,,
InterventionParticipants (Number)
Poor=0Fair=1Good=2Very Good=3Excellent=4
1% Diclofenac Sodium132046266
1% Diclofenac Sodium+3% Menthol32444359
3% Menthol61226265
Placebo91427214

PID at Rest

"PID at rest was calculated as PI at a given time point't' (at rest) subtracted by the PI at baseline. Participants assessed the severity of ankle pain (PI) using the NRS scale from 0 (no pain) to 10 (extreme pain).~PI was measured at baseline (prior to treatment) and at 10, 30 minutes and 1, 4, 6, 12, 18 and 24 hours after the first dose of treatment and twice daily after dosing." (NCT02100670)
Timeframe: Baseline to 10 days

,,,
Interventionscore on a scale (Mean)
PI at Baseline (n=117, 112, 77, 75)PID at 10 min. (n=117, 112, 77, 75)PID at 30 min. (n=117, 112, 77, 75)PID at 1 hour (n=117, 112, 77, 75)PID at 4 hour (n=117, 112, 77, 75)PID at 6 hour (n= 117, 112, 77, 75)PID at 12 hour (n= 117, 112, 77, 75)PID at 18 hour (n= 117, 112, 77, 75)PID at 24 hour (n= 117, 112, 77, 75)PID at 36 hour (n= 117, 112, 77, 75)PID at 48 hour (n=117, 112, 77, 75)PID at 60 hour (n= 117, 112, 77, 75)PID at 72 hour (n= 117, 112, 77, 75)PID at 84 hour (n= 113, 107, 75, 75)PID at 96 hour (n= 112, 107, 75, 74)PID at 108 hour (n=112, 107, 75, 74)PID at 120 hour (n= 111, 107, 74, 74)PID at 132 hour (n= 110, 107, 74, 74)PID at 144 hour (n= 110, 107, 74, 74)PID at 156 hour (n= 109, 107, 74, 74)PID at 168 hour (n= 105, 104, 73, 74)PID at 180 hour (n= 105, 104, 73, 72)PID at 192 hour (n= 101, 102, 71, 72)PID at 204 hour (n= 101, 100, 71, 72)PID at 216 hour (n= 95, 100, 69, 72)PID at 228 hour (n= 95, 100, 69, 72)PID at 240 hour (n= 32, 43, 22, 42)
1% Diclofenac Sodium7.40.430.450.620.530.620.861.141.391.321.531.831.912.192.172.432.482.782.773.113.153.383.303.613.874.024.23
1% Diclofenac Sodium+3% Menthol7.80.340.560.640.620.680.761.031.321.201.431.911.912.112.262.462.592.762.773.063.083.373.383.673.774.093.94
3% Menthol7.80.170.320.480.660.750.901.101.471.221.511.881.862.192.232.482.302.682.592.772.752.952.903.373.223.643.36
Placebo7.70.250.440.410.430.530.680.851.131.091.451.641.762.032.002.272.092.492.492.652.642.883.003.213.263.533.67

Skin Temperature

Skin temperature was measured by thermal imaging. (NCT02100670)
Timeframe: At 10, 30, 60 minutes, 4 and 6 hours

,,,
Interventiondegree celsius (°C) (Mean)
At 10 min.At 30 min.At 60 min.At 240 min.At 360 min.
1% Diclofenac Sodium29.3129.8130.7431.2631.53
1% Diclofenac Sodium+3% Menthol27.6928.2628.6430.5231.02
3% Menthol29.9230.5030.2231.1531.27
Placebo30.9331.4731.7831.5732.07

Sum of Pain Intensity Difference (SPID)

SPID was calculated as the time weighted sum of pain intensity differences (PID) from 0 to 7 Days. PID was calculated as PI at a given time point 't' subtracted by the PI at baseline. PI was measured on NRS scale from 0 (no pain) to 10 (extreme pain). The possible range of SPID for 0-6 hours was from -60 to 60, for 0-12 hours was from -120 to 120, for 0-1 day was from -240 to 240, for 0-3 days was from -720 to 720, for 0-7 days was from -1680 to 1680. A higher value of SPID indicates greater pain relief. (NCT02100670)
Timeframe: Baseline to Day 7

,,,
Interventionscore on a scale (Mean)
At 0-6 hoursAt 0-12 hoursAt 0-1 daysAt 1 to 3 daysAt 0 to 7 days
1% Diclofenac Sodium3.199.1326.54100.07452.44
1% Diclofenac Sodium+3% Menthol4.169.1926.01101.54451.12
3% Menthol4.7211.7430.91104.26464.96
Placebo4.3710.0526.2190.88438.45

Total Pain Relief (TOTPAR)

TOTPAR was calculated as sum of the products of PRS with time interval from one time point to the other. PRS was measured at each time point on a scale: 0= No pain relief, 1= A little or perceptible pain relief, 2= Meaningful pain relief, 3= A lot of relief, 4= Complete relief. The possible range of TOTPAR for 0-6 hours was from 0 to 24, for 0-12 hours was from 0 to 48, for 0-24 hours was from 0 to 96, for 0-72 hours was from 0 to 288, for 24-72 hours was from 0 to 192 and for 0-168 hours was from 0 to 672. (NCT02100670)
Timeframe: Baseline to 168 hours

,,,
InterventionPRS Score (0 - 4 scale) (Mean)
0-6 hours0-12 hours0- 24 hours0-72 hours24-72 hours0-168 hours
1% Diclofenac Sodium2.646.8116.1461.2445.11170.73
1% Diclofenac Sodium+3% Menthol2.816.8616.0460.1444.10172.97
3% Menthol3.278.0218.8566.6947.84184.17
Placebo2.756.3515.7158.7543.04174.00

Number of Participants Who Discontinued Due to Lack of Efficacy

Number of participants who discontinued due to lack of efficacy were reported. (NCT00864097)
Timeframe: Baseline up to end of study (Week 32)

InterventionParticipants (Count of Participants)
Placebo + Diclofenac9
Tanezumab 2.5 mg + Diclofenac3
Tanezumab 5 mg + Diclofenac7
Tanezumab 10 mg + Diclofenac2

Change From Baseline in 36-Item Short-Form Health Survey Version 2 (SF-36v2) Domain Scores at Week 12 and 24

SF-36v2 was a standardized survey evaluating 8 aspects of functional health and well-being: physical and social functioning, physical and role limitations due to emotional problems, bodily pain, general health, vitality, and mental health. The total score and the score for a section was an average of the individual question scores, which were scaled 0-100. Higher scores reflected better participant status and positive change indicated an improvement. (NCT00864097)
Timeframe: Baseline, Week 12, and 24

,,,
Interventionunits on a scale (Mean)
Baseline: General HealthBaseline: Physical FunctionBaseline: Role PhysicalBaseline: Bodily PainBaseline: VitalityBaseline: Social FunctionBaseline: Role EmotionalBaseline: Mental HealthChange at Week 12: General HealthChange at Week 12: Physical FunctionChange at Week 12: Role PhysicalChange at Week 12: Bodily PainChange at Week 12: VitalityChange at Week 12: Social FunctionChange at Week 12: Role EmotionalChange at Week 12: Mental HealthChange at Week 24: General HealthChange at Week 24: Physical FunctionChange at Week 24: Role PhysicalChange at Week 24: Bodily PainChange at Week 24: VitalityChange at Week 24: Social FunctionChange at Week 24: Role EmotionalChange at Week 24: Mental Health
Placebo + Diclofenac46.3733.5146.6732.9949.0861.0268.1562.804.677.367.618.763.805.021.923.132.416.215.179.141.664.36-0.551.27
Tanezumab 10 mg + Diclofenac49.3136.5247.4635.0651.2966.5569.7765.484.969.908.4912.765.344.22-1.261.663.088.505.9111.522.761.38-1.950.45
Tanezumab 2.5 mg + Diclofenac49.4136.2247.4435.6652.2267.6368.9666.575.2910.968.8112.514.236.252.241.554.518.788.4112.542.434.090.692.06
Tanezumab 5 mg + Diclofenac47.0034.7048.5033.9553.0065.8368.4464.636.5512.837.7115.183.794.172.172.204.9410.506.9613.272.583.67-1.331.63

Change From Baseline in 36-Item Short-Form Health Survey Version 2 (SF-36v2) Physical and Mental Component Scores at Week 12 and 24

SF-36v2: standardized survey evaluating 8 aspects of functional health and wellbeing (physical and social functioning, role limitations due to physical and emotional problems, bodily pain, general health, vitality, mental health). Total score for each aspect were scaled 0-100. Higher scores reflect better participant status and positive change indicated an improvement. For obtaining physical and mental component scores, z-score for each scale=(observed score - mean score for general 1990 United States [US] population)/corresponding standard deviation. The 2 component scores were obtained by multiplying each aspect z-score by physical or mental factor score coefficient (1990 general US population) and summing the eight products. Component scores indicated how many standard deviations higher (in case of positive z-score [better functioning])/lower (in case of negative z-score [worse functioning]) participant's value was relative to the mean of the reference population. (NCT00864097)
Timeframe: Baseline, Week 12 and 24

,,,
Interventionz-score (Mean)
Baseline: Physical Component ScoreBaseline: Mental Component ScoreChange at Week 12: Physical Component ScoreChange at Week 12: Mental Component ScoreChange at Week 24: Physical Component ScoreChange at Week 24: Mental Component Score
Placebo + Diclofenac-1.84-0.300.350.080.32-0.03
Tanezumab 10 mg + Diclofenac-1.76-0.150.51-0.060.43-0.14
Tanezumab 2.5 mg + Diclofenac-1.76-0.110.500.010.45-0.03
Tanezumab 5 mg + Diclofenac-1.80-0.170.56-0.030.50-0.10

Change From Baseline in Average Pain Score in the Index Knee or Hip at Weeks 1, 2, 3, 4, 6, 8, 10, 12, 16, 20, and 24

Participants were asked to assess index joint (knee/hip) pain during the past 24 hours on an 0-10 point integer scale ranging from 0 (no pain) to 10 (worst possible pain). Baseline score was calculated as the mean of the scores in the index joint over the 3 days days in the initial pain assessment period and a weekly mean was calculated using the daily pain scores in the index joint within each study week. The change from Baseline was calculated using the difference between each post-baseline weekly mean and the baseline mean score, where negative change indicated an improvement. (NCT00864097)
Timeframe: Baseline, Weeks 1, 2, 3, 4, 6, 8, 10, 12, 16, 20, and 24

,,,
Interventionunits on a scale (Mean)
BaselineChange at Week 1Change at Week 2Change at Week 3Change at Week 4Change at Week 6Change at Week 8Change at Week 10Change at Week 12Change at Week 16Change at Week 20Change at Week 24
Placebo + Diclofenac6.31-0.55-0.95-1.19-1.28-1.38-1.41-1.41-1.49-1.53-1.61-1.65
Tanezumab 10 mg + Diclofenac6.34-0.96-1.03-1.08-1.44-1.69-1.80-2.06-2.06-2.15-2.15-2.03
Tanezumab 2.5 mg + Diclofenac6.29-0.74-0.91-1.19-1.45-1.57-1.62-1.79-1.91-1.87-1.95-1.84
Tanezumab 5 mg + Diclofenac6.38-1.22-1.28-1.40-1.77-1.88-1.84-2.09-2.06-2.07-2.19-2.07

Change From Baseline in European Quality of Life - 5 Dimension (EQ-5D) Index Score at Week 24

EQ-5D was a standardized, participant-administered measure of health outcome. It provides a descriptive profile for 5 dimensions (mobility, self-care, usual activities, pain/discomfort, anxiety/depression), using 3 levels (no, moderate, or extreme dysfunction) and a single index value characterizing current health status using a visual analog scale with score ranging from 0 (worst) to 100 (best). EQ-5D summary index was obtained with a formula that weights each level of the dimensions. The index-based score was interpreted along a continuum of 0 (death) to 1 (perfect health). Negative change from baseline represented worsening. (NCT00864097)
Timeframe: Baseline, Week 24

,,,
Interventionunits on a scale (Mean)
Baseline: Index ScoreChange at Week 24: Index Score
Placebo + Diclofenac0.450.11
Tanezumab 10 mg + Diclofenac0.470.16
Tanezumab 2.5 mg + Diclofenac0.480.15
Tanezumab 5 mg + Diclofenac0.470.14

Change From Baseline in Patient Global Assessment (PGA) of Osteoarthritis Score at Week 16

"Participants answered: Considering all the ways your osteoarthritis in your index joint (knee/hip) affects you, how are you doing today? Participants responded by using a 5-point Likert scale, where 1 = very good (asymptomatic and no limitation of normal activities), 2 = good (mild symptoms and no limitation of normal activities), 3 = fair (moderate symptoms and limitation of some normal activities), 4 = poor (severe symptoms and inability to carry out most normal activities), and 5 = very poor (very severe symptoms which are intolerable and inability to carry out all normal activities). Higher score indicated worst condition." (NCT00864097)
Timeframe: Baseline, Week 16

,,,
Interventionunits on a scale (Mean)
BaselineChange at Week 16
Placebo + Diclofenac3.39-0.41
Tanezumab 10 mg + Diclofenac3.37-0.63
Tanezumab 2.5 mg + Diclofenac3.28-0.49
Tanezumab 5 mg + Diclofenac3.43-0.61

Change From Baseline in Patient Global Assessment (PGA) of Osteoarthritis Score at Weeks 2, 4, 8, 12, and 24

"Participants answered: Considering all the ways your osteoarthritis in your index joint (knee/hip) affects you, how are you doing today? Participants responded by using a 5-point Likert scale, where 1 = very good (asymptomatic and no limitation of normal activities), 2 = good (mild symptoms and no limitation of normal activities), 3 = fair (moderate symptoms and limitation of some normal activities), 4 = poor (severe symptoms and inability to carry out most normal activities), and 5 = very poor (very severe symptoms which are intolerable and inability to carry out all normal activities). Higher score indicated worst condition." (NCT00864097)
Timeframe: Baseline, Weeks 2, 4, 8, 12, and 24

,,,
Interventionunits on a scale (Mean)
Change at Week 2Change at Week 4Change at Week 8Change at Week 12Change at Week 24
Placebo + Diclofenac-0.36-0.40-0.37-0.45-0.45
Tanezumab 10 mg + Diclofenac-0.28-0.54-0.66-0.61-0.57
Tanezumab 2.5 mg + Diclofenac-0.37-0.45-0.44-0.52-0.46
Tanezumab 5 mg + Diclofenac-0.40-0.65-0.71-0.69-0.57

Change From Baseline in the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Pain Subscale Score at Weeks 2, 4, 8, 12 and 24

WOMAC: Self-administered, disease-specific questionnaire which assesses clinically important, participant-relevant symptoms for pain, stiffness and physical function in participants with OA. WOMAC pain subscale is a 5-item questionnaire used to assess the amount of pain experienced due to osteoarthritis in index knee or hip during past 48 hours. It is calculated as mean of the scores from 5 individual questions, each scored on a numerical rating scale (NRS) of 0 (no pain) to 10 (extreme pain), where higher scores indicate higher pain. Total score range for WOMAC pain subscale score is 0 (no pain) to 10 (extreme pain), where higher scores indicate higher pain. (NCT00864097)
Timeframe: Baseline, Weeks 2, 4, 8, 12, and 24

,,,
Interventionunits on a scale (Mean)
Change at Week 2Change at Week 4Change at Week 8Change at Week 12Change at Week 24
Placebo + Diclofenac-1.30-1.51-1.63-1.81-1.81
Tanezumab 10 mg + Diclofenac-0.86-1.93-2.34-2.42-2.19
Tanezumab 2.5 mg + Diclofenac-1.22-1.76-1.88-2.23-2.11
Tanezumab 5 mg + Diclofenac-1.21-2.12-2.22-2.50-2.24

Change From Baseline in the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Physical Function Subscale Score at Weeks 2, 4, 8, 12, and 24

WOMAC: Self-administered, disease-specific questionnaire which assesses clinically important, participant-relevant symptoms for pain, stiffness and physical function in participants with OA. WOMAC physical function is a 17-item questionnaire used to assess the degree of difficulty experienced due to osteoarthritis in index knee or hip during past 48 hours. It is calculated as mean of the scores from 17 individual questions, each scored on a NRS of 0 (no difficulty) to 10 (extreme difficulty), where higher scores indicate worse function. Total score range for WOMAC physical function subscale score is 0 (no difficulty) to 10 (extreme difficulty), where higher scores indicate worse function. Physical function refers to participant's ability to move around and perform usual activities of daily living. (NCT00864097)
Timeframe: Baseline, Weeks 2, 4, 8, 12, and 24

,,,
Interventionunits on a scale (Mean)
Change at Week 2Change at Week 4Change at Week 8Change at Week 12Change at Week 24
Placebo + Diclofenac-1.31-1.46-1.59-1.75-1.70
Tanezumab 10 mg + Diclofenac-1.06-1.81-2.13-2.28-2.08
Tanezumab 2.5 mg + Diclofenac-1.18-1.58-1.76-2.13-1.99
Tanezumab 5 mg + Diclofenac-1.30-2.09-2.22-2.43-2.17

Change From Baseline in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Average Score at Weeks 2, 4, 8, 12, 16, and 24

WOMAC Index: self-administered, disease-specific 24 item questionnaire which assesses clinically important, participant-relevant symptoms for pain (5 items), stiffness (2 items), and physical function (17 items) in participants with osteoarthritis of the hip and/or knee. WOMAC average score is the mean of the WOMAC pain, physical function and stiffness subscale scores and ranges from 0 to 10, with higher score indicating worse response. Greater reduction in WOMAC average score indicated greater improvement. (NCT00864097)
Timeframe: Baseline, Weeks 2, 4, 8, 12, 16, and 24

,,,
Interventionunits on a scale (Mean)
BaselineChange at Week 2Change at Week 4Change at Week 8Change at Week 12Change at Week 16Change at Week 24
Placebo + Diclofenac6.05-1.31-1.45-1.59-1.74-1.80-1.74
Tanezumab 10 mg + Diclofenac5.80-1.06-1.92-2.27-2.42-2.43-2.17
Tanezumab 2.5 mg + Diclofenac5.75-1.23-1.68-1.83-2.24-2.19-2.05
Tanezumab 5 mg + Diclofenac5.72-1.30-2.14-2.21-2.45-2.22-2.16

Change From Baseline in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Pain Subscale Item: Pain When Going Up or Downstairs at Weeks 2, 4, 8, 12, 16, and 24

"Participants answered the question: How much pain have you had when going up or down the stairs? Participants responded by using an 11-point scale, where 0 = no pain and 10 = extreme pain. Where 0 is the best response and negative change indicated an improvement." (NCT00864097)
Timeframe: Baseline, Weeks 2, 4, 8, 12, 16, and 24

,,,
Interventionunits on a scale (Mean)
BaselineChange at Week 2Change at Week 4Change at Week 8Change at Week 12Change at Week 16Change at Week 24
Placebo + Diclofenac7.24-1.38-1.58-1.78-2.03-2.00-1.95
Tanezumab 10 mg + Diclofenac7.06-1.21-2.10-2.64-2.77-2.79-2.56
Tanezumab 2.5 mg + Diclofenac7.04-1.49-2.10-2.15-2.54-2.54-2.44
Tanezumab 5 mg + Diclofenac7.05-1.55-2.39-2.51-2.86-2.53-2.53

Change From Baseline in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Pain Subscale Item: Pain When Walking on a Flat Surface at Weeks 2, 4, 8, 12, 16, and 24

"Participants answered the question: How much pain have you had when walking on a flat surface? Participants responded by using an 11-point scale where 0 = no pain and 10 = extreme pain. Where 0 is the best response and negative change indicated an improvement." (NCT00864097)
Timeframe: Baseline, Week 2, 4, 8, 12, 16, 24

,,,
Interventionunits on a scale (Mean)
BaselineChange at Week 2Change at Week 4Change at Week 8Change at Week 12Change at Week 16Change at Week 24
Placebo + Diclofenac6.12-1.34-1.47-1.62-1.83-1.95-1.84
Tanezumab 10 mg + Diclofenac5.99-0.89-1.87-2.25-2.41-2.34-2.10
Tanezumab 2.5 mg + Diclofenac5.91-1.23-1.75-1.81-2.15-2.14-2.08
Tanezumab 5 mg + Diclofenac5.81-1.07-2.01-2.05-2.35-2.09-2.09

Change From Baseline in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Pain Subscale Score at Week 16

WOMAC: Self-administered, disease-specific questionnaire which assesses clinically important, participant-relevant symptoms for pain, stiffness and physical function in participants with osteoarthritis (OA). WOMAC pain subscale is a 5-item questionnaire used to assess the amount of pain experienced due to osteoarthritis in index knee or hip during past 48 hours. It is calculated as mean of the scores from 5 individual questions, each scored on a numerical rating scale (NRS) of 0 (no pain) to 10 (extreme pain), where higher scores indicate higher pain. Total score range for WOMAC pain subscale score is 0 (no pain) to 10 (extreme pain), where higher scores indicate higher pain. (NCT00864097)
Timeframe: Baseline, Week 16

,,,
Interventionunits on a scale (Mean)
BaselineChange at Week 16
Placebo + Diclofenac6.06-1.91
Tanezumab 10 mg + Diclofenac5.87-2.42
Tanezumab 2.5 mg + Diclofenac5.78-2.18
Tanezumab 5 mg + Diclofenac5.76-2.28

Change From Baseline in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Physical Function Subscale Score at Week 16

WOMAC: Self-administered, disease-specific questionnaire which assesses clinically important, participant-relevant symptoms for pain, stiffness and physical function in participants with OA. WOMAC physical function is a 17-item questionnaire used to assess the degree of difficulty experienced due to osteoarthritis in index knee or hip during past 48 hours. It is calculated as mean of the scores from 17 individual questions, each scored on a NRS of 0 (no difficulty) to 10 (extreme difficulty), where higher scores indicate worse function. Total score range for WOMAC physical function subscale score is 0 (no difficulty) to 10 (extreme difficulty), where higher scores indicate worse function. Physical function refers to participant's ability to move around and perform usual activities of daily living. (NCT00864097)
Timeframe: Baseline, Week 16

,,,
Interventionunits on a scale (Mean)
BaselineChange at Week 16
Placebo + Diclofenac6.24-1.76
Tanezumab 10 mg + Diclofenac5.91-2.35
Tanezumab 2.5 mg + Diclofenac5.86-2.11
Tanezumab 5 mg + Diclofenac5.90-2.23

Change From Baseline in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Stiffness Subscale Score at Weeks 2, 4, 8, 12, 16, and 24

WOMAC: Self-administered, disease-specific questionnaire which assesses clinically important, participant-relevant symptoms for pain, stiffness and physical function in participants with OA. WOMAC stiffness subscale is a 2-item questionnaire used to assess the amount of stiffness experienced due to osteoarthritis in index knee or hip during past 48 hours. It is calculated as mean of the scores from 2 individual questions scored on NRS of (no stiffness) to 10 (extreme stiffness), with higher scores indicate higher stiffness. Total score range for WOMAC stiffness subscale score is (no stiffness) to 10 (extreme stiffness), where higher scores indicate higher stiffness. Stiffness is defined as a sensation of decreased ease in movement of knee/hip. Negative change indicated an improvement. (NCT00864097)
Timeframe: Baseline, Weeks 2, 4, 8, 12, 16, and 24

,,,
Interventionunits on a scale (Mean)
BaselineChange at Week 2Change at Week 4Change at Week 8Change at Week 12Change at Week 16Change at Week 24
Placebo + Diclofenac5.84-1.31-1.37-1.56-1.66-1.72-1.70
Tanezumab 10 mg + Diclofenac5.60-1.27-2.01-2.34-2.55-2.53-2.22
Tanezumab 2.5 mg + Diclofenac5.61-1.29-1.71-1.86-2.36-2.27-2.06
Tanezumab 5 mg + Diclofenac5.51-1.38-2.21-2.20-2.42-2.15-2.08

Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs)

An AE was any untoward medical occurrence in a participant who received study drug without regard to possibility of causal relationship. An SAE was an AE resulting in any of the following outcomes or deemed significant for any other reason: death; initial or prolonged inpatient hospitalization; life-threatening experience (immediate risk of dying); persistent or significant disability/incapacity; congenital anomaly. Treatment-emergent are events between first dose of study drug and up to 112 days after last dose that were absent before treatment or that worsened relative to pretreatment state. AEs included SAEs as well as non-serious AEs which occurred during the trial. (NCT00864097)
Timeframe: Baseline up to 112 days after last intravenous dose (up to Week 32)

,,,
InterventionParticipants (Count of Participants)
AEsSAEs
Placebo + Diclofenac538
Tanezumab 10 mg + Diclofenac7210
Tanezumab 2.5 mg + Diclofenac7112
Tanezumab 5 mg + Diclofenac738

Number of Participants With Change From Baseline in European Quality of Life - 5 Dimension (EQ-5D) Individual Health State Profile at Week 24

"EQ-5D was a standardized, participant-administered measure of health outcome. It provides a descriptive profile for 5 dimensions (mobility, self-care, usual activities, pain/discomfort, anxiety/depression), using 3 levels (no, moderate, or extreme dysfunction) and a single index value characterizing current health status using a visual analog scale with score ranging from 0 (worst) to 100 (best). Baseline EQ-5D individual health state profile was determined as number of participants no dysfunction, moderate or some dysfunction and extreme dysfunction and change from baseline in EQ-5D individual health state profile was determined as number of participants improved, no change or worsened." (NCT00864097)
Timeframe: Baseline, Week 24

,,,
InterventionParticipants (Count of Participants)
Baseline: Mobility-No DysfunctionBaseline: Mobility-Moderate DysfunctionBaseline: Mobility-Extreme DysfunctionBaseline: Self Care-No DysfunctionBaseline: Self Care-Moderate DysfunctionBaseline: Self Care-Extreme DysfunctionBaseline: Usual Activities-No DysfunctionBaseline: Usual Activities-Moderate DysfunctionBaseline: Usual Activities-Extreme DysfunctionBaseline: Pain/Discomfort-No DysfunctionBaseline: Pain/Discomfort-Moderate DysfunctionBaseline: Pain/Discomfort-Extreme DysfunctionBaseline: Anxiety/Depression-No DysfunctionBaseline: Anxiety/Depression-Moderate DysfunctionBaseline: Anxiety/Depression-Extreme DysfunctionChange at Week 24: Mobility-ImprovedChange at Week 24: Mobility-No ChangeChange at Week 24: Mobility-WorsenedChange at Week 24: Self Care-ImprovedChange at Week 24: Self Care-No ChangeChange at Week 24: Self Care-WorsenedChange at Week 24: Usual Activities-ImprovedChange at Week 24: Usual Activities-No ChangeChange at Week 24: Usual Activities-WorsenedChange at Week 24: Pain/Discomfort-ImprovedChange at Week 24: Pain/Discomfort-No ChangeChange at Week 24: Pain/Discomfort-WorsenedChange at Week 24: Anxiety/Depression-ImprovedChange at Week 24: Anxiety/Depression-No ChangeChange at Week 24: Anxiety/Depression-Worsened
Placebo + Diclofenac8143165870251161101143874726211274191181516125112811682710619
Tanezumab 10 mg + Diclofenac101350529211812341111337366625120030104112711173310571910719
Tanezumab 2.5 mg + Diclofenac71481619231314120125318272225129233112112712542912522611119
Tanezumab 5 mg + Diclofenac141360539612012642115337075530114632110831106133410972810913

Number of Participants With Intravenous Doses of Study Medication

Number of participants were reported based on the maximum number of intravenous (IV) doses of either tanezumab or placebo received. (NCT00864097)
Timeframe: Day 1 up to Week 16

,,,
InterventionParticipants (Count of Participants)
Number of IV Doses: 1Number of IV Doses: 2Number of IV Doses: 3
Placebo + Diclofenac1438100
Tanezumab 10 mg + Diclofenac1331101
Tanezumab 2.5 mg + Diclofenac934114
Tanezumab 5 mg + Diclofenac1526109

Percentage of Participants With At Least 30%, 50%, 70% and 90% Reduction From Baseline in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Pain Subscale Score; LOCF

WOMAC: Self-administered, disease-specific questionnaire which assesses clinically important, participant-relevant symptoms for pain, stiffness and physical function in participants with osteoarthritis (OA). WOMAC pain subscale is a 5-item questionnaire used to assess the amount of pain experienced due to osteoarthritis in index knee or hip during past 48 hours. It is calculated as mean of the scores from 5 individual questions, each scored on a numerical rating scale (NRS) of 0 (no pain) to 10 (extreme pain), where higher scores indicate higher pain. Total score range for WOMAC pain subscale score is 0 (no pain) to 10 (extreme pain), where higher scores indicate higher pain. Greater percentage reduction indicates greater improvement. Percentage of participants with reduction in WOMAC pain intensity of at least (>=) 30%, 50%, 70% and 90% at Weeks 2, 4, 8, 12, 16, 24 and 32 compared to baseline were classified as responders to WOMAC pain subscale and are reported here. (NCT00864097)
Timeframe: Baseline, Weeks 2, 4, 8, 12, 16, and 24

,,,
Interventionpercentage of participants (Number)
Week 2: At least 30% reductionWeek 2: At least 50% reductionWeek 2: At least 70% reductionWeek 2: At least 90% reductionWeek 4: At least 30% reductionWeek 4: At least 50% reductionWeek 4: At least 70% reductionWeek 4: At least 90% reductionWeek 8: At least 30% reductionWeek 8: At least 50% reductionWeek 8: At least 70% reductionWeek 8: At least 90% reductionWeek 12: At least 30% reductionWeek 12: At least 50% reductionWeek 12: At least 70% reductionWeek 12: At least 90% reductionWeek 16: At least 30% reductionWeek 16: At least 50% reductionWeek 16: At least 70% reductionWeek 16: At least 90% reductionWeek 24: At least 30% reductionWeek 24: At least 50% reductionWeek 24: At least 70% reductionWeek 24: At least 90% reduction
Placebo + Diclofenac30.313.84.62.042.117.15.92.043.425.03.92.048.727.07.22.050.030.913.22.048.028.312.53.9
Tanezumab 10 mg + Diclofenac24.19.02.80.750.330.311.72.163.438.619.36.263.442.824.84.866.249.019.36.959.342.121.48.3
Tanezumab 2.5 mg + Diclofenac28.816.06.41.351.926.910.31.951.927.69.65.157.136.516.76.454.535.917.35.858.338.518.68.3
Tanezumab 5 mg + Diclofenac32.016.77.31.357.334.012.76.057.338.017.34.764.046.724.08.761.340.020.06.759.340.022.78.0

Percentage of Participants With Cumulative Reduction From Baseline in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Pain Subscale Score at Week 16 and 24

WOMAC: Self-administered, disease-specific questionnaire which assesses clinically important, participant-relevant symptoms for pain, stiffness and physical function in participants with osteoarthritis (OA). WOMAC pain subscale is a 5-item questionnaire used to assess the amount of pain experienced due to osteoarthritis in index knee or hip during past 48 hours. It is calculated as mean of the scores from 5 individual questions, each scored on a numerical rating scale (NRS) of 0 (no pain) to 10 (extreme pain), where higher scores indicate higher pain. Total score range for WOMAC pain subscale score is 0 (no pain) to 10 (extreme pain), where higher scores indicate higher pain. Greater percentage reduction indicates greater improvement. Percentage of participants with cumulative reduction (as percent) (greater than 0%; >= 10, 20, 30, 40, 50, 60, 70, 80 and 90%; = 100 %) in WOMAC pain subscale from Baseline to Weeks 16 and 24 were reported. (NCT00864097)
Timeframe: Baseline, Week 16 and 24

,,,
Interventionpercentage of participants (Number)
Week 16: Greater than 0% reductionWeek 16: >=10% reductionWeek 16: >=20% reductionWeek 16: >=30% reductionWeek 16: >=40% reductionWeek 16: >=50% reductionWeek 16: >=60% reductionWeek 16: >=70% reductionWeek 16: >=80% reductionWeek 16: >=90% reductionWeek 16: 100% reductionWeek 24: Greater than 0% reductionWeek 24: >=10% reductionWeek 24: >=20% reductionWeek 24: >=30% reductionWeek 24: >=40% reductionWeek 24: >=50% reductionWeek 24: >=60% reductionWeek 24: >=70% reductionWeek 24: >=80% reductionWeek 24: >=90% reductionWeek 24: 100% reduction
Placebo + Diclofenac84.273.761.850.038.830.921.713.25.92.00.781.672.460.548.035.528.320.412.56.63.90.7
Tanezumab 10 mg + Diclofenac84.177.975.266.260.749.031.719.313.86.92.884.875.269.759.351.042.131.721.413.88.32.8
Tanezumab 2.5 mg + Diclofenac88.582.769.954.548.735.926.317.39.05.82.682.776.967.358.347.438.526.318.611.58.33.8
Tanezumab 5 mg + Diclofenac88.776.768.761.350.740.028.720.010.76.72.082.074.765.359.347.340.034.022.714.78.03.3

Percentage of Participants With Improvement of at Least 2 Points in Patient Global Assessment (PGA) of Osteoarthritis; Baseline Observation Carried Forward (BOCF)

"Participants answered: Considering all the ways your osteoarthritis in your index joint (knee/hip) affects you, how are you doing today? Participants responded by using a 5-point Likert scale, where 1 = very good (asymptomatic and no limitation of normal activities), 2 = good (mild symptoms and no limitation of normal activities), 3 = fair (moderate symptoms and limitation of some normal activities), 4 = poor (severe symptoms and inability to carry out most normal activities), and 5 = very poor (very severe symptoms which are intolerable and inability to carry out all normal activities). Higher score indicated worst condition. A decrease of at least 2 points on the 5-point scale relative to baseline value indicates improvement." (NCT00864097)
Timeframe: Weeks 2, 4, 8, 12, 16, and 24

,,,
Interventionpercentage of participants (Number)
Week 2Week 4Week 8Week 12Week 16Week 24
Placebo + Diclofenac5.96.65.36.64.65.3
Tanezumab 10 mg + Diclofenac5.511.713.810.314.59.7
Tanezumab 2.5 mg + Diclofenac5.83.26.46.45.84.5
Tanezumab 5 mg + Diclofenac4.714.717.313.314.010.0

Percentage of Participants With Improvement of at Least 2 Points in Patient Global Assessment (PGA) of Osteoarthritis; LOCF

"Participants answered: Considering all the ways your osteoarthritis in your index joint (knee/hip) affects you, how are you doing today? Participants responded by using a 5-point Likert scale, where 1 = very good (asymptomatic and no limitation of normal activities), 2 = good (mild symptoms and no limitation of normal activities), 3 = fair (moderate symptoms and limitation of some normal activities), 4 = poor (severe symptoms and inability to carry out most normal activities), and 5 = very poor (very severe symptoms which are intolerable and inability to carry out all normal activities). Higher score indicated worst condition. A decrease of at least 2 points on the 5-point scale relative to baseline value indicated improvement." (NCT00864097)
Timeframe: Weeks 2, 4, 8, 12, 16, and 24

,,,
Interventionpercentage of participants (Number)
Week 2Week 4Week 8Week 12Week 16Week 24
Placebo + Diclofenac5.96.65.36.64.65.9
Tanezumab 10 mg + Diclofenac5.512.414.512.416.612.4
Tanezumab 2.5 mg + Diclofenac5.83.26.46.45.85.8
Tanezumab 5 mg + Diclofenac4.714.718.014.014.712.7

Percentage of Participants With Outcome Measures in Rheumatology - Osteoarthritis Research Society International (OMERACT-OARSI) Response; LOCF

OMERACT-OARSI responder: participant has >=50 percent (%) change and >=2 absolute change from Baseline in either WOMAC pain or physical function subscale scores or at least 2 of the following being true: >=20% change and >=1 absolute change from Baseline in WOMAC pain subscale; >=20% change and >=1 absolute change from Baseline in the WOMAC physical function subscale; >=20% change and >=1 absolute change from Baseline in PGA of osteoarthritis. WOMAC pain and physical function score: 0 to 10 with higher score = worse response. PGA score: 1 = very good and 5 = very poor. (NCT00864097)
Timeframe: Weeks 2, 4, 8, 12, 16, and 24

,,,
Interventionpercentage of participants (Number)
Week 2Week 4Week 8Week 12Week 16Week 24
Placebo + Diclofenac44.751.357.260.557.955.3
Tanezumab 10 mg + Diclofenac34.559.369.773.172.467.6
Tanezumab 2.5 mg + Diclofenac37.257.158.367.366.765.4
Tanezumab 5 mg + Diclofenac43.365.368.073.366.764.7

Time to Discontinuation (TTD) Due to Lack of Efficacy

Median time to discontinuation due to lack of efficacy was estimated using Kaplan-Meier method. (NCT00864097)
Timeframe: Baseline up to Week 16 and 24

,,,
Interventiondays (Median)
Week 16Week 24
Placebo + DiclofenacNANA
Tanezumab 10 mg + DiclofenacNANA
Tanezumab 2.5 mg + DiclofenacNANA
Tanezumab 5 mg + DiclofenacNANA

Percent Change From Baseline in Pain Score During Week 1

Participants assessed their knee pain using a visual analog scale (VAS) where 0=no pain and 100=worst possible pain. Pain scores were recorded in an electronic diary prior to and 4 hours after the first daily application of diclofenac gel for breakthrough pain. The daily percent change in pain scores over the 7 days prior to Week 1 were averaged. Percent change from Baseline (average pain score 7 days prior to first treatment) was calculated as (value at baseline - value at post-baseline visit) / (value at baseline) x 100. A positive change from Baseline indicates improvement. (NCT01383954)
Timeframe: Baseline and Week 1

Interventionpercent change (Mean)
Diclofenac Gel33.3

Percent Change From Baseline in Pain Score During Week 2

Participants assessed their knee pain using a visual analog scale (VAS) where 0=no pain and 100=worst possible pain. Pain scores were recorded in an electronic diary prior to and 4 hours after the first daily application of diclofenac gel for breakthrough pain. The daily percent change in pain scores over the 7 days prior to Week 2 were averaged. Percent change from baseline (average pain score 7 days prior to first treatment) was calculated as (value at baseline - value at post-baseline visit)/ (value at baseline) x 100. A positive change from baseline indicates improvement. (NCT01383954)
Timeframe: Baseline and Week 2

Interventionpercent change (Mean)
Diclofenac Gel33.3

Pain Scores on Standardized Experimental Pain Testing

Pain scores on standardized experimental pain testing, with collection of Visual analog scales (VAS) on a 0-100 scale 0 (no pain)- 100 (worst pain imaginable) Higher values represent a worse outcome (more pain) (NCT02194088)
Timeframe: baseline and 1 hour pain measurement

,
Interventionunits on a scale (Mean)
Baseline1 hour Assessment
Pain Medication: Diclofenac and Atropine59.644.1
Placebo54.045.3

Patient Pain Level

Pain level will be measured on a numeric visual analogue scale of 0-10 with 0 being no pain and 10 being the worst pain ever. (NCT02046317)
Timeframe: 60 minutes after initial femoral block

Interventionunits on a scale (Mean)
Echogenic Needle1.25
Standard of Care Needle3.75

Patient Pain Level

Pain level will be measured on a numeric visual analogue scale of 0-10 with 0 being no pain and 10 being the worst pain ever. (NCT02046317)
Timeframe: baseline

Interventionunits on a scale (Mean)
Echogenic Needle7.50
Standard of Care Needle8.00

Flow-Mediated Dilation (FMD)

Brachial artery FMD induced by reactive hyperemia will be used to assess vascular endothelial function at baseline and several hours after each experimental intervention. (NCT01398943)
Timeframe: Post FMD was taken approximately 110 min after baseline

,
Interventionpercentage of change in FMD (Mean)
PlaceboAOC Treatment
All Controls6.76.9
All COPD Patients3.14.7

Pulse Wave Velocity

A measure of vascular stiffness at baseline and several hours after each experimental intervention. (NCT01398943)
Timeframe: Post PWV was taken approximately 90 min after baseline

,
Interventionm/sec (Mean)
PlaceboAOC Treatment
All Controls1110
All COPD Patients1411

Number of Participants With a Responder Rate Greater Than 50% on the Numeric Rating Pain Scale (NRS) Improvement

Participants in this study underwent TPIs by the following method. The needle was inserted into the trigger point with the goal of eliciting a local twitch responses(LTRs). When a LTR was obtained, 0.1mL of randomized drug was injected into that location within the muscle. This was repeated until LTRs disappeared, or 1.0mL had been injected, whichever came first. This was performed in a similar manner for all affected muscles, up to a maximum of 2mL. Participants self-report their brief pain inventory at each of their injections (up to four subsequent injections) based off of the standardized Numeric Rating pain Scale (NRS). The NRS is nationally recognized numeric scale from zero to ten, with zero being an example of no pain, one to three would demonstrate mild pain, four to six would be moderate pain, seven to nine would be severe pain and a ten would be the worst pain possible. Improvement in BPI was determined if their NRS score went down with each injection(s). (NCT03028012)
Timeframe: Pre-Post Injections Up to Three Months

InterventionParticipants (Count of Participants)
Ketorolac1
Lidocaine0
Dexamethasone0

Brief Pain Inventory (BPI) - Modified

The BPI was evaluated on a scale from 0-10. Zero would mean no interference and 10 would be calculated at complete interferences. We used a 7-point questionnaire about pain. All scores were calculated at baseline and three months. (NCT03028012)
Timeframe: Baseline and Three Months

Interventionscore on a scale (Number)
Participant Number #3 at BaselineParticipant Number #3 at 3 MonthsParticipant Number #8 at BaselineParticipant #8 at 3 Months
Ketorolac8353

Numeric Rating Pain Scale (NRS) at Baseline and Three Months.

TPI were treated with a needle inserted into the trigger point with the goal of eliciting a local twitch responses(LTRs). When a LTR was obtained, 0.1mL of randomized drug was injected into that location within the muscle. This was repeated until LTRs disappeared, or 1.0mL had been injected, whichever came first. Such was performed in a similar manner for all affected muscles, up to a maximum of 2mL. Participants self-report their brief pain inventory at each of their injections (up to four subsequent injections) based off of the standardized Numeric Rating pain Scale (NRS). The NRS is nationally recognized numeric scale from zero to ten, with zero being an example of no pain,one to three would demonstrate mild pain, four to six would be moderate pain, seven to nine would be severe pain and a ten would be the worst pain possible. Improvement in BPI was determined if their NRS score went down with each injection(s). (NCT03028012)
Timeframe: Pre-Injection and Three Month Post Injection(s)

Interventionscore on a scale (Number)
Participant Number 3 at BaselineParticipant Number 3 at 3 MonthsParticipant Number 8 at BaselineParticipant Number 8 at 3 Months
Ketorolac8353

Reviews

49 reviews available for diclofenac and Ache

ArticleYear
Perspectives on the Two-Pore Domain Potassium Channel TREK-1 (TWIK-Related K(+) Channel 1). A Novel Therapeutic Target?
    Journal of medicinal chemistry, 2016, 06-09, Volume: 59, Issue:11

    Topics: Arrhythmias, Cardiac; Depression; Epilepsy; Humans; Inflammation; Models, Molecular; Molecular Struc

2016
Efficacy of ultramicronised diclofenac in patients with osteoarthritis - systematic review with network meta-analysis.
    European review for medical and pharmacological sciences, 2021, Volume: 25, Issue:22

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Diclofenac; Humans; Network Meta-Analysis; Osteo

2021
Efficacy of ketorolac in the treatment of acute migraine attack: A systematic review and meta-analysis.
    Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 2022, Volume: 29, Issue:9

    Topics: Caffeine; Dexamethasone; Diclofenac; Humans; Ketorolac; Metoclopramide; Migraine Disorders; Pain; Ph

2022
Non-steroidal anti-inflammatory drugs (NSAIDs), pain and aging: Adjusting prescription to patient features.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2022, Volume: 150

    Topics: Aged; Aging; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 2 Inhibitors; Diclofenac; Etori

2022
Sterile water injections for management of renal colic pain: a systematic review.
    Scandinavian journal of urology, 2022, Volume: 56, Issue:3

    Topics: Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Humans; Morphine Derivatives; Pa

2022
Efficacy and Safety of NSAIDs in Infants: A Comprehensive Review of the Literature of the Past 20 Years.
    Paediatric drugs, 2022, Volume: 24, Issue:6

    Topics: Adolescent; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Celecoxib; C

2022
Comparison of different nonsteroidal anti-inflammatory drugs for cesarean section: a systematic review and network meta-analysis.
    Korean journal of anesthesiology, 2023, Volume: 76, Issue:6

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cesarean Section; Diclofenac; Female; Humans; In

2023
Meta-analysis Comparing Celecoxib with Diclofenac Sodium in Patients with Knee Osteoarthritis.
    Pain medicine (Malden, Mass.), 2021, 02-23, Volume: 22, Issue:2

    Topics: Celecoxib; Diclofenac; Humans; Osteoarthritis, Knee; Pain; Treatment Outcome

2021
Topical nonsteroidal anti-inflammatory drugs in the treatment of knee osteoarthritis: a systematic review and meta-analysis.
    The Physician and sportsmedicine, 2021, Volume: 49, Issue:4

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Humans; Knee Joint; Osteoarthritis, Knee; Pain

2021
Rationale and evidence for the incorporation of heparin into the diclofenac epolamine medicated plaster.
    Current medical research and opinion, 2019, Volume: 35, Issue:6

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Heparin; Humans; Inflammation; Osteoarthritis,

2019
Current methods of analgesia for transrectal ultrasonography (TRUS)-guided prostate biopsy -- a systematic review.
    BJU international, 2014, Volume: 113 Suppl 2

    Topics: Administration, Rectal; Analgesia; Anesthesia, Local; Anesthetics, Local; Biopsy; Diclofenac; Gels;

2014
[Diclofenac up2date - Part 1: Pharmacology and comparison with other drugs].
    Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS, 2014, Volume: 49, Issue:10

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Chemistry, Pharmaceutical; Contraindications; Diclofenac; H

2014
Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysis.
    Annals of internal medicine, 2015, Jan-06, Volume: 162, Issue:1

    Topics: Acetaminophen; Adrenal Cortex Hormones; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Ster

2015
Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysis.
    Annals of internal medicine, 2015, Jan-06, Volume: 162, Issue:1

    Topics: Acetaminophen; Adrenal Cortex Hormones; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Ster

2015
Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysis.
    Annals of internal medicine, 2015, Jan-06, Volume: 162, Issue:1

    Topics: Acetaminophen; Adrenal Cortex Hormones; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Ster

2015
Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysis.
    Annals of internal medicine, 2015, Jan-06, Volume: 162, Issue:1

    Topics: Acetaminophen; Adrenal Cortex Hormones; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Ster

2015
Diclofenac sodium injection (akis(®), dicloin (®)): a review of its use in the management of pain.
    Clinical drug investigation, 2015, Volume: 35, Issue:6

    Topics: 2-Hydroxypropyl-beta-cyclodextrin; Adult; Anti-Inflammatory Agents, Non-Steroidal; beta-Cyclodextrin

2015
WITHDRAWN: Diclofenac for acute pain in children.
    The Cochrane database of systematic reviews, 2015, Jul-02, Issue:7

    Topics: Acute Disease; Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Child; Diclofenac; Humans; Pain;

2015
Efficacy and Safety Profile of Diclofenac/Cyclodextrin and Progesterone/Cyclodextrin Formulations: A Review of the Literature Data.
    Drugs in R&D, 2016, Volume: 16, Issue:2

    Topics: 2-Hydroxypropyl-beta-cyclodextrin; beta-Cyclodextrins; Biological Availability; Cyclodextrins; Diclo

2016
Alpha blockers in the management of ureteric lithiasis: A meta-analysis.
    International journal of clinical practice, 2017, Volume: 71, Issue:1

    Topics: Adrenergic alpha-Antagonists; Analgesics; Diclofenac; Humans; Pain; Pain Measurement; Time Factors;

2017
Review of the pharmaceutical properties and clinical effects of the topical NSAID formulation, diclofenac epolamine.
    Current medical research and opinion, 2008, Volume: 24, Issue:10

    Topics: Administration, Topical; Anti-Inflammatory Agents, Non-Steroidal; Bone Diseases; Delayed-Action Prep

2008
Diclofenac epolamine (Flector) patch: evidence for topical activity.
    Clinical drug investigation, 2009, Volume: 29, Issue:1

    Topics: Administration, Topical; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Humans; Musculoskeleta

2009
Diclofenac for acute pain in children.
    The Cochrane database of systematic reviews, 2009, Oct-07, Issue:4

    Topics: Acute Disease; Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Child; Diclofenac; Humans; Pain;

2009
Diclofenac: an update on its mechanism of action and safety profile.
    Current medical research and opinion, 2010, Volume: 26, Issue:7

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Humans; Models, Biological; Pain; Signal Transd

2010
Evidence-based intravenous pain treatment with analgesic infusion regimens.
    Arzneimittel-Forschung, 2010, Volume: 60, Issue:5

    Topics: Analgesics; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Diazepam; Diclofenac; Drug

2010
Review of the efficacy and tolerability of the diclofenac epolamine topical patch 1.3% in patients with acute pain due to soft tissue injuries.
    Clinical therapeutics, 2010, Volume: 32, Issue:6

    Topics: Acute Disease; Administration, Cutaneous; Anti-Inflammatory Agents, Non-Steroidal; Clinical Trials a

2010
Topical diclofenac epolamine patch 1.3% for treatment of acute pain caused by soft tissue injury.
    International journal of clinical practice, 2010, Volume: 64, Issue:11

    Topics: Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Contusions; Diclofenac; Humans; Pain; Soft Tiss

2010
Insights into the effects of diclofenac and other non-steroidal anti-inflammatory agents on ion channels.
    The Journal of pharmacy and pharmacology, 2012, Volume: 64, Issue:10

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Drug Design; Drug Interactions; Drug S

2012
Evidence-based emergency medicine. Update: do ophthalmic nonsteroidal anti-inflammatory drugs reduce the pain associated with simple corneal abrasion without delaying healing?
    Annals of emergency medicine, 2003, Volume: 41, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analgesics; Anti-Bacterial Agents; Anti-Inflammatory Age

2003
[Clinical pharmacology of the selective COX-2 inhibitors].
    Der Orthopade, 2003, Volume: 32, Issue:12

    Topics: Acute Disease; Administration, Oral; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis

2003
Aceclofenac in the management of inflammatory pain.
    Expert opinion on pharmacotherapy, 2004, Volume: 5, Issue:6

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Clinical Trials as Topic; Diclofenac

2004
Lumiracoxib (Prexige): a new selective COX-2 inhibitor.
    International journal of clinical practice, 2004, Volume: 58, Issue:6

    Topics: Acute Disease; Chronic Disease; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibi

2004
[Assessment of a topical NSAIDs in the treatment of pain and inflammation. The example of Flector Plaster, a local bioadhesive plaster containing diclofenac epolamine].
    Presse medicale (Paris, France : 1983), 2004, Aug-28, Volume: 33, Issue:14 Pt 2

    Topics: Administration, Topical; Animals; Ankle Injuries; Anti-Inflammatory Agents, Non-Steroidal; Athletic

2004
The use of topical diclofenac for pain in osteoarthritis of the knee: a review.
    British journal of community nursing, 2006, Volume: 11, Issue:11

    Topics: Administration, Cutaneous; Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Chemistry,

2006
Diclofenac potassium 12.5mg tablets for mild to moderate pain and fever: a review of its pharmacology, clinical efficacy and safety.
    Clinical drug investigation, 2007, Volume: 27, Issue:3

    Topics: Cyclooxygenase Inhibitors; Diclofenac; Dose-Response Relationship, Drug; Fever; Humans; Molecular St

2007
Lumiracoxib in the management of osteoarthritis and acute pain.
    Expert opinion on pharmacotherapy, 2007, Volume: 8, Issue:10

    Topics: Acute Disease; Animals; Cardiovascular Diseases; Cyclooxygenase 2 Inhibitors; Diclofenac; Drug Appro

2007
Pain relief in osteoarthritis and rheumatoid arthritis: TENS.
    British journal of community nursing, 2007, Volume: 12, Issue:8

    Topics: Adjuvants, Immunologic; Analgesia; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; C

2007
Clinical use and pharmacological properties of selective COX-2 inhibitors.
    European journal of clinical pharmacology, 2008, Volume: 64, Issue:3

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Celecoxib; Cyclooxygenase 2 Inhibito

2008
Topical diclofenac and its role in pain and inflammation: an evidence-based review.
    Current medical research and opinion, 2008, Volume: 24, Issue:4

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 2 Inhibitors; Diclofenac; Double-Blind Metho

2008
Diclofenac sodium: a review of its pharmacological properties and therapeutic use in rheumatic diseases and pain of varying origin.
    Drugs, 1980, Volume: 20, Issue:1

    Topics: Adult; Animals; Arthritis, Rheumatoid; Aspirin; Cyclooxygenase Inhibitors; Diclofenac; Drug Interact

1980
Central antinociceptive effects of non-steroidal anti-inflammatory drugs and paracetamol. Experimental studies in the rat.
    Acta anaesthesiologica Scandinavica. Supplementum, 1995, Volume: 103

    Topics: Acetaminophen; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arginine; Behavior, Animal; Brain;

1995
Piroxicam-beta-cyclodextrin in the treatment of acute pain of rheumatic disease.
    European journal of rheumatology and inflammation, 1993, Volume: 12, Issue:4

    Topics: Acute Disease; Adult; beta-Cyclodextrins; Controlled Clinical Trials as Topic; Cyclodextrins; Diclof

1993
[Singular diaphragm-like colonic stricture and short-term administration of a non-steroidal anti-inflammatory drug].
    Gastroenterologie clinique et biologique, 1994, Volume: 18, Issue:5

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Colectomy; Colitis, Ulcerative; Colonic Diseases; Col

1994
Meta-analysis of three double-blind comparative trials with sustained-release etodolac in the treatment of osteoarthritis of the knee.
    Rheumatology international, 1993, Volume: 13, Issue:2 Suppl

    Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Delay

1993
Aceclofenac. A review of its pharmacodynamic properties and therapeutic potential in the treatment of rheumatic disorders and in pain management.
    Drugs, 1996, Volume: 52, Issue:1

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Clinical Trials as Topic; Diclofenac; Humans; Pain

1996
Hyaluronan as a drug delivery system for diclofenac: a hypothesis for mode of action.
    International journal of tissue reactions, 1995, Volume: 17, Issue:4

    Topics: Animals; Carcinoma, Basal Cell; Carotid Stenosis; Diclofenac; Drug Delivery Systems; Humans; Hyaluro

1995
[Pharma-clinics. The drug of the month. Aceclofenac (Biofenac)].
    Revue medicale de Liege, 1999, Volume: 54, Issue:1

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Humans; Joint Diseases; Pain

1999
Celecoxib clinical profile.
    Rheumatology (Oxford, England), 2000, Volume: 39 Suppl 2

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cardiovascular Diseases; Celec

2000
Aceclofenac: a reappraisal of its use in the management of pain and rheumatic disease.
    Drugs, 2001, Volume: 61, Issue:9

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cartilage Oligomeric Matrix Protein; Diclofenac; D

2001
[What is the role of aceclofenac in the therapeutic arsenal against chronic osteoarthritis pathologies?].
    Revue medicale de Liege, 2001, Volume: 56, Issue:7

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cartilage; Chronic Disease; Diclofen

2001
Overall safety of Arthrotec.
    Scandinavian journal of rheumatology. Supplement, 1992, Volume: 96

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Constipation; Diarrhea;

1992
Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
    Drugs, 1988, Volume: 35, Issue:3

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Clinical Trials as Topic; Diclofenac; D

1988

Trials

176 trials available for diclofenac and Ache

ArticleYear
Comparison of the Efficacy and Safety of Ketoprofen Plaster and Diclofenac Plaster for Osteoarthritis-Related Knee Pain: A Multicenter, Randomized, Active-Controlled, Open-Label, Parallel-Group, Phase III Clinical Trial.
    Clinical therapeutics, 2021, Volume: 43, Issue:10

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Double-Blind Method; Humans; Ketoprofen;

2021
Pain Relief for Hysterosalpingography: A Randomized Controlled, Double Blinded Trial Comparing Suppository Diclofenac, Prilocaine/Lignocaine (EMLA) Cream And Placebo.
    West African journal of medicine, 2021, Dec-30, Volume: 38, Issue:12

    Topics: Diclofenac; Female; Humans; Hysterosalpingography; Lidocaine; Pain; Prilocaine; Prospective Studies

2021
Efficacy and safety of S-flurbiprofen plaster in knee osteoarthritis patients: A 2-week randomized controlled Phase III clinical trial compared to diclofenac gel.
    International journal of rheumatic diseases, 2022, Volume: 25, Issue:5

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Double-Blind Method; Flurbiprofen; Humans; Oste

2022
Diclofenac-hyaluronate conjugate (diclofenac etalhyaluronate) intra-articular injection for hip, ankle, shoulder, and elbow osteoarthritis: a randomized controlled trial.
    BMC musculoskeletal disorders, 2022, Apr-20, Volume: 23, Issue:1

    Topics: Ankle; Diclofenac; Double-Blind Method; Elbow; Humans; Hyaluronic Acid; Injections, Intra-Articular;

2022
Efficacy of Cabbage Leaf versus Cooling Gel Pad or Diclofenac Gel for Patients with Knee Osteoarthritis: A Randomized Open-Labeled Controlled Clinical Trial.
    Pain research & management, 2022, Volume: 2022

    Topics: Aged; Brassica; Diclofenac; Humans; Osteoarthritis, Knee; Pain; Plant Leaves; Quality of Life; Treat

2022
Effect of Adjunctive Acupuncture on Pain Relief Among Emergency Department Patients With Acute Renal Colic Due to Urolithiasis: A Randomized Clinical Trial.
    JAMA network open, 2022, 08-01, Volume: 5, Issue:8

    Topics: Acupuncture Therapy; Diclofenac; Emergency Service, Hospital; Humans; Male; Middle Aged; Pain; Renal

2022
Randomized, double-blind, noninferiority study of diclofenac diethylamine 2.32% gel applied twice daily versus diclofenac diethylamine 1.16% gel applied four times daily in patients with acute ankle sprain.
    BMC musculoskeletal disorders, 2022, Dec-24, Volume: 23, Issue:1

    Topics: Ankle Injuries; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Double-Blind Method; Humans; Pa

2022
Dry needling on latent and active myofascial trigger points versus oral diclofenac in patients with knee osteoarthritis: a randomized controlled trial.
    BMC musculoskeletal disorders, 2023, Jan-18, Volume: 24, Issue:1

    Topics: Diclofenac; Dry Needling; Humans; Myofascial Pain Syndromes; Osteoarthritis, Knee; Pain; Trigger Poi

2023
The efficacy of intradermal sterile water application in severe renal colic: a randomised clinical trial.
    Urolithiasis, 2023, Oct-12, Volume: 51, Issue:1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Double-Blind Method; Fentanyl; Humans; Injectio

2023
Comparison of efficacy of diclofenac and tramadol in relieving pain in patients of acute pancreatitis: A randomized parallel group double blind active controlled pilot study.
    European journal of pain (London, England), 2020, Volume: 24, Issue:3

    Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Double-Blind Method; Humans; Pai

2020
A novel diclofenac gel (AMZ001) applied once or twice daily in subjects with painful knee osteoarthritis: A randomized, placebo-controlled clinical trial.
    Seminars in arthritis and rheumatism, 2020, Volume: 50, Issue:6

    Topics: Diclofenac; Humans; Knee Joint; Osteoarthritis, Knee; Pain; Treatment Outcome

2020
Topical diclofenac vs placebo for the treatment of chronic Achilles tendinopathy: A randomized controlled clinical trial.
    PloS one, 2021, Volume: 16, Issue:3

    Topics: Administration, Topical; Adult; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Chron

2021
Efficacy and safety of topical diclofenac/menthol gel for ankle sprain: A randomized, double-blind, placebo- and active-controlled trial.
    The Journal of international medical research, 2017, Volume: 45, Issue:2

    Topics: Administration, Cutaneous; Adolescent; Adult; Ankle; Ankle Injuries; Anti-Inflammatory Agents, Non-S

2017
Diclofenac for pain associated with intravitreal injections: a prospective, randomized, placebo-controlled study.
    Clinical & experimental ophthalmology, 2017, Volume: 45, Issue:9

    Topics: Administration, Oral; Administration, Topical; Aged; Angiogenesis Inhibitors; Anti-Inflammatory Agen

2017
Efficacy and safety of adalimumab by intra-articular injection for moderate to severe knee osteoarthritis: An open-label randomized controlled trial.
    The Journal of international medical research, 2018, Volume: 46, Issue:1

    Topics: Adalimumab; Aged; Antirheumatic Agents; Celecoxib; Diclofenac; Female; Humans; Hyaluronic Acid; Ibup

2018
Comparison of three analgesic drug regimens with twelfth subcostal nerve block for pain control during extracorporeal shock wave lithotripsy.
    International urology and nephrology, 2018, Volume: 50, Issue:1

    Topics: Adult; Analgesics, Opioid; Anesthetics, Local; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac;

2018
Effect of the Buzzy Application on Pain and Injection Satisfaction in Adult Patients Receiving Intramuscular Injections.
    Pain management nursing : official journal of the American Society of Pain Management Nurses, 2018, Volume: 19, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Fear; Female; H

2018
Comparison of diclofenac gel, ibuprofen gel, and ibuprofen gel with levomenthol for the topical treatment of pain associated with musculoskeletal injuries.
    The Journal of international medical research, 2019, Volume: 47, Issue:9

    Topics: Administration, Topical; Adolescent; Adult; Aged; Diclofenac; Female; Gels; Humans; Ibuprofen; Male;

2019
Comparison of gastrointestinal safety and tolerability of aceclofenac with diclofenac: a multicenter, randomized, double-blind study in patients with knee osteoarthritis.
    Current medical research and opinion, 2013, Volume: 29, Issue:7

    Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Double-Blind Method; Drug Therapy,

2013
[Case-control study on stiletto needle and Dichofenac Diethylammon for the treatment of knee osteoarthritis pain].
    Zhongguo gu shang = China journal of orthopaedics and traumatology, 2012, Volume: 25, Issue:12

    Topics: Adult; Aged; Biomechanical Phenomena; Case-Control Studies; Diclofenac; Female; Humans; Male; Middle

2012
Sublingual misoprostol prior to insertion of a T380A intrauterine device in women with no previous vaginal delivery.
    The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 2013, Volume: 18, Issue:4

    Topics: Administration, Sublingual; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac;

2013
Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial.
    Annals of the rheumatic diseases, 2014, Volume: 73, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Hum

2014
A randomized, double-blind, placebo-controlled multicentre study to evaluate the efficacy and safety of diclofenac 4% spray gel in the treatment of acute uncomplicated ankle sprain.
    The Journal of international medical research, 2013, Volume: 41, Issue:4

    Topics: Acute Disease; Administration, Topical; Adult; Ankle Injuries; Anti-Inflammatory Agents, Non-Steroid

2013
Comparative study between three analgesic agents for the pain management during extracorporeal shock wave lithotripsy.
    Urology journal, 2013, Sep-26, Volume: 10, Issue:3

    Topics: Adult; Analgesia; Anesthetics, Local; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Female; H

2013
[Impact of combined therapy using glucosamine sulfate and anti-inflammatory agent on pain severity in patients with osteoarthritis: prospective, non-controlled postmarketing study].
    Klinicheskaia meditsina, 2013, Volume: 91, Issue:5

    Topics: Aged; Anti-Inflammatory Agents; Cardiovascular Agents; Diclofenac; Drug Therapy, Combination; Escin;

2013
The 24-h progression of menstrual pain in women with primary dysmenorrhea when given diclofenac potassium: a randomized, double-blinded, placebo-controlled crossover study.
    Archives of gynecology and obstetrics, 2014, Volume: 289, Issue:5

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Cross-Over Studies; Diclofenac; Dose-Response Relati

2014
The effect on pain of three different methods of intramuscular injection: A randomized controlled trial.
    International journal of nursing practice, 2016, Volume: 22, Issue:2

    Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Clinical Nursing Research; Diclofenac; F

2016
Dermal scarification versus intramuscular diclofenac sodium injection for the treatment of renal colic: a prospective randomized clinical trial.
    Urolithiasis, 2014, Volume: 42, Issue:6

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Complementary Therapies; Diclofenac; Female; Humans;

2014
Effect of local infusion of NSAID analgesics administered alone or in combination on the pain associated with band castration in calves.
    Australian veterinary journal, 2015, Volume: 93, Issue:8

    Topics: Age Factors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Behavior, Animal; C

2015
Efficacy and safety of diclofenac sodium 2% topical solution for osteoarthritis of the knee: a randomized, double-blind, vehicle-controlled, 4 week study.
    Current medical research and opinion, 2016, Volume: 32, Issue:2

    Topics: Administration, Topical; Aged; Anti-Inflammatory Agents, Non-Steroidal; Chemistry, Pharmaceutical; D

2016
Effect of paracetamol, dexketoprofen trometamol, lidocaine spray, pethidine & diclofenac sodium application for pain relief during fractional curettage: A randomized controlled trial.
    The Indian journal of medical research, 2015, Volume: 142, Issue:4

    Topics: Acetaminophen; Adult; Aged; Analgesia; Curettage; Diclofenac; Female; Gynecologic Surgical Procedure

2015
Diclofenac plus lidocaine gel for pain relief during intrauterine device insertion. A randomized, double-blinded, placebo-controlled study.
    Contraception, 2016, Volume: 93, Issue:6

    Topics: Administration, Intravaginal; Adult; Anesthetics, Local; Anti-Inflammatory Agents, Non-Steroidal; Di

2016
Double-blind Randomized Placebo-controlled Clinical Trial of Efficiency of Nonsteroidal Anti-inflammatory Drugs in the Control of Post-endodontic Pain.
    Journal of endodontics, 2016, Volume: 42, Issue:6

    Topics: Acetaminophen; Adult; Anesthetics, Local; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Dose-

2016
Double-blind Randomized Placebo-controlled Clinical Trial of Efficiency of Nonsteroidal Anti-inflammatory Drugs in the Control of Post-endodontic Pain.
    Journal of endodontics, 2016, Volume: 42, Issue:6

    Topics: Acetaminophen; Adult; Anesthetics, Local; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Dose-

2016
Double-blind Randomized Placebo-controlled Clinical Trial of Efficiency of Nonsteroidal Anti-inflammatory Drugs in the Control of Post-endodontic Pain.
    Journal of endodontics, 2016, Volume: 42, Issue:6

    Topics: Acetaminophen; Adult; Anesthetics, Local; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Dose-

2016
Double-blind Randomized Placebo-controlled Clinical Trial of Efficiency of Nonsteroidal Anti-inflammatory Drugs in the Control of Post-endodontic Pain.
    Journal of endodontics, 2016, Volume: 42, Issue:6

    Topics: Acetaminophen; Adult; Anesthetics, Local; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Dose-

2016
Variability in conditioned pain modulation predicts response to NSAID treatment in patients with knee osteoarthritis.
    BMC musculoskeletal disorders, 2016, 07-13, Volume: 17

    Topics: Administration, Topical; Anti-Inflammatory Agents, Non-Steroidal; Case-Control Studies; Diclofenac;

2016
Variability in conditioned pain modulation predicts response to NSAID treatment in patients with knee osteoarthritis.
    BMC musculoskeletal disorders, 2016, 07-13, Volume: 17

    Topics: Administration, Topical; Anti-Inflammatory Agents, Non-Steroidal; Case-Control Studies; Diclofenac;

2016
Variability in conditioned pain modulation predicts response to NSAID treatment in patients with knee osteoarthritis.
    BMC musculoskeletal disorders, 2016, 07-13, Volume: 17

    Topics: Administration, Topical; Anti-Inflammatory Agents, Non-Steroidal; Case-Control Studies; Diclofenac;

2016
Variability in conditioned pain modulation predicts response to NSAID treatment in patients with knee osteoarthritis.
    BMC musculoskeletal disorders, 2016, 07-13, Volume: 17

    Topics: Administration, Topical; Anti-Inflammatory Agents, Non-Steroidal; Case-Control Studies; Diclofenac;

2016
A comparison of efficacy of doxazosin 4 and 8 mg in medical expulsive therapy of distal ureteral stones: a prospective randomized clinical trial.
    Urolithiasis, 2017, Volume: 45, Issue:5

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Analgesics; Diclofenac; Dose-Response Relationship,

2017
Side effects can enhance treatment response through expectancy effects: an experimental analgesic randomized controlled trial.
    Pain, 2017, Volume: 158, Issue:6

    Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Anticipation, Psychological; Atropine; D

2017
Comparison of efficacy between oral morphine sulphate and diclofenac suppository for analgesia during transrectal ultrasound-guided prostate biopsy.
    Acta medica Indonesiana, 2008, Volume: 40, Issue:3

    Topics: Administration, Oral; Aged; Aged, 80 and over; Analgesics; Analgesics, Opioid; Anti-Inflammatory Age

2008
A randomised, double-blind study comparing lumiracoxib with naproxen for acute musculoskeletal pain.
    International journal of clinical practice, 2008, Volume: 62, Issue:11

    Topics: Acute Disease; Adult; Cyclooxygenase 2 Inhibitors; Diclofenac; Dose-Response Relationship, Drug; Dou

2008
Comparison of three analgesic treatment protocols for pain management during extracorporeal shock wave lithotripsy.
    Urologia internationalis, 2009, Volume: 82, Issue:3

    Topics: Adult; Analgesia; Anesthetics, Combined; Anesthetics, Local; Anti-Inflammatory Agents, Non-Steroidal

2009
Succinylcholine-induced myalgia in obstetric patients scheduled for caesarean section--diclofenac vs placebo patches.
    Middle East journal of anaesthesiology, 2009, Volume: 20, Issue:3

    Topics: Administration, Cutaneous; Adult; Anti-Inflammatory Agents, Non-Steroidal; Cesarean Section; Diclofe

2009
Correlation of pain relief with physical function in hand osteoarthritis: randomized controlled trial post hoc analysis.
    Arthritis research & therapy, 2010, Volume: 12, Issue:1

    Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Di

2010
Correlation of pain relief with physical function in hand osteoarthritis: randomized controlled trial post hoc analysis.
    Arthritis research & therapy, 2010, Volume: 12, Issue:1

    Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Di

2010
Correlation of pain relief with physical function in hand osteoarthritis: randomized controlled trial post hoc analysis.
    Arthritis research & therapy, 2010, Volume: 12, Issue:1

    Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Di

2010
Correlation of pain relief with physical function in hand osteoarthritis: randomized controlled trial post hoc analysis.
    Arthritis research & therapy, 2010, Volume: 12, Issue:1

    Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Di

2010
'Multimodal' approach to management of prostate biopsy pain and effects on sexual function: efficacy of levobupivacaine adjuvant to diclofenac sodium - a prospective randomized trial.
    Andrologia, 2010, Volume: 42, Issue:1

    Topics: Aged; Analgesia; Anesthetics, Local; Anti-Inflammatory Agents, Non-Steroidal; Biopsy, Needle; Bupiva

2010
Extent and time course of pain intensity upon treatment with a topical diclofenac sodium patch versus placebo in acute traumatic injury based on a validated end point: post hoc analysis of a randomized placebo-controlled trial.
    Expert opinion on pharmacotherapy, 2010, Volume: 11, Issue:4

    Topics: Acute Disease; Administration, Topical; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal;

2010
Transrectal ultrasound-guided prostate biopsy, periprostatic local anesthesia and pain tolerance.
    Bosnian journal of basic medical sciences, 2010, Volume: 10, Issue:1

    Topics: Aged; Anesthetics, Local; Anti-Inflammatory Agents, Non-Steroidal; Biopsy, Needle; Diclofenac; Human

2010
Comparison of the analgesic effects of dexketoprofen and diclofenac during shockwave lithotripsy: a randomized, double-blind clinical trial.
    Journal of endourology, 2010, Volume: 24, Issue:6

    Topics: Adult; Aged; Analgesics; Diclofenac; Double-Blind Method; Humans; Ketoprofen; Lithotripsy; Male; Mid

2010
Effect on pain of changing the needle prior to administering medicine intramuscularly: a randomized controlled trial.
    Journal of advanced nursing, 2011, Volume: 67, Issue:3

    Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Clinical Nursing Research; Diclofenac; F

2011
A comparative assessment of the clinical efficacy of intranasal desmopressin spray and diclofenac in the treatment of renal colic.
    Urological research, 2011, Volume: 39, Issue:5

    Topics: Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Antidiuretic Agents; Deamino Arginine Vasopress

2011
[Comparative observation on hip osteoarthritis treated with electroacupuncture and medication].
    Zhongguo zhen jiu = Chinese acupuncture & moxibustion, 2010, Volume: 30, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Electroacupunct

2010
Zaltoprofen, a noninferior alternative to diclofenac for the treatment of primary knee osteoarthritis -- a comparative evaluation of efficacy and safety in a 4-week, multicentric, randomized, double-blind, double-dummy trial.
    Expert opinion on pharmacotherapy, 2011, Volume: 12, Issue:7

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Benzopyrans; Diclofenac; Double-Blind Method; Drug A

2011
Analgesic efficacy and safety of the diclofenac epolamine topical patch 1.3% (DETP) in minor soft tissue injury.
    International journal of sports medicine, 2011, Volume: 32, Issue:8

    Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non

2011
Medical expulsive therapy using alfuzosin for patient presenting with ureteral stone less than 10mm: a prospective randomized controlled trial.
    International journal of urology : official journal of the Japanese Urological Association, 2011, Volume: 18, Issue:7

    Topics: Acetaminophen; Adult; Aged; Analgesics, Non-Narcotic; Analgesics, Opioid; Anti-Inflammatory Agents,

2011
[Application of a seven-day buprenorphine transdermal patch in multimorbid patients on long-term ibuprofen or diclofenac].
    MMW Fortschritte der Medizin, 2011, Jan-13, Volume: 152 Suppl 4

    Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Analgesics, Opioid; Anti-Inflammatory Agents, No

2011
A 13-week, multicenter, randomized, double-blind study of lumiracoxib in hip osteoarthritis.
    Clinical rheumatology, 2011, Volume: 30, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Cyclooxygenase 2 Inhibitors; Diclofenac; Double-Blind Method; Female

2011
Comparison of ocular tolerability between preserved and preservative-free diclofenac sodium drops.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2011, Volume: 27, Issue:4

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Female; Humans; Male; Middle Aged; Ophth

2011
Treatment of acute, non-traumatic pain using a combination of diclofenac-cholestyramine, uridine triphosphate, cytidine monophosphate, and hydroxycobalamin.
    Proceedings of the Western Pharmacology Society, 2010, Volume: 53

    Topics: Acute Disease; Adult; Anti-Inflammatory Agents, Non-Steroidal; Cholestyramine Resin; Cytidine Monoph

2010
Efficacy and safety of diclofenac diethylamine 2.32% gel in acute ankle sprain.
    Medicine and science in sports and exercise, 2012, Volume: 44, Issue:9

    Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Ankle Injuries; Diclofenac; Dou

2012
Efficacy and tolerability of DHEP-heparin plaster in reducing pain in mild-to-moderate muscle contusions: a double-blind, randomized trial.
    Current medical research and opinion, 2012, Volume: 28, Issue:8

    Topics: Administration, Topical; Adolescent; Adult; Aged; Algorithms; Anti-Inflammatory Agents, Non-Steroida

2012
A diclofenac suppository-nabumetone combination therapy for arthritic pain relief and a monitoring method for the diclofenac binding capacity of HSA site II in rheumatoid arthritis.
    Biopharmaceutics & drug disposition, 2013, Volume: 34, Issue:2

    Topics: Aged; Arthritis, Rheumatoid; Binding Sites; Butanones; Cyclooxygenase Inhibitors; Diclofenac; Drug M

2013
Preliminary study of highly cross-linked hyaluronic acid-based combination therapy for management of knee osteoarthritis-related pain.
    Drug design, development and therapy, 2013, Volume: 7

    Topics: Adjuvants, Immunologic; Anti-Inflammatory Agents, Non-Steroidal; Blood Sedimentation; C-Reactive Pro

2013
Primary prevention of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in Helicobacter pylori positive patients: a randomised, double blind, placebo controlled, clinical trial.
    Gut, 2002, Volume: 51, Issue:3

    Topics: Adult; Amoxicillin; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Clarithromycin; Dicl

2002
Results of a randomized, dose-ranging trial of etoricoxib in patients with osteoarthritis.
    Rheumatology (Oxford, England), 2002, Volume: 41, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Cyclo

2002
A comparison of intraoperative celiac plexus block with pharmacological therapy as a treatment for pain of unresectable pancreatic cancer.
    Journal of hepato-biliary-pancreatic surgery, 2002, Volume: 9, Issue:3

    Topics: Aged; Aged, 80 and over; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Autonomic Nerv

2002
A study of co-treatment of nonsteroidal anti-inflammatory drugs (NSAIDs) with misoprostol for cervical priming before suction termination of first trimester pregnancy.
    Contraception, 2003, Volume: 67, Issue:2

    Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adolescent; Adult; Anti-Inflammatory Agents,

2003
Efficacy of topical nonsteroidal antiinflammatory drugs in mastalgia treatment.
    Journal of the American College of Surgeons, 2003, Volume: 196, Issue:4

    Topics: Administration, Topical; Adult; Aged; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal;

2003
A multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled, parallel-group comparison of diclofenac-K and ibuprofen for the treatment of adults with influenza-like symptoms.
    Clinical therapeutics, 2003, Volume: 25, Issue:2

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Double-Blind Method; Drug Administration

2003
Peripheral and central antihyperalgesic effects of diclofenac in a model of human inflammatory pain.
    Clinical pharmacology and therapeutics, 2003, Volume: 74, Issue:2

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Central Nervous System; Cross-Over

2003
Effectiveness of leech therapy in osteoarthritis of the knee: a randomized, controlled trial.
    Annals of internal medicine, 2003, Nov-04, Volume: 139, Issue:9

    Topics: Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Humans; Knee

2003
Randomised controlled trial of the onset of analgesic efficacy of dexketoprofen and diclofenac in lower limb injury.
    Emergency medicine journal : EMJ, 2003, Volume: 20, Issue:6

    Topics: Acute Disease; Administration, Oral; Adult; Analgesics; Diclofenac; Double-Blind Method; Female; Hum

2003
Efficacy of tamsulosin in the medical management of juxtavesical ureteral stones.
    The Journal of urology, 2003, Volume: 170, Issue:6 Pt 1

    Topics: Administration, Oral; Adolescent; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagoni

2003
Diclofenac suppository analgesia for transrectal ultrasound guided biopsies of the prostate: a double-blind, randomized controlled trial.
    The Journal of urology, 2004, Volume: 171, Issue:4

    Topics: Aged; Analgesia; Biopsy, Needle; Diclofenac; Double-Blind Method; Humans; Male; Pain; Prospective St

2004
[Using prostaglandin inhibitor dicloberl in patients with ureteral calculi].
    Likars'ka sprava, 2004, Issue:2

    Topics: Adult; Aged; Analgesics, Opioid; Diclofenac; Drug Therapy, Combination; Female; Humans; Male; Middle

2004
Oral enzyme combination versus diclofenac in the treatment of osteoarthritis of the knee--a double-blind prospective randomized study.
    Clinical rheumatology, 2004, Volume: 23, Issue:5

    Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Bromelains; Diclofenac; Double-Blind

2004
Efficacy and safety of four doses of lumiracoxib versus diclofenac in patients with knee or hip primary osteoarthritis: a phase II, four-week, multicenter, randomized, double-blind, placebo-controlled trial.
    Arthritis and rheumatism, 2004, Aug-15, Volume: 51, Issue:4

    Topics: Aged; Cyclooxygenase Inhibitors; Diclofenac; Double-Blind Method; Female; Health Status; Humans; Mal

2004
Rectal analgesia for the relief of perineal pain after childbirth: a randomised controlled trial of diclofenac suppositories.
    BJOG : an international journal of obstetrics and gynaecology, 2004, Volume: 111, Issue:10

    Topics: Administration, Rectal; Adult; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Doub

2004
Diclofenac systemic exposure is not increased when topical diclofenac is applied to ultraviolet-induced erythema.
    European journal of clinical pharmacology, 2004, Volume: 60, Issue:8

    Topics: Administration, Cutaneous; Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Are

2004
Lumiracoxib.
    Drugs, 2004, Volume: 64, Issue:19

    Topics: Administration, Oral; Arthritis, Rheumatoid; Celecoxib; Cyclooxygenase Inhibitors; Diclofenac; Doubl

2004
Acupuncture as a complementary therapy to the pharmacological treatment of osteoarthritis of the knee: randomised controlled trial.
    BMJ (Clinical research ed.), 2004, Nov-20, Volume: 329, Issue:7476

    Topics: Acupuncture Therapy; Aged; Anti-Inflammatory Agents, Non-Steroidal; Combined Modality Therapy; Diclo

2004
[Ocular tolerance of a new formulation of nonpreserved diclofenac].
    Journal francais d'ophtalmologie, 2004, Volume: 27, Issue:7

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Drug Administration Schedule; Dry Eye Sy

2004
[Proof of the pharmacodynamic activity of Flector Plaster in healthy volunteers and patients suffering from osteo-arthritis of the knee].
    Presse medicale (Paris, France : 1983), 2004, Aug-28, Volume: 33, Issue:14 Pt 2

    Topics: Administration, Topical; Adult; Diclofenac; Double-Blind Method; Female; Humans; Knee Joint; Male; O

2004
Chinese herbal recipe versus diclofenac in symptomatic treatment of osteoarthritis of the knee: a randomized controlled trial [ISRCTN70292892].
    BMC complementary and alternative medicine, 2004, Dec-13, Volume: 4

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Dizziness; Double-Blind Method; Drugs, C

2004
Effect of diclofenac pretreatment on pain during propofol injection.
    Anaesthesia and intensive care, 2004, Volume: 32, Issue:6

    Topics: Adolescent; Adult; Anesthetics, Intravenous; Chi-Square Distribution; Diclofenac; Dose-Response Rela

2004
The effect on mechanical pain threshold over human muscles by oral administration of granisetron and diclofenac-sodium.
    Pain, 2005, Volume: 113, Issue:3

    Topics: Administration, Oral; Adult; Case-Control Studies; Cyclooxygenase Inhibitors; Diclofenac; Female; Gr

2005
Topical versus systemic diclofenac in the treatment of temporo-mandibular joint dysfunction symptoms.
    Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale, 2004, Volume: 24, Issue:5

    Topics: Administration, Oral; Administration, Topical; Adult; Anti-Inflammatory Agents, Non-Steroidal; Diclo

2004
Comparison of the analgesic effects of a fixed-dose combination of orphenadrine and diclofenac (Neodolpasse) with its single active ingredients diclofenac and orphenadrine: a placebo-controlled study using laser-induced somatosensory-evoked potentials fro
    Drugs in R&D, 2005, Volume: 6, Issue:4

    Topics: Adult; Analgesics; Capsaicin; Cross-Over Studies; Diclofenac; Double-Blind Method; Drug Combinations

2005
Treatment of osteoarthritis of the knee with a topical diclofenac solution: a randomised controlled, 6-week trial [ISRCTN53366886].
    BMC musculoskeletal disorders, 2005, Aug-08, Volume: 6

    Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Di

2005
Treatment of osteoarthritis of the knee with a topical diclofenac solution: a randomised controlled, 6-week trial [ISRCTN53366886].
    BMC musculoskeletal disorders, 2005, Aug-08, Volume: 6

    Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Di

2005
Treatment of osteoarthritis of the knee with a topical diclofenac solution: a randomised controlled, 6-week trial [ISRCTN53366886].
    BMC musculoskeletal disorders, 2005, Aug-08, Volume: 6

    Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Di

2005
Treatment of osteoarthritis of the knee with a topical diclofenac solution: a randomised controlled, 6-week trial [ISRCTN53366886].
    BMC musculoskeletal disorders, 2005, Aug-08, Volume: 6

    Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Di

2005
Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a prospective randomized 13-week study versus placebo and celecoxib.
    Clinical rheumatology, 2006, Volume: 25, Issue:1

    Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Celecoxib; C

2006
Randomized double-blind trial comparing oral paracetamol and oral nonsteroidal antiinflammatory drugs for treating pain after musculoskeletal injury.
    Annals of emergency medicine, 2005, Volume: 46, Issue:4

    Topics: Acetaminophen; Adult; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Dizziness; Female; Humans

2005
Analgesic efficacy of a lecithin-vehiculated diclofenac epolamine gel in shoulder periarthritis and lateral epicondylitis: a placebo-controlled, multicenter, randomized, double-blind clinical trial.
    Drugs under experimental and clinical research, 2005, Volume: 31, Issue:4

    Topics: Analgesics; Diclofenac; Double-Blind Method; Gels; Humans; Pain; Periarthritis; Placebos; Shoulder;

2005
Diclofenac suppository administration in conjunction with lidocaine gel during transrectal ultrasound-guided prostate biopsy: prospective, randomized, placebo-controlled study.
    Urology, 2005, Volume: 66, Issue:4

    Topics: Analgesia; Anesthetics, Local; Biopsy; Diclofenac; Drug Therapy, Combination; Gels; Humans; Lidocain

2005
Efficacy of topical diclofenac diethylamine gel in osteoarthritis of the knee.
    The Journal of rheumatology, 2005, Volume: 32, Issue:12

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Double-Blind Method; Female; Gels; Humans

2005
Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study.
    The American journal of medicine, 2006, Volume: 119, Issue:3

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase Inhibitors; Diclofenac; Double-Bl

2006
Evaluation of a diclofenac transdermal patch for the attenuation of venous cannulation pain: a prospective, randomised, double-blind, placebo-controlled study.
    Anaesthesia, 2006, Volume: 61, Issue:4

    Topics: Administration, Cutaneous; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Buttocks; Dic

2006
Efficacy and tolerability of diclofenac potassium sachets in migraine: a randomized, double-blind, cross-over study in comparison with diclofenac potassium tablets and placebo.
    Cephalalgia : an international journal of headache, 2006, Volume: 26, Issue:5

    Topics: Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Cross-Over Studies; Diclofenac

2006
Pre-surgical child behavior ratings and pain management after two different techniques of tonsil surgery.
    International journal of pediatric otorhinolaryngology, 2006, Volume: 70, Issue:10

    Topics: Acetaminophen; Adolescent; Analgesics, Non-Narcotic; Analgesics, Opioid; Anesthesia; Anti-Inflammato

2006
Topical ketoprofen TDS patch versus diclofenac gel: efficacy and tolerability in benign sport related soft-tissue injuries.
    British journal of sports medicine, 2007, Volume: 41, Issue:3

    Topics: Administration, Topical; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Athletic Injuri

2007
Transdermal diclofenac patch vs eutectic mixture of local anesthetics for venous cannulation pain.
    Canadian journal of anaesthesia = Journal canadien d'anesthesie, 2007, Volume: 54, Issue:3

    Topics: Adult; Anesthesia, Local; Anesthetics, Local; Catheterization, Peripheral; Diclofenac; Double-Blind

2007
Preparation, in vitro, preclinical and clinical evaluations of once daily sustained release tablets of aceclofenac.
    Archives of pharmacal research, 2007, Volume: 30, Issue:2

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Delayed-Action Preparations; Dic

2007
Pain relieving effect of short-course, pulse prednisolone in managing frozen shoulder.
    Journal of pain & palliative care pharmacotherapy, 2007, Volume: 21, Issue:1

    Topics: Adult; Aged; Anti-Inflammatory Agents; Bursitis; Diclofenac; Female; Humans; Male; Middle Aged; Pain

2007
A randomized comparison of different methods of analgesia in abortion using manual vacuum aspiration.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2007, Volume: 99, Issue:2

    Topics: Abortion, Incomplete; Adult; Analgesia, Obstetrical; Anesthesia, Obstetrical; Anti-Inflammatory Agen

2007
[Comparison of the time to analgetic and anti-inflammatory effect in the treatment of gouty arthritis with nimesulide and sodium diclofenac].
    Terapevticheskii arkhiv, 2007, Volume: 79, Issue:5

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Gouty; Diclofenac; Female; Humans; Male; Pain; P

2007
The efficacy of paracetamol in the treatment of ankle sprains in comparison with diclofenac sodium.
    Saudi medical journal, 2007, Volume: 28, Issue:12

    Topics: Acetaminophen; Adult; Analgesics, Non-Narcotic; Ankle Injuries; Anti-Inflammatory Agents, Non-Steroi

2007
Comfrey extract ointment in comparison to diclofenac gel in the treatment of acute unilateral ankle sprains (distortions).
    Arzneimittel-Forschung, 2007, Volume: 57, Issue:11

    Topics: Acute Disease; Administration, Topical; Adult; Anti-Inflammatory Agents, Non-Steroidal; Area Under C

2007
Diclofenac gel for osteoarthritis.
    The Medical letter on drugs and therapeutics, 2008, Apr-21, Volume: 50, Issue:1284

    Topics: Administration, Topical; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Drug Administration Sc

2008
Bioequivalence and pharmacokinetic evaluation of two branded formulations of aceclofenac 100 mg: a single-dose, randomized, open-label, two-period crossover comparison in healthy Korean adult volunteers.
    Clinical therapeutics, 2008, Volume: 30, Issue:4

    Topics: Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Chromatography, High Pressure

2008
[Evaluation of the efficacy of a single daily administration of slow-release diclofenac in the treatment of degenerative and non-degenerative arthropathies. Multicenter study concerning 643 patients].
    La Clinica terapeutica, 1984, Apr-30, Volume: 109, Issue:2

    Topics: Adolescent; Adult; Aged; Arthritis, Rheumatoid; Clinical Trials as Topic; Diclofenac; Drug Administr

1984
A short-term, double-blind comparison between indoprofen and diclofenac in osteoarthritis.
    European journal of rheumatology and inflammation, 1983, Volume: 6, Issue:2

    Topics: Adult; Aged; Clinical Trials as Topic; Diclofenac; Double-Blind Method; Female; Humans; Indoprofen;

1983
Comparison of diclofenac and indomethacin suppositories in rheumatoid arthritis.
    Clinical rheumatology, 1984, Volume: 3, Issue:1

    Topics: Arthritis, Rheumatoid; Clinical Trials as Topic; Diclofenac; Double-Blind Method; Drug Tolerance; Hu

1984
Treatment of primary dysmenorrhea with diclofenac sodium.
    European journal of obstetrics, gynecology, and reproductive biology, 1981, Volume: 12, Issue:3

    Topics: Adult; Clinical Trials as Topic; Diclofenac; Double-Blind Method; Dysmenorrhea; Female; Humans; Mens

1981
Comparison of the onset and duration of the analgesic effect of dipyrone, 1 or 2 g, by the intramuscular or intravenous route, in acute renal colic.
    European journal of clinical pharmacology, 1995, Volume: 48, Issue:2

    Topics: Adult; Diclofenac; Dipyrone; Double-Blind Method; Female; Humans; Injections, Intramuscular; Injecti

1995
Femoral nerve block in extracapsular femoral neck fractures.
    The Journal of bone and joint surgery. British volume, 1995, Volume: 77, Issue:6

    Topics: Aged; Aged, 80 and over; Analgesics, Opioid; Bupivacaine; Diclofenac; Female; Femoral Neck Fractures

1995
Nonsteroidal antiinflammatory drugs for cancer pain: comparison between misoprostol and ranitidine in prevention of upper gastrointestinal damage.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Antineop

1995
Double-blind study evaluating by endoscopy the tolerability of nimesulide and diclofenac on the gastric mucosa in osteoarthritic patients.
    European journal of rheumatology and inflammation, 1994, Volume: 14, Issue:4

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Double-Blind Method; Endoscopy; Female; Gastric

1994
Efficacy and tolerability of diclofenac dispersible in painful osteoarthrosis.
    Clinical rheumatology, 1993, Volume: 12, Issue:1

    Topics: Diclofenac; Double-Blind Method; Female; Hip Joint; Humans; Knee Joint; Male; Middle Aged; Osteoarth

1993
Salsalate, a nonacetylated salicylate, is as efficacious as diclofenac in patients with rheumatoid arthritis. Salsalate-Diclofenac Study Group.
    The Journal of rheumatology, 1995, Volume: 22, Issue:4

    Topics: Aged; Arthritis, Rheumatoid; Diclofenac; Double-Blind Method; Female; Humans; Male; Middle Aged; Mul

1995
Comparative studies with tolfenamic acid in rheumatic disorders.
    Pharmacology & toxicology, 1994, Volume: 75 Suppl 2

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Diclofenac; Double-Blind Method; Dru

1994
A comparative study of signal versus aggregate methods of outcome measurement based on the WOMAC Osteoarthritis Index. Western Ontario and McMaster Universities Osteoarthritis Index.
    The Journal of rheumatology, 1994, Volume: 21, Issue:11

    Topics: Aged; Data Interpretation, Statistical; Diclofenac; Double-Blind Method; Health Status Indicators; H

1994
n of 1 trials comparing a non-steroidal anti-inflammatory drug with paracetamol in osteoarthritis.
    BMJ (Clinical research ed.), 1994, Oct-22, Volume: 309, Issue:6961

    Topics: Acetaminophen; Adult; Aged; Aged, 80 and over; Analgesia; Capsules; Diclofenac; Double-Blind Method;

1994
Choosing the correct pain relief for extracorporeal lithotripsy.
    British journal of urology, 1994, Volume: 74, Issue:3

    Topics: Adult; Aged; Analgesia; Diclofenac; Female; Humans; Infusions, Intravenous; Lithotripsy; Male; Meper

1994
Parenteral dipyrone versus diclofenac and placebo in patients with acute lumbago or sciatic pain: randomized observer-blind multicenter study.
    International journal of clinical pharmacology and therapeutics, 1994, Volume: 32, Issue:4

    Topics: Adult; Diclofenac; Dipyrone; Female; Hemodynamics; Humans; Injections, Intramuscular; Low Back Pain;

1994
Effect of preoperative i.m. administration of diclofenac on suxamethonium-induced myalgia.
    British journal of anaesthesia, 1993, Volume: 71, Issue:2

    Topics: Adult; Diclofenac; Double-Blind Method; Elective Surgical Procedures; Humans; Injections, Intramuscu

1993
Worldwide experience with etodolac (Lodine) 300 mg b.i.d. in the treatment of osteoarthritis.
    Rheumatology international, 1993, Volume: 13, Issue:2 Suppl

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Delayed-Action Preparations; Diclofenac; Double-Blind Me

1993
Diclofenac evaluated in a human experimental model of central pain.
    Pain, 1993, Volume: 54, Issue:2

    Topics: Adolescent; Adult; Diclofenac; Double-Blind Method; Electric Stimulation; Electrophysiology; Female;

1993
Diclofenac for pain relief after arthroscopy: a comparison of early and delayed treatment.
    Acta anaesthesiologica Scandinavica, 1993, Volume: 37, Issue:8

    Topics: Arthroscopy; Diclofenac; Double-Blind Method; Female; Humans; Knee Joint; Male; Pain; Time Factors

1993
Morphine-sparing effect of diclofenac in cancer pain.
    European journal of clinical pharmacology, 1993, Volume: 44, Issue:1

    Topics: Adult; Aged; Analgesia, Patient-Controlled; Diclofenac; Double-Blind Method; Drug Therapy, Combinati

1993
Effect of intravenous diclofenac on pain and recovery profile after day-case laparoscopy.
    European journal of anaesthesiology, 1993, Volume: 10, Issue:2

    Topics: Acetaminophen; Adult; Ambulatory Care; Diclofenac; Double-Blind Method; Female; Fentanyl; Humans; In

1993
Comparative efficacy of diclofenac dispersible 50 mg and ibuprofen 400 mg in patients with primary dysmenorrhea. A randomized, double-blind, within-patient, placebo-controlled study.
    International journal of clinical pharmacology and therapeutics, 1995, Volume: 33, Issue:9

    Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Cross-Over Studies; Diclofenac; Double-B

1995
Aceclofenac in comparison to ketoprofen in the treatment of rheumatoid arthritis.
    Rheumatology international, 1995, Volume: 15, Issue:3

    Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Diclofenac;

1995
A controlled clinical investigation of 3% diclofenac/2.5% sodium hyaluronate topical gel in the treatment of uncontrolled pain in chronic oral NSAID users with osteoarthritis.
    International journal of tissue reactions, 1995, Volume: 17, Issue:4

    Topics: Administration, Oral; Administration, Topical; Analgesics; Anti-Inflammatory Agents, Non-Steroidal;

1995
[Use of sodium diclofenac in acute renal colic].
    Orvosi hetilap, 1996, Nov-10, Volume: 137, Issue:45

    Topics: Adult; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Colic; Diclofenac; Female; Humans; Kidne

1996
Ibuprofen and diclofenac sodium in the treatment of osteoarthritis: a comparative trial of two once-daily sustained-release NSAID formulations.
    Current medical research and opinion, 1996, Volume: 13, Issue:8

    Topics: Activities of Daily Living; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal;

1996
Effects of four analgesic treatments on the behavioural and cortisol responses of 3-week-old lambs to tail docking.
    Veterinary journal (London, England : 1997), 1997, Volume: 153, Issue:1

    Topics: Administration, Topical; Aging; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavi

1997
Opioid-sparing effect of diclofenac in cancer pain.
    Journal of pain and symptom management, 1997, Volume: 14, Issue:1

    Topics: Aged; Analgesia, Patient-Controlled; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Di

1997
The effectiveness of topical diclofenac in relieving discomfort following traumatic corneal abrasions.
    Eye (London, England), 1997, Volume: 11 ( Pt 1)

    Topics: Administration, Topical; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Corneal Injuries; Dic

1997
Sustained relief of oral aphthous ulcer pain from topical diclofenac in hyaluronan: a randomized, double-blind clinical trial.
    Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 1997, Volume: 84, Issue:4

    Topics: Administration, Topical; Adolescent; Adult; Analgesics; Analysis of Variance; Anesthetics, Local; An

1997
Topical analgesics for knee arthrosis: a parallel study of ketoprofen gel and diclofenac emulgel.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 1997, Volume: 80, Issue:9

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Chi-Square Distribution; Diclofenac; Female; Gel

1997
Diclofenac dispersible provides superior analgesia with faster onset of action compared to naproxen granular in patients with acute, painful, minor sports injuries.
    The Journal of sports medicine and physical fitness, 1997, Volume: 37, Issue:3

    Topics: Acute Disease; Adolescent; Adult; Aged; Ambulatory Care; Analgesics; Anti-Inflammatory Agents, Non-S

1997
Therapeutic equivalence of diclofenac sustained-released 75 mg tablets and diclofenac enteric-coated 50 mg tablets in the treatment of painful osteoarthritis.
    International journal of clinical practice, 1997, Volume: 51, Issue:6

    Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Delayed-Action Preparations; Diclo

1997
[Diclofenac for treatment of postoperative pain after hip arthroplasty in older patients].
    Chirurgia narzadow ruchu i ortopedia polska, 1997, Volume: 62, Issue:5

    Topics: Aged; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Arthroplasty, Replacement, Hip; D

1997
Prospective randomized double-blind trial of neurolytic coeliac plexus block in patients with pancreatic cancer.
    The British journal of surgery, 1998, Volume: 85, Issue:2

    Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Autonomic Nerve Block; Celiac Plexus; Diclofen

1998
Double-blind evaluation of short-term analgesic efficacy of orally administered diclofenac, diclofenac plus codeine, and diclofenac plus imipramine in chronic cancer pain.
    Pain, 1998, Volume: 74, Issue:2-3

    Topics: Administration, Oral; Adult; Aged; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Anti

1998
The effect of diclofenac sodium on the initial comfort of RGP contact lenses: a pilot study.
    Journal of the American Optometric Association, 1999, Volume: 70, Issue:8

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Contact Lenses; Cross-Over Studies; Diclofenac; Doub

1999
Double-blind controlled clinical study of the efficacy and tolerability of diclofenac-N-(2-hydroxyethyl)-pyrrolidine lecithin gel compared with diclofenac-N-(2-hydroxyethyl)-pyrrolidine gel in patients with peri and extraarticular inflammatory diseases.
    Drugs under experimental and clinical research, 1999, Volume: 25, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Chemistry, Phar

1999
Comparison of therapeutic efficacy of nimesulide and diclofenac in patients with degenerative joint diseases.
    Journal of the Indian Medical Association, 1999, Volume: 97, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Dou

1999
Population pharmacokinetics of fast release oral diclofenac in healthy volunteers: relation to pharmacodynamics in an experimental pain model.
    Pharmaceutical research, 2000, Volume: 17, Issue:1

    Topics: Administration, Oral; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Cross-Over Studies

2000
Topical diclofenac patch relieves minor sports injury pain: results of a multicenter controlled clinical trial.
    Journal of pain and symptom management, 2000, Volume: 19, Issue:4

    Topics: Administration, Topical; Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Athletic

2000
Postoperative pain therapy after lumbar disc surgery.
    Acta neurochirurgica, 1999, Volume: 141, Issue:6

    Topics: Adult; Aged; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Diskectomy; Dr

1999
Intrathecal methylprednisolone for intractable postherpetic neuralgia.
    The New England journal of medicine, 2000, Nov-23, Volume: 343, Issue:21

    Topics: Aged; Anesthetics, Local; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Diclofe

2000
A prospective, open, single blind, randomized study comparing four analgesics in the treatment of peripheral injury in the emergency department.
    European journal of emergency medicine : official journal of the European Society for Emergency Medicine, 2000, Volume: 7, Issue:2

    Topics: Acetaminophen; Adult; Aged; Analgesics; Analysis of Variance; Arm Injuries; Diclofenac; Emergency Se

2000
Endoscopic evaluation of the gastrotolerance of short-term antalgic treatment with low dose k-diclofenac: a comparison of ibuprofen and aspirin.
    Fundamental & clinical pharmacology, 2001, Volume: 15, Issue:1

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diclofenac; Duodenum; Endoscopy, Gastrointe

2001
Comparison of the morphine-sparing effects of diclofenac sodium and ketorolac tromethamine after major orthopedic surgery.
    Journal of clinical anesthesia, 2002, Volume: 14, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Analgesia, Patient-Controlled; Analgesics, Opioid; Anti-Inflammatory

2002
[Diclofenac in the treatment of inflammatory and degenerative diseases of the locomotor system].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 1977, Jul-01, Volume: 30, Issue:13

    Topics: Adult; Aged; Clinical Trials as Topic; Diclofenac; Drug Evaluation; Humans; Indomethacin; Inflammati

1977
Four commonly prescribed non-steroidal anti-inflammatory drugs for rheumatoid arthritis.
    European journal of rheumatology and inflammation, 1991, Volume: 11, Issue:2

    Topics: Administration, Oral; Arthritis, Rheumatoid; Cross-Over Studies; Delayed-Action Preparations; Diclof

1991
Double-blind, randomized and parallel comparison between droxicam and diclofenac sodium in patients with coxarthrosis and gonarthrosis.
    European journal of rheumatology and inflammation, 1991, Volume: 11, Issue:4

    Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Double-Blind Method; Female; Human

1991
[Drug therapy in severe tumor pain. Comparative study of a new combination preparation versus diclofenac-Na].
    Fortschritte der Medizin, 1992, Aug-10, Volume: 110, Issue:22

    Topics: Adult; Aged; Aged, 80 and over; Codeine; Diclofenac; Double-Blind Method; Drug Combinations; Female;

1992
Overall safety of Arthrotec.
    Scandinavian journal of rheumatology. Supplement, 1992, Volume: 96

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Constipation; Diarrhea;

1992
Pharmacokinetics and efficacy of carbamoylphenoxyacetid acid.
    International journal of clinical pharmacology, therapy, and toxicology, 1992, Volume: 30, Issue:11

    Topics: Analgesics; Diclofenac; Humans; Pain; Salicylamides

1992
[Gonalgia: treatment with therapeutic local anesthesia. Results of a controlled comparative study versus diclofenac].
    Fortschritte der Medizin, 1991, Dec-10, Volume: 109, Issue:35

    Topics: Adult; Anesthesia, Local; Diclofenac; Female; Humans; Knee Joint; Lidocaine; Male; Middle Aged; Pain

1991
Diclofenac delays healing of gastroduodenal mucosal lesions. Double-blind, placebo-controlled endoscopic study in healthy volunteers.
    Digestive diseases and sciences, 1991, Volume: 36, Issue:5

    Topics: Adult; Candidiasis; Diclofenac; Double-Blind Method; Duodenoscopy; Duodenum; Esophageal Diseases; Es

1991
An observer-blind comparison of diclofenac potassium, piroxicam and placebo in the treatment of ankle sprains.
    Current medical research and opinion, 1990, Volume: 12, Issue:4

    Topics: Adult; Ankle Injuries; Diclofenac; Female; Humans; Male; Middle Aged; Pain; Piroxicam; Single-Blind

1990
Intramuscular diclofenac sodium versus intravenous Baralgin in the treatment of renal colic.
    DICP : the annals of pharmacotherapy, 1990, Volume: 24, Issue:4

    Topics: Adult; Aminopyrine; Benzophenones; Blood Pressure; Colic; Diclofenac; Dipyrone; Double-Blind Method;

1990
Controlled-release indomethacin and sustained-release diclofenac sodium in the treatment of osteoarthritis: a comparative controlled clinical trial in general practice.
    Current medical research and opinion, 1990, Volume: 12, Issue:3

    Topics: Adult; Aged; Delayed-Action Preparations; Diclofenac; Double-Blind Method; Female; Humans; Indometha

1990
Controlled-release indomethacin and sustained-release diclofenac sodium in the treatment of rheumatoid arthritis: a comparative controlled clinical trial.
    Current medical research and opinion, 1990, Volume: 12, Issue:3

    Topics: Adult; Aged; Arthritis, Rheumatoid; Delayed-Action Preparations; Diclofenac; Double-Blind Method; Fe

1990
Double-blind evaluation of analgesic efficacy of orally administered diclofenac, nefopam, and acetylsalicylic acid (ASA) plus codeine in chronic cancer pain.
    Pain, 1989, Volume: 36, Issue:2

    Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Analgesics; Aspirin; Chronic Disea

1989
Joint pain and quality of life; results of a randomised trial.
    British journal of clinical pharmacology, 1989, Volume: 27, Issue:2

    Topics: Acetaminophen; Adult; Aged; Clinical Trials as Topic; Delayed-Action Preparations; Dextropropoxyphen

1989
[Acute pain due to kidney/ureter stones treated with intramuscular Voltaren or Ketogan].
    Ugeskrift for laeger, 1987, Nov-30, Volume: 149, Issue:49

    Topics: Adult; Aged; Allylamine; Amines; Analgesics, Opioid; Diclofenac; Drug Combinations; Female; Humans;

1987
Use of diclofenac in analgesia.
    The American journal of medicine, 1986, Apr-28, Volume: 80, Issue:4B

    Topics: Analgesia; Back Pain; Biliary Tract Diseases; Clinical Trials as Topic; Colic; Diclofenac; Double-Bl

1986
[Sodium diclofenac in the treatment of biliary pain: a controlled study using hyoscine N-butylbromide].
    La Clinica terapeutica, 1988, Sep-30, Volume: 126, Issue:6

    Topics: Adult; Aged; Butylscopolammonium Bromide; Cholecystitis; Cholelithiasis; Clinical Trials as Topic; C

1988
Treatment of pain owing to acute ureteral obstruction with prostaglandin-synthetase inhibitor: a prospective randomized study.
    The Journal of urology, 1986, Volume: 136, Issue:2

    Topics: Adolescent; Adult; Butylscopolammonium Bromide; Clinical Trials as Topic; Cyclooxygenase Inhibitors;

1986
Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
    Drugs, 1988, Volume: 35, Issue:3

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Clinical Trials as Topic; Diclofenac; D

1988
Effects of a non-steroidal anti-inflammatory drug on delayed onset muscle soreness and indices of damage.
    British journal of sports medicine, 1988, Volume: 22, Issue:1

    Topics: Adolescent; Adult; Aspartate Aminotransferases; Creatine Kinase; Creatinine; Diclofenac; Double-Blin

1988
Efficacy of diclofenac in ankylosing spondylitis.
    The American journal of medicine, 1986, Apr-28, Volume: 80, Issue:4B

    Topics: Adult; Aged; Clinical Trials as Topic; Diclofenac; Double-Blind Method; Female; Gastrointestinal Dis

1986
[New etiopathologic and therapeutic perspectives in ureteral colic. Evaluation of clinical experience with diclofenac sodium and indomethacin].
    Recenti progressi in medicina, 1986, Volume: 77, Issue:9

    Topics: Clinical Trials as Topic; Diclofenac; Double-Blind Method; Humans; Indomethacin; Narcotics; Pain; Pa

1986
Diclofenac versus lidocaine as injection therapy in myofascial pain.
    Scandinavian journal of rheumatology, 1986, Volume: 15, Issue:2

    Topics: Diclofenac; Female; Humans; Injections, Intramuscular; Lidocaine; Male; Middle Aged; Myofascial Pain

1986
Double-blind preference and compliance multicentre study in osteoarthritis: once-a-day treatment.
    Clinical rheumatology, 1985, Volume: 4, Issue:3

    Topics: Adult; Aged; Aspirin; Clinical Trials as Topic; Diclofenac; Double-Blind Method; Drug Administration

1985
Experimental pain induced by electrical and thermal stimulation of the skin in healthy man: sensitivity to 75 and 150 mg diclofenac sodium in comparison with 60 mg codeine and placebo.
    British journal of clinical pharmacology, 1986, Volume: 21, Issue:1

    Topics: Acoustic Stimulation; Adult; Codeine; Diclofenac; Electric Stimulation; Female; Hot Temperature; Hum

1986
Diclofenac in the treatment of ankylosing spondylitis: review of worldwide clinical experience and report of a double-blind comparison with indomethacin.
    Seminars in arthritis and rheumatism, 1985, Volume: 15, Issue:2 Suppl 1

    Topics: Adolescent; Adult; Aged; Diclofenac; Double-Blind Method; Female; Humans; Indomethacin; Male; Middle

1985

Other Studies

206 other studies available for diclofenac and Ache

ArticleYear
Synthesis and pharmacological evaluation of some 3-phenyl-2-substituted-3H-quinazolin-4-one as analgesic, anti-inflammatory agents.
    Bioorganic & medicinal chemistry, 2007, Jan-01, Volume: 15, Issue:1

    Topics: Administration, Oral; Analgesics; Animals; Anti-Inflammatory Agents; Carrageenan; Dose-Response Rela

2007
Rotationally constrained 2,4-diamino-5,6-disubstituted pyrimidines: a new class of histamine H4 receptor antagonists with improved druglikeness and in vivo efficacy in pain and inflammation models.
    Journal of medicinal chemistry, 2008, Oct-23, Volume: 51, Issue:20

    Topics: Amines; Animals; Anti-Inflammatory Agents; Disease Models, Animal; Histamine Antagonists; Ligands; M

2008
Regioselective reaction: synthesis and pharmacological study of Mannich bases containing ibuprofen moiety.
    European journal of medicinal chemistry, 2009, Volume: 44, Issue:9

    Topics: Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspergillus; Edema; Esch

2009
Discovery and optimization of novel purines as potent and selective CB2 agonists.
    Bioorganic & medicinal chemistry letters, 2012, Aug-01, Volume: 22, Issue:15

    Topics: Animals; Drug Evaluation, Preclinical; Furans; Half-Life; Humans; Pain; Purines; Rats; Receptor, Can

2012
Rational design, synthesis and evaluation of chromone-indole and chromone-pyrazole based conjugates: identification of a lead for anti-inflammatory drug.
    European journal of medicinal chemistry, 2014, Apr-22, Volume: 77

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Capsaicin; Chromones; Cyclooxygenase 1; Cyclooxyge

2014
Discovery of potent aryl-substituted 3-[(3-methylpyridine-2-carbonyl) amino]-2,4-dimethyl-benzoic acid EP4 antagonists with improved pharmacokinetic profile.
    Bioorganic & medicinal chemistry letters, 2016, Feb-01, Volume: 26, Issue:3

    Topics: Animals; Benzoic Acid; Disease Models, Animal; Dogs; Drug Evaluation, Preclinical; Half-Life; Humans

2016
Substituted Indazoles as Nav1.7 Blockers for the Treatment of Pain.
    Journal of medicinal chemistry, 2016, Apr-14, Volume: 59, Issue:7

    Topics: Analgesics; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Electrophysiology; Ev

2016
Bioisosteric Development of Multitarget Nonsteroidal Anti-Inflammatory Drug-Carbonic Anhydrases Inhibitor Hybrids for the Management of Rheumatoid Arthritis.
    Journal of medicinal chemistry, 2020, 03-12, Volume: 63, Issue:5

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Carbonic Anhydrase Inhibito

2020
One-Step Fabrication of Hollow Spherical Cellulose Beads: Application in pH-Responsive Therapeutic Delivery.
    ACS applied materials & interfaces, 2022, Jan-26, Volume: 14, Issue:3

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Biocompatible Materials; Cellulose; Diclofenac; Drug Carrie

2022
Complete Plaque Regression in Patients with Peyronie's Disease After Multimodal Treatment with Antioxidants: A Report of 2 Cases.
    The American journal of case reports, 2022, Apr-17, Volume: 23

    Topics: Antioxidants; Combined Modality Therapy; Diclofenac; Humans; Male; Middle Aged; Pain; Penile Indurat

2022
Venlafaxine HCl Encapsulated in Niosome: Green and Eco-friendly Formulation for the Management of Pain.
    AAPS PharmSciTech, 2022, May-20, Volume: 23, Issue:5

    Topics: Analgesics; Animals; Anti-Inflammatory Agents; Cholesterol; Diclofenac; Liposomes; Pain; Rats; Surfa

2022
Reduced risk of NSAID-Induced adverse events with concomitant use of misoprostol (MICRO study).
    Pharmacotherapy, 2022, Volume: 42, Issue:7

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Humans; Misoprostol; Pain; Proportional Hazards

2022
Comparison of Therapeutic Effects of Topical Application of Diclofenac Sodium Nanoparticles and Conventional Placebo on Knee Osteoarthritis.
    Cellular and molecular biology (Noisy-le-Grand, France), 2022, Mar-31, Volume: 68, Issue:3

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Humans; Liposomes; Nanoparticles; Osteoarthriti

2022
Patients with Peyronie's disease achieve complete plaque regression after multimodal treatment with antioxidants: a case series.
    Journal of medical case reports, 2022, Oct-08, Volume: 16, Issue:1

    Topics: Adult; Antioxidants; Combined Modality Therapy; Diclofenac; Humans; Male; Middle Aged; Pain; Penile

2022
Preclinical comparison of antinociceptive effects between ibuprofen, diclofenac, naproxen, and acetaminophen on acid-stimulated body stretching and acid-depressed feeding behaviors in rats.
    Behavioural pharmacology, 2022, 12-01, Volume: 33, Issue:8

    Topics: Acetaminophen; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Feeding Beh

2022
Development of zinc ferrite nanoparticles with enhanced photocatalytic performance for remediation of environmentally toxic pharmaceutical waste diclofenac sodium from wastewater.
    Environmental research, 2023, 01-01, Volume: 216, Issue:Pt 2

    Topics: Diclofenac; Ferric Compounds; Humans; Nanoparticles; Pain; Wastewater; Zinc Oxide

2023
[Evaluation of topical therapy of patients with osteoarthritis of small joints of the hands with Voltaren® Emulgel® 2% (diclofenac diethylamine 2%)].
    Terapevticheskii arkhiv, 2021, May-15, Volume: 93, Issue:5

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthralgia; Diclofenac; Female; Humans; Male; Osteoarthriti

2021
Analgesic effects and arthritic changes following intra-articular injection of diclofenac etalhyaluronate in a rat knee osteoarthritis model.
    BMC musculoskeletal disorders, 2022, Nov-07, Volume: 23, Issue:1

    Topics: Analgesics; Animals; Calcitonin Gene-Related Peptide; Diclofenac; Disease Models, Animal; Hyaluronic

2022
Influence of Poloxamer 188 on Anti-Inflammatory and Analgesic Effects of Diclofenac-Loaded Nanoemulsion: Formulation, Optimization and in Vitro/in Vivo Evaluation.
    Journal of pharmaceutical sciences, 2023, Volume: 112, Issue:12

    Topics: Analgesics; Anti-Inflammatory Agents; Diclofenac; Edema; Emulsions; Humans; Pain; Poloxamer; Seizure

2023
Diclofenac sodium and dexamethasone co-therapy restores brain neuron-specific enolase (NSE), S-100 Beta and glial fibrillary acid protein (GFAP) proteins in experimental rat's model: A possible inhibition of P-glycoprotein.
    Cellular and molecular biology (Noisy-le-Grand, France), 2023, Sep-30, Volume: 69, Issue:9

    Topics: Animals; Anti-Inflammatory Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Brain; D

2023
Diclofenac Mouthwash as a potential therapy for reducing pain and discomfort in chemo-radiotherapy-induced oral mucositis.
    Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 2020, Volume: 49, Issue:9

    Topics: Chemoradiotherapy; Diclofenac; Head and Neck Neoplasms; Humans; Mouthwashes; Pain; Prospective Studi

2020
[The chemoreactomic analysis of the central mechanisms of action of non-steroidal anti-inflammatory drugs].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2020, Volume: 120, Issue:1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Humans; Ketoprofen; Opiate Alkaloids; Pain; Pir

2020
The authors reply: ISWI vs diclofenac for renal colic.
    The American journal of emergency medicine, 2020, Volume: 38, Issue:9

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Humans; Pain; Renal Colic

2020
Intradermal sterile water injection in acute renal colic.
    The American journal of emergency medicine, 2021, Volume: 40

    Topics: Diclofenac; Humans; Injections, Intradermal; Pain; Renal Colic; Water

2021
Citryl-imine-PEG-ylated chitosan hydrogels - Promising materials for drug delivery applications.
    International journal of biological macromolecules, 2020, Nov-01, Volume: 162

    Topics: Animals; Chitosan; Diclofenac; Disease Models, Animal; Drug Delivery Systems; Hydrogels; Pain; Polye

2020
Intradermal sterile water injection for acute renal colic pain.
    The American journal of emergency medicine, 2020, Volume: 38, Issue:9

    Topics: Diclofenac; Humans; Pain; Pain Management; Renal Colic; Water

2020
Reply to correspondence: Intradermal sterile water injection for acute renal colic pain. MS 23569R1.
    The American journal of emergency medicine, 2021, Volume: 43

    Topics: Diclofenac; Humans; Injections, Intradermal; Pain; Renal Colic; Water

2021
Myositis Ossificans of the Adductor Longus in a Soccer Player.
    The Journal of orthopaedic and sports physical therapy, 2020, Volume: 50, Issue:10

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Groin; Hematoma; Humans; Magnetic Resonance Ima

2020
Re: Gul A, Gul M. Intracutaneous sterile water injection for pain relief during extracorporeal shock wave lithotripsy: comparison with diclofenac sodium. Urolithiasis. 2020 Apr;48(2):103-108. doi:10.1007/s00240-019-01147-9. Epub 2019 Jul 5.
    Urolithiasis, 2021, Volume: 49, Issue:4

    Topics: Diclofenac; Humans; Lithotripsy; Pain; Urolithiasis; Water

2021
Transdermal Permeation and Skin Retention of Diclofenac and Etofenamate/Flufenamic Acid From Over-the-Counter Pain Relief Products.
    Journal of pharmaceutical sciences, 2021, Volume: 110, Issue:6

    Topics: Administration, Cutaneous; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Flufenamic Acid; Gel

2021
Effects of Spirulina platensis on pain and inflammation in long Evans rats.
    Pakistan journal of pharmaceutical sciences, 2020, Volume: 33, Issue:5

    Topics: Analgesics; Animals; Anti-Inflammatory Agents; Diclofenac; Disease Models, Animal; Female; Formaldeh

2020
The effective interplay of (non-) selective NSAIDs with neostigmine in animal models of analgesia and inflammation.
    BMC pharmacology & toxicology, 2021, 05-01, Volume: 22, Issue:1

    Topics: Acetic Acid; Analgesia; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Dic

2021
Intravenous Acetaminophen vs Intravenous Diclofenac in the Management of Painful Crisis in Sickle Cell Disease: Authors' Reply.
    Indian pediatrics, 2021, 05-15, Volume: 58, Issue:5

    Topics: Acetaminophen; Administration, Intravenous; Anemia, Sickle Cell; Diclofenac; Humans; Pain

2021
Intravenous Acetaminophen vs Intravenous Diclofenac in the Management of Painful Crisis in Sickle Cell Disease.
    Indian pediatrics, 2021, 05-15, Volume: 58, Issue:5

    Topics: Acetaminophen; Administration, Intravenous; Anemia, Sickle Cell; Diclofenac; Humans; Pain

2021
Population scale data reveals the antidepressant effects of ketamine and other therapeutics approved for non-psychiatric indications.
    Scientific reports, 2017, 05-03, Volume: 7, Issue:1

    Topics: Adverse Drug Reaction Reporting Systems; Analgesics; Anti-Bacterial Agents; Anti-Inflammatory Agents

2017
Surgical suture braided with a diclofenac-loaded strand of poly(lactic-co-glycolic acid) for local, sustained pain mitigation.
    Materials science & engineering. C, Materials for biological applications, 2017, Oct-01, Volume: 79

    Topics: Animals; Diclofenac; Lactic Acid; Pain; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolym

2017
Layering of different materials to achieve optimal conditions for treatment of painful wounds.
    International journal of pharmaceutics, 2017, Aug-30, Volume: 529, Issue:1-2

    Topics: Bandages; Biocompatible Materials; Cells, Cultured; Diclofenac; Fibroblasts; Humans; Lidocaine; Pain

2017
NSAIDs relieve osteoarthritis (OA) pain, but cardiovascular safety in question even for diclofenac, ibuprofen, naproxen, and celecoxib: what are the alternatives?
    Scandinavian journal of pain, 2017, Volume: 16

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Diclofenac; Humans; Ibuprofen; Naproxen; Network

2017
A case-history illustrates importance of knowledge of drug-interactions when pain-patients are prescribed non-pain drugs for co-morbidities.
    Scandinavian journal of pain, 2017, Volume: 17

    Topics: Aged; Comorbidity; Diclofenac; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; F

2017
Antinociceptive tolerance to NSAIDs in the anterior cingulate cortex is mediated via endogenous opioid mechanism.
    BMC pharmacology & toxicology, 2018, 01-06, Volume: 19, Issue:1

    Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Drug Tolerance; Gyrus Cing

2018
Population scale retrospective analysis reveals distinctive antidepressant and anxiolytic effects of diclofenac, ketoprofen and naproxen in patients with pain.
    PloS one, 2018, Volume: 13, Issue:4

    Topics: Anti-Anxiety Agents; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Anxiety; Cohort

2018
[In process].
    Medizinische Monatsschrift fur Pharmazeuten, 2017, Volume: 40, Issue:4

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Diclofenac; Hip; Humans; Knee; Pain; Treatment O

2017
[Pharmacological profile of a novel nonhuman primate model of knee osteoarthritis].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2018, Volume: 152, Issue:3

    Topics: Analgesics, Opioid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aprepitant; Diclofenac; Duloxe

2018
Defective bone repair in diclofenac treated C57Bl6 mice with and without lipopolysaccharide induced systemic inflammation.
    Journal of cellular physiology, 2019, Volume: 234, Issue:3

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Endothelial Cells; Humans; Inflammatio

2019
Analgesic Activity of Acid-Sensing Ion Channel 3 (ASIС3) Inhibitors: Sea Anemones Peptides Ugr9-1 and APETx2 versus Low Molecular Weight Compounds.
    Marine drugs, 2018, Dec-12, Volume: 16, Issue:12

    Topics: Acetic Acid; Acid Sensing Ion Channel Blockers; Acid Sensing Ion Channels; Analgesics; Animals; Biol

2018
Factors affecting the results of analgesic therapy. Results of the Russian multicentre study of NOTE (NSAID: Open-label Trial of Efficacy).
    Terapevticheskii arkhiv, 2018, Jun-20, Volume: 90, Issue:6

    Topics: Adult; Aged; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Diclofenac; Female; Hum

2018
Does format matter for comprehension of a facial affective scale and a numeric scale for pain by adults with Down syndrome?
    Research in developmental disabilities, 2013, Volume: 34, Issue:10

    Topics: Acetaminophen; Adult; Affect; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Cog

2013
Drug analogs of COX-2 selective inhibitors lumiracoxib and valdecoxib derived from in silico search and optimization.
    Anti-inflammatory & anti-allergy agents in medicinal chemistry, 2014, Volume: 13, Issue:1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Computer Simulation; Cyclooxygenase

2014
More pain for painkillers.
    Time, 2013, Jun-24, Volume: 181, Issue:24

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiovascular Diseases; Celecoxib; Cyclooxygenase

2013
Comparison of the effects of dexketoprofen trometamol, meloxicam and diclofenac sodium on fibular fracture healing, kidney and liver: an experimental rat model.
    Injury, 2014, Volume: 45, Issue:3

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biomechanical Phenomena; Diclofenac; Fibula; Fract

2014
Comparison of the effects of crocin, safranal and diclofenac on local inflammation and inflammatory pain responses induced by carrageenan in rats.
    Pharmacological reports : PR, 2013, Volume: 65, Issue:5

    Topics: Analgesics; Animals; Anti-Inflammatory Agents; Carotenoids; Carrageenan; Cyclohexenes; Diclofenac; D

2013
The effects of Phα1β, a spider toxin, calcium channel blocker, in a mouse fibromyalgia model.
    Toxicon : official journal of the International Society on Toxinology, 2014, Volume: 81

    Topics: Animals; Brain; Calcium Channel Blockers; Diclofenac; Disease Models, Animal; Dopamine; Fibromyalgia

2014
P-glycoprotein modulates morphine uptake into the CNS: a role for the non-steroidal anti-inflammatory drug diclofenac.
    PloS one, 2014, Volume: 9, Issue:2

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; ATP Binding Cassette Transporter, Subfamily B, Mem

2014
Antinociceptive tolerance to NSAIDs microinjected into dorsal hippocampus.
    BMC pharmacology & toxicology, 2014, Feb-28, Volume: 15

    Topics: Analgesics, Opioid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Diclofenac;

2014
Optimization of aceclofenac solid dispersion using Box-Behnken design: in-vitro and in-vivo evaluation.
    Current drug delivery, 2014, Volume: 11, Issue:3

    Topics: Acetic Acid; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Cellulose; C

2014
Synthesis, hydrolysis kinetics and pharmacological evaluation of aceclofenac prodrugs.
    Anti-inflammatory & anti-allergy agents in medicinal chemistry, 2015, Volume: 13, Issue:3

    Topics: Acetic Acid; Analgesics; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal;

2015
Synergistic effect of the interaction between curcumin and diclofenac on the formalin test in rats.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2014, Oct-15, Volume: 21, Issue:12

    Topics: Analgesics; Animals; Curcumin; Diclofenac; Drug Synergism; Female; Formaldehyde; Pain; Pain Measurem

2014
Clinical inquiry: does topical diclofenac relieve osteoarthritis pain?
    The Journal of family practice, 2015, Volume: 64, Issue:2

    Topics: Administration, Cutaneous; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Humans; Osteoarthrit

2015
Evaluation of antinociceptive activity of nanoliposome-encapsulated and free-form diclofenac in rats and mice.
    International journal of nanomedicine, 2015, Volume: 10

    Topics: Acetic Acid; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Diclofenac;

2015
Complete Freund's adjuvant-induced reduction of exploratory activity in a novel environment as an objective nociceptive endpoint for sub-acute inflammatory pain model in rats.
    European journal of pain (London, England), 2015, Volume: 19, Issue:10

    Topics: Adjuvants, Immunologic; Amines; Analgesics; Animals; Behavior, Animal; Celecoxib; Cyclohexanecarboxy

2015
Design and Synthesis of Mannich bases as Benzimidazole Derivatives as Analgesic Agents.
    Anti-inflammatory & anti-allergy agents in medicinal chemistry, 2015, Volume: 14, Issue:1

    Topics: Acetic Acid; Analgesics; Animals; Benzimidazoles; Diclofenac; Disease Models, Animal; Drug Evaluatio

2015
Toona sinensis leaf extract has antinociceptive effect comparable with non-steroidal anti-inflammatory agents in mouse writhing test.
    BMC complementary and alternative medicine, 2015, Mar-19, Volume: 15

    Topics: Acetic Acid; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Cycloox

2015
Acute kidney failure associated with anaphylactic shock caused by diclofenac sodium.
    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2015, Volume: 25, Issue:4

    Topics: Acute Kidney Injury; Anaphylaxis; Cyclooxygenase Inhibitors; Diclofenac; Humans; Injections, Intramu

2015
Behavioral and neurochemical analysis of ongoing bone cancer pain in rats.
    Pain, 2015, Volume: 156, Issue:10

    Topics: Adenocarcinoma; Analgesics, Opioid; Anesthetics, Local; Animals; Anti-Inflammatory Agents, Non-Stero

2015
Design, synthesis and QSAR studies on a series of 2, 5-disubstituted- 1,3,4-oxadiazole derivatives of diclofenac and naproxen for analgesic and anti-inflammatory activity.
    Medicinal chemistry (Shariqah (United Arab Emirates)), 2015, Volume: 11, Issue:8

    Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Drug Design; Female; Infla

2015
Prevalence, trends, patterns and associations of analgesic use in Germany.
    BMC pharmacology & toxicology, 2015, Oct-01, Volume: 16

    Topics: Acetaminophen; Adolescent; Adult; Age Factors; Aged; Analgesics; Aspirin; Diclofenac; Drug Therapy;

2015
Antiinflammatory and analgesic effects of Eurycoma longifolia extracts.
    Archives of pharmacal research, 2016, Volume: 39, Issue:3

    Topics: Analgesics; Animals; Anti-Inflammatory Agents; Aspirin; Cells, Cultured; Cyclooxygenase 2; Diclofena

2016
Novel elastic membrane vesicles (EMVs) and ethosomes-mediated effective topical delivery of aceclofenac: a new therapeutic approach for pain and inflammation.
    Drug delivery, 2016, Volume: 23, Issue:8

    Topics: Administration, Cutaneous; Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal

2016
Common pain relievers may increase heart problems. High-dosage ibuprofen and diclofenac linked to elevated risk of death; naproxen, acetaminophen offer alternatives.
    DukeMedicine healthnews, 2010, Volume: 16, Issue:9

    Topics: Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Humans; Ibuprofen; Naproxen; Pai

2010
Association of terpinolene and diclofenac presents antinociceptive and anti-inflammatory synergistic effects in a model of chronic inflammation.
    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2016, Jun-20, Volume: 49, Issue:7

    Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Cyclohexane Monoterpe

2016
Review: Some NSAIDs, notably diclofenac, improved knee or hip pain and function in osteoarthritis vs other NSAIDs.
    Annals of internal medicine, 2016, 07-19, Volume: 165, Issue:2

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Hip; Humans; Osteoarthritis, Knee; Pain

2016
Diclofenac rectal suppository: an effective modality for perineal pain.
    JPMA. The Journal of the Pakistan Medical Association, 2016, Volume: 66, Issue:8

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Cesarean Section; Cohort Studies; Cross-Sectional St

2016
Cost-effectiveness of Low-dose Submicron Diclofenac Compared With Generic Diclofenac.
    Clinical therapeutics, 2016, Volume: 38, Issue:11

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Cost-Benefit Analysis; Diclofenac; Drugs, Generic; Humans;

2016
The application of ATR-FTIR spectroscopy and multivariate data analysis to study drug crystallisation in the stratum corneum.
    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2017, Volume: 111

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Chromatography, High Pressure Liquid; Cluster Anal

2017
Corticosteroid transdermal delivery significantly improves arthritis pain and functional disability.
    Drug delivery and translational research, 2017, Volume: 7, Issue:1

    Topics: Administration, Cutaneous; Anti-Inflammatory Agents; Arthritis; Betamethasone Valerate; C-Reactive P

2017
Primidone inhibits TRPM3 and attenuates thermal nociception in vivo.
    Pain, 2017, Volume: 158, Issue:5

    Topics: Adrenergic Uptake Inhibitors; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Calcium;

2017
Anti-inflammatory and analgesic activities of some newly synthesized pyridinedicarbonitrile and benzopyranopyridine derivatives.
    Acta pharmaceutica (Zagreb, Croatia), 2008, Volume: 58, Issue:2

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzopyrans; Carrageenan; Diclofenac; Disease Mode

2008
New topical anti-inflammatory drugs may curb arthritis pain.
    Mayo Clinic health letter (English ed.), 2008, Volume: 26, Issue:4

    Topics: Administration, Topical; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Diclofenac; Humans; Pai

2008
Pharmacokinetics and pharmacodynamics of diclofenac in the presence and absence of glibenclamide in the rat.
    Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, 2008, Volume: 11, Issue:3

    Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biological Availability; Dic

2008
Recurrent severe angioedema associated with imidapril and diclofenac.
    Allergology international : official journal of the Japanese Society of Allergology, 2008, Volume: 57, Issue:4

    Topics: Airway Obstruction; Angioedema; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents,

2008
[Summary of the practice guideline 'Urolithiasis' (first revision) from the Dutch College of General Practitioners].
    Nederlands tijdschrift voor geneeskunde, 2008, Nov-08, Volume: 152, Issue:45

    Topics: Analgesics, Opioid; Diclofenac; Family Practice; Humans; Morphine; Netherlands; Pain; Practice Patte

2008
Antinociceptive activity of methanolic extract of Epilobium hirsutum.
    Pakistan journal of biological sciences : PJBS, 2007, Aug-15, Volume: 10, Issue:16

    Topics: Acetic Acid; Analgesics; Analysis of Variance; Animals; Diclofenac; Epilobium; Male; Medicine, Tradi

2007
Synergy between enzyme inhibitors of fatty acid amide hydrolase and cyclooxygenase in visceral nociception.
    The Journal of pharmacology and experimental therapeutics, 2009, Volume: 329, Issue:1

    Topics: Acetic Acid; Amidohydrolases; Animals; Benzamides; Carbamates; Cyclooxygenase Inhibitors; Diclofenac

2009
Effects of analgesics on the plantar incision-induced drop of the noxious heat threshold measured with an increasing-temperature water bath in the rat.
    European journal of pharmacology, 2009, Mar-01, Volume: 605, Issue:1-3

    Topics: Acetaminophen; Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Diclofenac; Disease Models, An

2009
Treating osteoarthritis topically: Voltaren Gel for pain relief.
    Nursing for women's health, 2009, Volume: 13, Issue:1

    Topics: Administration, Topical; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Female; Humans; Osteoa

2009
Delirium due to a drug-drug interaction of lithium and an NSAID.
    The journal of nutrition, health & aging, 2009, Volume: 13, Issue:3

    Topics: Accidental Falls; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Antidepressi

2009
Anti-inflammatories and heart failure-identifying patients at risk.
    Journal of pain and symptom management, 2009, Volume: 37, Issue:3

    Topics: Analgesics, Opioid; Anti-Inflammatory Agents; Chondrosarcoma; Diclofenac; Heart Failure; Humans; Mal

2009
Anti-inflammatory, analgesic and antipyretic activity of aqueous extract of fresh leaves of Coccinia indica.
    Inflammopharmacology, 2009, Volume: 17, Issue:4

    Topics: Acetaminophen; Analgesics; Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents; Cucurbitacea

2009
The selective metabotropic glutamate receptor 7 allosteric agonist AMN082 inhibits inflammatory pain-induced and incision-induced hypersensitivity in rat.
    Behavioural pharmacology, 2009, Volume: 20, Issue:7

    Topics: Allosteric Regulation; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzhydryl Compounds; Carra

2009
Prospective observational study of adverse drug reactions to diclofenac in children.
    British journal of clinical pharmacology, 2009, Volume: 68, Issue:2

    Topics: Adverse Drug Reaction Reporting Systems; Child; Child, Preschool; Confidence Intervals; Diclofenac;

2009
Comparison of mechanical allodynia and the affective component of inflammatory pain in rats.
    Neuropharmacology, 2010, Volume: 58, Issue:2

    Topics: Analgesics, Non-Narcotic; Animals; Behavior, Animal; Celecoxib; Central Nervous System Agents; Diclo

2010
Grading of monosodium iodoacetate-induced osteoarthritis reveals a concentration-dependent sensitization of nociceptors in the knee joint of the rat.
    Neuroscience letters, 2009, Nov-13, Volume: 465, Issue:2

    Topics: Action Potentials; Alkylating Agents; Animals; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac;

2009
Antioxidant, anti-inflammatory and analgesic potential of the Citrus decumana L. peel extract.
    Inflammopharmacology, 2009, Volume: 17, Issue:5

    Topics: Analgesics; Animals; Anti-Inflammatory Agents; Antioxidants; Ascorbic Acid; Citrus; Diclofenac; Dise

2009
Topical diclofenac solution.
    Drugs, 2009, Volume: 69, Issue:18

    Topics: Activities of Daily Living; Administration, Cutaneous; Administration, Oral; Anti-Inflammatory Agent

2009
Pharmacokinetic of diclofenac in the presence and absence of glibenclamide in the rat.
    Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, 2009, Volume: 12, Issue:3

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Chromatography, High Pressure Liquid; Diclofenac;

2009
Preliminary studies on the antinociceptive activity of Vaccinium ashei berry in experimental animal models.
    Journal of medicinal food, 2010, Volume: 13, Issue:2

    Topics: Acetic Acid; Analgesics; Animals; Anthocyanins; Blueberry Plants; Diclofenac; Disease Models, Animal

2010
Analgesic and anti-inflammatory effects of Pistacia integerrima extracts in mice.
    Journal of ethnopharmacology, 2010, May-27, Volume: 129, Issue:2

    Topics: Abdominal Pain; Acetic Acid; Analgesics; Animals; Anti-Inflammatory Agents; Diclofenac; Dose-Respons

2010
Synthesis, analgesic and anti-inflammatory activities of some novel pyrazolines derivatives.
    Bioorganic & medicinal chemistry letters, 2010, Jun-15, Volume: 20, Issue:12

    Topics: Analgesics; Animals; Anti-Inflammatory Agents; Diclofenac; Drug Design; Edema; Hydrazines; Mice; Pai

2010
Diclofenac patch: clinical applications beyond pain control.
    Journal of pain and symptom management, 2010, Volume: 39, Issue:6

    Topics: Administration, Cutaneous; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Humans; Myofascial P

2010
Time to significant pain reduction following DETP application vs placebo for acute soft tissue injuries.
    Current medical research and opinion, 2010, Volume: 26, Issue:8

    Topics: Acute Disease; Administration, Topical; Adolescent; Adult; Aged; Ankle Joint; Anti-Inflammatory Agen

2010
Is the sulphonamide radical in the celecoxib molecule essential for its analgesic activity?
    Pharmacological research, 2010, Volume: 62, Issue:5

    Topics: Acetazolamide; Animals; Celecoxib; Cyclooxygenase 2 Inhibitors; Diclofenac; Dose-Response Relationsh

2010
Effectiveness of doxazosin in the management of lower ureteral stones in male and female patients.
    International urology and nephrology, 2011, Volume: 43, Issue:3

    Topics: Adolescent; Adrenergic alpha-1 Receptor Antagonists; Adult; Anti-Inflammatory Agents, Non-Steroidal;

2011
[Unilateral odynophagia in rheumatoid arthritis].
    Laryngo- rhino- otologie, 2011, Volume: 90, Issue:8

    Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cooperative Behavior; Deglutition Disorders; Diagnosis,

2011
Toxicities of raw Alocasia odora.
    Human & experimental toxicology, 2011, Volume: 30, Issue:10

    Topics: Adult; Airway Obstruction; Alocasia; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Di

2011
Pain management of children and adolescents with sickle cell disease presenting to the emergency department.
    Saudi medical journal, 2011, Volume: 32, Issue:2

    Topics: Acetaminophen; Adolescent; Analgesics, Non-Narcotic; Analgesics, Opioid; Anemia, Sickle Cell; Anti-I

2011
Preemptive analgesic effects of midazolam and diclofenac in rat model.
    Bosnian journal of basic medical sciences, 2011, Volume: 11, Issue:2

    Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Disease Models, Animal; Fo

2011
Gastrointestinal tolerability of diclofenac epolamine topical patch 1.3%: a pooled analysis of 14 clinical studies.
    Postgraduate medicine, 2011, Volume: 123, Issue:4

    Topics: Adult; Age Factors; Aged; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Female; Gastrointesti

2011
Anti-inflammatory and analgesic activity of protocatechuic acid in rats and mice.
    Inflammopharmacology, 2011, Volume: 19, Issue:5

    Topics: Acetic Acid; Analgesics; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal;

2011
Targeting A-type K(+) channels in primary sensory neurons for bone cancer pain in a rat model.
    Pain, 2012, Volume: 153, Issue:3

    Topics: 4-Aminopyridine; Activating Transcription Factor 3; Animals; Anti-Inflammatory Agents, Non-Steroidal

2012
Evaluation of analgesic and anti-inflammatory activity of diospyros cordifolia extract.
    African journal of traditional, complementary, and alternative medicines : AJTCAM, 2011, Volume: 8, Issue:1

    Topics: Analgesics; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac;

2011
Design, synthesis, computational and biological evaluation of some new hydrazino derivatives of DHA and pyranopyrazoles.
    European journal of medicinal chemistry, 2012, Volume: 50

    Topics: Acetic Acid; Analgesics; Animals; Anti-Inflammatory Agents; Carrageenan; Computational Biology; Cycl

2012
Anti-inflammatory and analgesic potential of a novel steroidal derivative from Bryophyllum pinnatum.
    Fitoterapia, 2012, Volume: 83, Issue:5

    Topics: Acetic Acid; Analgesics; Animals; Anti-Inflammatory Agents; Behavior, Animal; Carrageenan; Diclofena

2012
Evaluation of antinociceptive and anti-inflammatory activity of hydromethanol extract of Cocos nucifera L.
    Inflammopharmacology, 2013, Volume: 21, Issue:1

    Topics: Analgesics; Animals; Anti-Inflammatory Agents; Antioxidants; Cocos; Diclofenac; Disease Models, Anim

2013
The monoacylglycerol lipase inhibitor JZL184 suppresses inflammatory pain in the mouse carrageenan model.
    Life sciences, 2013, Mar-19, Volume: 92, Issue:8-9

    Topics: Amidohydrolases; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzodioxoles; Carrageenan; Diclo

2013
Semi-mechanistic modeling of the interaction between the central and peripheral effects in the antinociceptive response to lumiracoxib in rats.
    The AAPS journal, 2012, Volume: 14, Issue:4

    Topics: Animals; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Diclofenac; Disease Models, Animal; Female;

2012
Anti-inflammatory and antinociceptive properties of dantrolene sodium in rats and mice.
    Pharmacological research, 2002, Volume: 45, Issue:6

    Topics: Acetic Acid; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Dantrolene;

2002
A new method of continuous maxillary nerve block with an indwelling catheter.
    Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2002, Volume: 94, Issue:2

    Topics: Adult; Aged; Analgesics, Non-Narcotic; Anesthesia, General; Anesthetics, Inhalation; Anesthetics, Lo

2002
Decrease in efficacy and potency of nonsteroidal anti-inflammatory drugs by chronic delta(9)-tetrahydrocannabinol administration.
    The Journal of pharmacology and experimental therapeutics, 2002, Volume: 303, Issue:1

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Arachidonic Acids; Aspirin; Camp

2002
Effect of resiniferatoxin on the noxious heat threshold temperature in the rat: a novel heat allodynia model sensitive to analgesics.
    British journal of pharmacology, 2003, Volume: 139, Issue:1

    Topics: Acetaminophen; Analgesics; Animals; Diclofenac; Diterpenes; Dose-Response Relationship, Drug; Female

2003
[Measurement of postoperative pain: analysis of the sensitivity of various self-evaluation instruments].
    Revista espanola de anestesiologia y reanimacion, 2003, Volume: 50, Issue:5

    Topics: Adult; Aged; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Female; Humans

2003
The antinociceptive effect of iontophoretic direct application of diclofenac to arthritic knee-joints of rats.
    Life sciences, 2003, Aug-29, Volume: 73, Issue:15

    Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Diclofenac; D

2003
Antinociceptive synergy, additivity, and subadditivity with combinations of oral glucosamine plus nonopioid analgesics in mice.
    The Journal of pharmacology and experimental therapeutics, 2003, Volume: 307, Issue:2

    Topics: Acetaminophen; Administration, Oral; Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents, No

2003
Summaries for patients. Leeches to treat knee osteoarthritis.
    Annals of internal medicine, 2003, Nov-04, Volume: 139, Issue:9

    Topics: Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Humans; Knee

2003
Modulatory effect of cyclooxygenase inhibitors on sildenafil-induced antinociception.
    Pharmacology, 2003, Volume: 69, Issue:4

    Topics: Animals; Carrageenan; Cyclic GMP; Cyclooxygenase Inhibitors; Diclofenac; Drug Synergism; Enzyme Inhi

2003
Synthesis, analgesic, anti-inflammatory and antibacterial activities of some novel 2-methyl-3-substituted quinazolin-4-(3H)-ones.
    Biological & pharmaceutical bulletin, 2003, Volume: 26, Issue:12

    Topics: Administration, Oral; Analgesics; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Ster

2003
Anti-hyperalgesic activity of the cox-2 inhibitor lumiracoxib in a model of bone cancer pain in the rat.
    Pain, 2004, Volume: 107, Issue:1-2

    Topics: Analysis of Variance; Animals; Behavior, Animal; Bone Density; Bone Neoplasms; Cyclooxygenase 2; Cyc

2004
Synthesis and anti-inflammatory, analgesic, ulcerogenic and lipid peroxidation activities of some new 2-[(2,6-dichloroanilino) phenyl]acetic acid derivatives.
    European journal of medicinal chemistry, 2004, Volume: 39, Issue:6

    Topics: Acetates; Analgesics; Aniline Compounds; Animals; Anti-Inflammatory Agents, Non-Steroidal; Diclofena

2004
[Systematic pain treatment following Colles' fracture].
    Ugeskrift for laeger, 2004, May-24, Volume: 166, Issue:22

    Topics: Acetaminophen; Adolescent; Adult; Aged; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Ster

2004
[Transient osteoporosis of the hip in pregnancy: a report of three cases].
    Acta orthopaedica et traumatologica turcica, 2004, Volume: 38, Issue:3

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Bed Rest; Diagnosis, Differential; Diclofenac; Femal

2004
[Prostate biopsy -- less pain through diclofenac].
    Aktuelle Urologie, 2004, Volume: 35, Issue:5

    Topics: Administration, Rectal; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibiotic P

2004
[Rational therapy of urolithiasis in every-day practice].
    Deutsche medizinische Wochenschrift (1946), 2004, Oct-29, Volume: 129, Issue:44

    Topics: Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Colic; Cyclooxygenase Inhibitors; Deamino Argin

2004
Acid-induced pain and its modulation in humans.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2004, Dec-01, Volume: 24, Issue:48

    Topics: Acid Sensing Ion Channels; Administration, Cutaneous; Adult; Amiloride; Analgesics; Anti-Inflammator

2004
Synthesis, biological evaluation and kinetic studies of glyceride prodrugs of diclofenac.
    Indian journal of experimental biology, 2004, Volume: 42, Issue:11

    Topics: Acetic Acid; Analgesics; Animals; Anti-Inflammatory Agents; Carrageenan; Chromatography, High Pressu

2004
Efficacy and relevance of topical diclofenac for osteoarthritic pain.
    Archives of internal medicine, 2005, Mar-14, Volume: 165, Issue:5

    Topics: Administration, Topical; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Humans; Osteoarthritis

2005
Peripheral and spinal mechanisms of antinociceptive action of lumiracoxib.
    European journal of pharmacology, 2005, Apr-18, Volume: 513, Issue:1-2

    Topics: Analgesics; Animals; Apamin; Behavior, Animal; Charybdotoxin; Diclofenac; Dose-Response Relationship

2005
Diclofenac pretreatment for propofol.
    Anaesthesia and intensive care, 2005, Volume: 33, Issue:4

    Topics: Anesthetics, Intravenous; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Fentanyl; Humans; Mid

2005
Topical diclofenac for the treatment of eyeache in Miller-Fisher syndrome.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2006, Volume: 244, Issue:8

    Topics: Administration, Topical; Adult; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Eye Diseases; H

2006
Nonsteroidal anti-inflammatory drug use in ankylosing spondylitis--a population-based survey.
    Clinical rheumatology, 2006, Volume: 25, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cohort Studies;

2006
[Paracetamol has the same effect as non-steroidal anti-inflammatory agents in acute musculoskeletal injuries].
    Ugeskrift for laeger, 2006, May-15, Volume: 168, Issue:20

    Topics: Acetaminophen; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Humans

2006
Antiinflammatory and analgesic effects of Psidium guajava Linn. (Myrtaceae) leaf aqueous extract in rats and mice.
    Methods and findings in experimental and clinical pharmacology, 2006, Volume: 28, Issue:7

    Topics: Acetic Acid; Analgesics; Analgesics, Opioid; Animals; Anti-Inflammatory Agents; Diclofenac; Female;

2006
Antinociceptive effects of the aqueous extract of Brugmansia suaveolens flowers in mice.
    Biological research for nursing, 2007, Volume: 8, Issue:3

    Topics: Acetic Acid; Analgesics; Analysis of Variance; Animals; Diclofenac; Disease Models, Animal; Drug Eva

2007
Spontaneous nociceptive behaviour in female mice with Freund's complete adjuvant- and carrageenan-induced monoarthritis.
    Brain research, 2007, Apr-27, Volume: 1143

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Behavior, Animal; Carrage

2007
Oral administration of Ginkgo biloba extract, EGb-761 inhibits thermal hyperalgesia in rodent models of inflammatory and post-surgical pain.
    British journal of pharmacology, 2007, Volume: 151, Issue:2

    Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Diclofenac; Dis

2007
The local antinociceptive actions of nonsteroidal antiinflammatory drugs in the mouse radiant heat tail-flick test.
    Anesthesia and analgesia, 2007, Volume: 104, Issue:4

    Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diclofenac; Dipyrone; Disease

2007
Heat injury-induced drop of the noxious heat threshold measured with an increasing-temperature water bath: a novel rat thermal hyperalgesia model.
    European journal of pharmacology, 2007, Jun-14, Volume: 564, Issue:1-3

    Topics: Acetaminophen; Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Diclofenac; Dose-Response Rela

2007
[Painful ophthalmoplegia in children: Tolosa-Hunt syndrome or ophthalmoplegic migraine?].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2007, Volume: 14, Issue:8

    Topics: Adolescent; Adrenal Cortex Hormones; Child, Preschool; Diclofenac; Female; Humans; Male; Migraine Di

2007
Analgesic and antiinflammatory effects of mollic acid glucoside, a 1 alpha-hydroxycycloartenoid saponin extractive from Combretum molle R. Br. ex G. Don (Combretaceae) leaf.
    Phytotherapy research : PTR, 2008, Volume: 22, Issue:1

    Topics: Acetic Acid; Analgesics; Animals; Anti-Inflammatory Agents; Combretum; Diclofenac; Edema; Female; Hi

2008
Antinociceptive effect from Davilla elliptica hydroalcoholic extract.
    Journal of ethnopharmacology, 2007, Sep-05, Volume: 113, Issue:2

    Topics: Administration, Oral; Analgesics; Animals; Arginine; Behavior, Animal; Brazil; Cyclooxygenase Inhibi

2007
[Lumiracoxib--Prexigem].
    Journal de pharmacie de Belgique, 2007, Volume: 62, Issue:3

    Topics: Arthritis; Cyclooxygenase 2 Inhibitors; Diclofenac; Humans; Pain

2007
Control of pain during transrectal ultrasound-guided prostate biopsy: a prospective study comparing two methods.
    Urologia internationalis, 2007, Volume: 79, Issue:4

    Topics: Aged; Biopsy, Needle; Case-Control Studies; Diclofenac; Humans; Injections, Intramuscular; Lidocaine

2007
Etoricoxib: new drug. Avoid using cox-2 inhibitors for pain.
    Prescrire international, 2007, Volume: 16, Issue:92

    Topics: Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cardiovascular Diseases; Clinical

2007
A diclofenac patch (Flector) for pain.
    The Medical letter on drugs and therapeutics, 2008, Jan-14, Volume: 50, Issue:1277

    Topics: Administration, Cutaneous; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Drug Administration

2008
Diclofenac attenuates the regional effect of lambda-carrageenan on blood-brain barrier function and cytoarchitecture.
    The Journal of pharmacology and experimental therapeutics, 2008, Volume: 325, Issue:2

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood-Brain Barrier; Brain; Carrageenan; Cyclooxyg

2008
[Multicenter study on the use of injectable diclofenac in pain states: analysis of the clinical data on 1873 patients].
    La Clinica terapeutica, 1983, Sep-30, Volume: 106, Issue:6

    Topics: Adolescent; Adult; Aged; Diclofenac; Drug Evaluation; Drug Tolerance; Female; Humans; Injections, In

1983
Effect of etodolac on prostaglandin E2 biosynthesis, active oxygen generation and bradykinin formation.
    Prostaglandins, leukotrienes, and essential fatty acids, 1994, Volume: 51, Issue:6

    Topics: Animals; Aspirin; Bradykinin; Bromelains; Cartilage, Articular; Cell Line; Concanavalin A; Depressio

1994
[Muscle aches and biochemical changes following a ultra-marathon in the cold--modification by diclofenac].
    Schweizerische Zeitschrift fur Medizin und Traumatologie = Revue suisse pour medecine et traumatologie, 1994, Issue:2

    Topics: Adult; C-Reactive Protein; Cold Temperature; Creatine Kinase; Diclofenac; Female; Humans; Male; Midd

1994
Antinociceptive effects of non-steroidal anti-inflammatory drugs in a rat model of unilateral hindpaw inflammation.
    European journal of pharmacology, 1994, May-12, Volume: 257, Issue:1-2

    Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Dose-Response Relationship

1994
Suxamethonium-induced myalgia.
    British journal of anaesthesia, 1994, Volume: 73, Issue:1

    Topics: Diclofenac; Humans; Muscular Diseases; Pain; Succinylcholine

1994
NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions.
    General pharmacology, 1993, Volume: 24, Issue:1

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Carrageenan; Cyclooxygena

1993
Analgesia for ESWL.
    Anaesthesia and intensive care, 1993, Volume: 21, Issue:2

    Topics: Administration, Rectal; Analgesia; Diclofenac; Humans; Lithotripsy; Pain; Suppositories

1993
Impairment of renal function after treatment of a burn patient with diclofenac, a non-steroidal antiinflammatory drug.
    Burns : journal of the International Society for Burn Injuries, 1995, Volume: 21, Issue:6

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Burns; Diclofenac; Female; Humans; Pain; Renal Insuff

1995
Enhanced effects of co-administered dexamethasone and diclofenac on inflammatory pain processing and associated spinal c-Fos expression in the rat.
    Pain, 1996, Volume: 64, Issue:3

    Topics: Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Dexamethaso

1996
The course of pain and the restriction of mobility in patients with shoulder complaints in general practice.
    Rheumatology international, 1997, Volume: 16, Issue:6

    Topics: Adult; Age Factors; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Humans; Middle Aged; Pain;

1997
Diclofenac sodium for pain relief following laparoscopic sterilization.
    Tropical doctor, 1997, Volume: 27, Issue:2

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Double-Blind Method; Female; Humans; Laparoscop

1997
Effects of the combined oral administration of NSAIDs and dextromethorphan on behavioral symptoms indicative of arthritic pain in rats.
    Pain, 1996, Volume: 68, Issue:1

    Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Beh

1996
Reduction by antiinflammatory drugs of the response of corneal sensory nerve fibers to chemical irritation.
    Investigative ophthalmology & visual science, 1997, Volume: 38, Issue:10

    Topics: Acetic Acid; Analgesia; Animals; Anti-Inflammatory Agents, Non-Steroidal; Calcium Channel Blockers;

1997
[Clinical thinking and decision making in practice. A patient with flank pain and anuria].
    Nederlands tijdschrift voor geneeskunde, 1997, May-10, Volume: 141, Issue:19

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Anuria; Diclofenac; Humans; Kidney Pelvis; Male; Middle Age

1997
[Intramuscular injections of diclofenac].
    Deutsche medizinische Wochenschrift (1946), 1997, Sep-26, Volume: 122, Issue:39

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Humans; Injections, Intramuscular; Pain

1997
Comparative analgesic activity of nimesulide and diclofenac by intramuscular route: correlation with pharmacokinetic profile of nimesulide.
    Pharmacology, 1998, Volume: 56, Issue:3

    Topics: Acetic Acid; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Cycloox

1998
Topical diclofenac sodium in the management of anesthetic abuse keratopathy.
    American journal of ophthalmology, 1998, Volume: 125, Issue:5

    Topics: Administration, Topical; Adult; Anesthetics, Local; Anti-Inflammatory Agents, Non-Steroidal; Corneal

1998
Differential effect of selective cyclooxygenase-2 (COX-2) inhibitor NS 398 and diclofenac on formalin-induced nociception in the rat.
    Neuroscience letters, 1998, May-22, Volume: 248, Issue:1

    Topics: Animals; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diclofenac; Dose-

1998
Antinociceptive effect of meloxicam, in neurogenic and inflammatory nociceptive models in mice.
    Inflammation research : official journal of the European Histamine Research Society ... [et al.], 1998, Volume: 47, Issue:7

    Topics: Abdominal Muscles; Acetic Acid; Analgesics; Analgesics, Opioid; Animals; Capsaicin; Cyclooxygenase I

1998
On the analgesic effect of sodium diclofenac in pain-induced functional impairment in the rat.
    Proceedings of the Western Pharmacology Society, 1998, Volume: 41

    Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Caffeine; Diclofenac; Dose-Response Re

1998
Analgesia for termination of pregnancy.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1999, Volume: 89, Issue:8

    Topics: Abortion, Induced; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Female; Humans; Ketorolac; P

1999
[Symptomatic triangular bone. A case report].
    Revue de chirurgie orthopedique et reparatrice de l'appareil moteur, 1999, Volume: 85, Issue:5

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Carpal Bones; Diclofenac; Humans; Immobilization; Ma

1999
Analgesia in soft-tissue injury: current practice in Auckland is not supported by the available evidence.
    The New Zealand medical journal, 1999, Oct-08, Volume: 112, Issue:1097

    Topics: Acetaminophen; Adult; Analgesia; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal;

1999
Glutamate and kynurenate in the rat central nervous system following treatments with tail ischaemia or diclofenac.
    The Journal of pharmacy and pharmacology, 2000, Volume: 52, Issue:1

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Central Nervous System; Chromatography, High Press

2000
Pharmacological and immunohistochemical characterization of a mouse model of acute herpetic pain.
    Japanese journal of pharmacology, 2000, Volume: 83, Issue:4

    Topics: Acetates; Amines; Amitriptyline; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants;

2000
Effect of dexamethasone plus vitamin B complex in the PIFIR model.
    Proceedings of the Western Pharmacology Society, 2000, Volume: 43

    Topics: Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Dexamethasone; Diclofena

2000
Sildenafil increases diclofenac antinociception in the formalin test.
    European journal of pharmacology, 2001, Apr-27, Volume: 418, Issue:3

    Topics: Analgesics; Animals; Cyclooxygenase Inhibitors; Diclofenac; Dose-Response Relationship, Drug; Drug S

2001
Non-steroidal hip arthropathy: case histories and differential diagnosis.
    Hospital medicine (London, England : 1998), 2001, Volume: 62, Issue:5

    Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Diagnosis, Differential; Diclofena

2001
Participation of COX, IL-1 beta and TNF alpha in formalin-induced inflammatory pain.
    Proceedings of the Western Pharmacology Society, 2001, Volume: 44

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Blocking; Celecoxib; Cyclooxygenase In

2001
Central antinociceptive-analgesic effect of diclofenac.
    Pain, 2002, Volume: 95, Issue:3

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Humans; Nociceptors; Pain

2002
Pharmacological evidence for the activation of K(+) channels by diclofenac.
    European journal of pharmacology, 2002, Mar-01, Volume: 438, Issue:1-2

    Topics: 4-Aminopyridine; Analgesics; Analgesics, Opioid; Animals; Anti-Inflammatory Agents, Non-Steroidal; A

2002
Neostigmine interactions with non steroidal anti-inflammatory drugs.
    British journal of pharmacology, 2002, Volume: 135, Issue:7

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cholinesterase Inhibitors; Diclofenac; Disease Mod

2002
Comparison of the antinociceptive effect of celecoxib, diclofenac and resveratrol in the formalin test.
    Life sciences, 2002, Feb-22, Volume: 70, Issue:14

    Topics: Analgesia; Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Celecoxib; Cyclooxyge

2002
Antinociceptive, anti-inflammatory and acute toxicity effects of Zhumeria majdae extracts in mice and rats.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2002, Volume: 9, Issue:2

    Topics: Acetic Acid; Analgesics; Analgesics, Opioid; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Ag

2002
Patient and physician satisfaction with aceclofenac: results of the European Observational Cohort Study (experience with aceclofenac for inflammatory pain in daily practice). Aceclofenac is the treatment of choice for patients and physicians in the manage
    Current medical research and opinion, 2002, Volume: 18, Issue:3

    Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Cohort Studies; Diclofenac;

2002
[Study of the anti-inflammatory and analgesic actions of diclofenac in traumatology and orthopedic surgery].
    Revue medicale de Liege, 1977, Jan-01, Volume: 32, Issue:1

    Topics: Adult; Analgesics; Anti-Inflammatory Agents; Diclofenac; Female; Humans; Inflammation; Male; Middle

1977
Localization of the central antinociceptive effects of diclofenac in the rat.
    Brain research, 1992, Sep-11, Volume: 590, Issue:1-2

    Topics: Animals; Brain; Diclofenac; Disease Models, Animal; Male; Microinjections; Pain; Periaqueductal Gray

1992
Diclofenac does not modify morphine bioavailability in cancer patients.
    Pain, 1992, Volume: 48, Issue:3

    Topics: Aged; Biological Availability; Chromatography, High Pressure Liquid; Diclofenac; Drug Interactions;

1992
Muscle damage with diclofenac injections.
    Anaesthesia, 1992, Volume: 47, Issue:5

    Topics: Diclofenac; Humans; Muscles; Pain

1992
Morphine intoxication during acute reversible renal insufficiency.
    Journal of palliative care, 1992,Summer, Volume: 8, Issue:2

    Topics: Acute Kidney Injury; Aged; Bone Neoplasms; Diclofenac; Drug Therapy, Combination; Humans; Male; Morp

1992
Pharmacological properties of five diclofenac metabolites identified in human plasma.
    Agents and actions, 1991, Volume: 34, Issue:1-2

    Topics: Animals; Arthritis, Experimental; Diclofenac; Dinoprostone; Edema; Humans; In Vitro Techniques; Macr

1991
Clinical experiences in the treatment of pain in rheumatology.
    The Clinical journal of pain, 1991, Volume: 7 Suppl 1

    Topics: Adult; Aged; Diclofenac; Female; Humans; Indomethacin; Male; Meclofenamic Acid; Middle Aged; Oxyphen

1991
Pharmacology of the potent new non-steroidal anti-inflammatory agent aceclofenac.
    Arzneimittel-Forschung, 1991, Volume: 41, Issue:12

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Benzoquinones; Capillary

1991
Morphine intoxication during acute reversible renal insufficiency.
    Journal of palliative care, 1991,Winter, Volume: 7, Issue:4

    Topics: Acute Kidney Injury; Aged; Bone Neoplasms; Diclofenac; Humans; Male; Morphine; Pain; Poisoning; Pros

1991
Acquired Brown's syndrome in systemic lupus erythematosus: another ocular manifestation.
    Clinical rheumatology, 1990, Volume: 9, Issue:3

    Topics: Adult; Diclofenac; Diplopia; Fever; Humans; Hydroxychloroquine; Ibuprofen; Lupus Erythematosus, Syst

1990
Pharmacology of diclofenac sodium.
    The American journal of medicine, 1986, Apr-28, Volume: 80, Issue:4B

    Topics: Analgesics; Animals; Arachidonic Acid; Arachidonic Acids; Cyclooxygenase Inhibitors; Diclofenac; Dos

1986
Behavioural and electrophysiological evidence for an analgesic effect of a non-steroidal anti-inflammatory agent, sodium diclofenac.
    Pain, 1988, Volume: 35, Issue:3

    Topics: Action Potentials; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Diclofenac; Dose-Res

1988
[Combination therapy of transcutaneous electric nerve stimulation and iontophoresis with benzydamine and diclofenac].
    Arzneimittel-Forschung, 1988, Volume: 38, Issue:6

    Topics: Benzydamine; Body Temperature; Combined Modality Therapy; Diclofenac; Electric Stimulation Therapy;

1988
A new metabolite of diclofenac sodium in human plasma.
    Xenobiotica; the fate of foreign compounds in biological systems, 1988, Volume: 18, Issue:10

    Topics: Adult; Animals; Biotransformation; Cattle; Chemical Phenomena; Chemistry; Diclofenac; Gas Chromatogr

1988
[Efficacy of diclofenac continuous perfusion in hyperalgic bone metastases. Apropos of 20 cases treated at Gustave Roussy Institute].
    Bulletin du cancer, 1988, Volume: 75, Issue:6

    Topics: Adult; Aged; Bone Neoplasms; Diclofenac; Female; Humans; Infusions, Intravenous; Male; Middle Aged;

1988
Differentiation of peripheral and central effects of analgesic drugs.
    International journal of tissue reactions, 1985, Volume: 7, Issue:1

    Topics: Acetaminophen; Analgesics; Animals; Aspirin; Diclofenac; Male; Morphine; Pain; Rabbits; Reflex

1985
Diclofenac sodium in the treatment of rheumatoid arthritis and osteoarthritis.
    Seminars in arthritis and rheumatism, 1985, Volume: 15, Issue:2 Suppl 1

    Topics: Arthritis, Rheumatoid; Aspirin; Diclofenac; Double-Blind Method; Female; Humans; Ibuprofen; Male; Mi

1985
Diclofenac in the treatment of painful joints and traumatic tendinitis (including strains and sprains): a brief review.
    Seminars in arthritis and rheumatism, 1985, Volume: 15, Issue:2 Suppl 1

    Topics: Diclofenac; Flufenamic Acid; Humans; Ibuprofen; Indomethacin; Joint Diseases; Ketoprofen; Naproxen;

1985